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ABSTRACT 
 
In recent years, mental illness in pregnant and postpartum women has become a public health 
concern. Untreated and undertreated maternal mental illness has a significant negative impact on 
not only the mother, but also on the baby and family. Further, many women do not seek help or 
access mental health care due to stigma surrounding mental illness, the unrealistic social 
expectations of motherhood, and the fear of being judged or rejected. An interpretive descriptive 
study informed by a feminist perspective was conducted with six postpartum women who sought 
maternal mental health care services. Semi-structured interviews provided an opportunity to 
explore women’s experiences of having a maternal mental illness, accessing care, and the role of 
stigma. Analysis focused on the bio-psycho-social dimensions of their experiences. A shared 
experience and meaning emerged: self stigma and expectations of motherhood, stigma and 
infertility, factors influencing self stigma, level of self-efficacy, and treatment satisfaction, 
engagement and outcome. Findings are discussed with reference to the current literature on 
maternal mental illness, stigma, and infertility. Findings are conceptualized using Brown’s 
(2006) Shame Resilience Theory, implications for practice are presented including women’s 
advice to other women, and recommendations for future research are made. 
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CHAPTER 1: INTRODUCTION 
 
I came to this project when I applied for a funded position (Saskatchewan Health 
Research Foundation) as a graduate student to conduct a qualitative inquiry of maternal mental 
health as a Master’s thesis. My interest in researching women’s mental health issues began with 
my first introduction to women and gender studies; hence, this position provided the opportunity 
to continue my interest and research in this area. Due to my personal experience with maternal 
mental illness, this project was particularly meaningful for me, especially in view of meeting the 
needs of pregnant and postpartum women struggling with mental illness in my community. 
However, it was not until I read the scientific research for this study that I pondered the impact 
of having increasingly severe antenatal anxiety and depression during and after each of my four 
pregnancies, on myself, my children and my family. Consequently, I believe in the importance 
and the value of having health care that targets and supports the needs of women with maternal 
mental health problems by providing better access to mental health care services and promoting 
educational opportunities for health care providers. I also recognize the limitations of a 
biomedical model and the importance of identifying and addressing psycho-social factors and 
issues of stigmatization when helping women with mental health problems, and including their 
families when providing mental health care services, information/education, and support.  
Maternal Mental Health   
In recent years, mental illness in pregnant and postpartum women has become a public 
health concern. Mental health problems, such as anxiety and depression, are twice as likely to 
affect women than men (Parikh, Lam, & CANMAT Depression Work Group, 2006). Depression 
is one of the greatest causes of worldwide maternal mental illness in women of childbearing age 
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- approximately 15 to 44 years- and the “contribution to the Global Burden of Disease (GBD) is 
7% of the total (GBD) for women of all ages” (World Health Organization, 2008).  Postpartum 
depression (PPD) occurring within the first year after delivery, affects 10% to 25% of women 
globally (Brockington, 2004; Gold, 2002; Marcus, 2009; McCarthy & McMahon, 2008). 
Although PPD is most often associated with maternal mental illness, other indications of mental 
illness are important to consider. Prevalence rates for antepartum depression (during pregnancy) 
in different populations of women, range from 4 to 57% (Bennett, Einarson, Taddio, Koren, & 
Einarson, 2004; Bowen, Bowen, Butt, Rahman, & Muhajarine, 2012; Marcus, 2009).  Further, 
depression and anxiety, during and after pregnancy, have been found to occur simultaneously (up 
to 33%) in mothers with mental illness (Austin et al., 2010; Britton, 2005). Hence, the 
importance of considering not only depressive symptoms, but also anxiety symptoms when 
pregnant and postpartum women seek help from their health care providers. Moreover, pre-
existing mental illness increases the risk of developing maternal mental illness during and/or 
after pregnancy (Austin, Tully, & Parker, 2007; Bandelow et al., 2006; Gold, 2002).  
Research indicates that women with prolonged and/or undertreated maternal mental 
illness are: at an increased risk of complications during pregnancy; more likely to have adverse 
neonatal outcomes; less likely to breastfeed; may have problems with infant-mother attachment; 
at risk for chronicity and severity of maternal mental illness; and more likely to have problems 
with self care, sleep, and substance abuse (Bonari et al., 2004; Bowen et al., 2012; Da Costa et 
al., 2010; Marcus, 2009; Seto, Cornelius, Goldschmidt, Morimoto, & Day, 2005).  In addition, 
there is an increased likelihood for children of anxious and depressed mothers to have 
psychopathology, developmental problems, difficulty with feeding and sleeping, and they may 
have more emotional and behavioural problems than children of non-depressed mothers 
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(Bellingham-Young & Adamson-Macedo, 2003; Marcus, 2009; Talge, Neal, & Glover, 2007).  
Hence, there is a growing need for ensuring optimal mental health for women during their 
reproductive years by providing adequate maternal mental health care to enhance the well-being 
of mothers and their families, which would further facilitate healthy child development 
(Muhajarine, 1999).  
Prolonged or undertreated maternal mental illness has deleterious effects not only on the 
mother and baby, but also on the spouse placing undue strain on relationships and family 
functioning. For instance, depression ranged from 24% to 50% among men whose spouse had 
PPD (Goodman, 2004). Indeed, the lack of detection and treatment of maternal mental illness has 
devastating and long-lasting ramifications for the mother, the baby and the family unit, and the 
community-at-large.  
Although research indicates the frequency and potential negative effects of maternal 
mental health are an increasing concern, symptoms of depression and anxiety in pregnant and 
postpartum women are often overlooked by women and their primary care providers (Cohen & 
Nonacs, 2005; Gold, 2002; Marcus, 2009). There is controversy surrounding the use of 
psychotropic medication in pregnant and postpartum women, despite readily available evidence-
based information regarding the efficacy and safety of certain medications (Einarson, 2009a; 
Wisner, Applebaum, Uhl, & Goldkind, 2009). Further, when health care providers use 
psychotropic medication to treat women with mental illness, they are more likely to be overly 
cautious and to undertreat pregnant women (Einarson, 2009b; Yonkers et al., 2009).   
The treatment of maternal mental illness has been predominately based on a biomedical 
model that focuses on psycho-pharmaceutical interventions. According to Tufano (2000), the 
biomedical model concerns itself with:  
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…the disease processes and pathology associated with disorders or illness. The focus of 
the biomedical model is to alleviate symptoms and find cures based on scientific 
evidence from research. Treatment is given in a medically prescriptive manner and 
designed to improve the malfunctioning physical component of disease and disorders. 
The biomedical model provides an objective and structured way to deliver health care, a 
necessary and effective mission. Therefore, with the context of its very definition and 
core, the biomedical model focuses on the physical entities of disability rather than the 
psychosocial impact of a disability (p. 113). 
Research indicates that pregnant and postpartum women with mental health problems 
often receive inadequate mental health care, and/or do not seek help due to: a lack of personal 
insight and awareness of symptoms; stigma and a fear of being judged; a lack of knowledge of 
PPD; denying and minimizing their symptoms; a lack of and /or limited access to mental health 
care services; and under-diagnosis by health care providers who may minimize or discount 
women’s symptoms of emotional distress (Dennis & Chung-Lee, 2006; Marcus, 2009; Pinto-
Foltz & Logsdon, 2008). Consequently, several qualitative researchers have suggested the 
importance of exploring women’s subjective experiences of living with maternal mental illness 
and identifying various help-seeking barriers/facilitators experienced by pregnant and 
postpartum women. This approach would expand existing knowledge beyond the biomedical 
model and enhance a deeper understanding of women’s experiences of maternal mental illness 
and its psycho-social dimensions so that health care professionals can provide effective treatment 
and support (Dennis & Chung-Lee, 2006; McCarthy & McMahon, 2008; Pinto-Foltz & Logsdon, 
2008; Wardrop & Popadiuk, 2013). Therefore, the primary goal of this study was to explore 
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women’s lived experience of maternal mental illness and accessing care within their socio-
cultural context. 
One of the greatest barriers to seeking care for and managing maternal mental illness is 
the stigma surrounding it (Ahmed, Stewart, Teng, Wahoush, & Gagnon, 2008; Corrigan & 
Wassell, 2008; Dennis & Chung-Lee, 2006; Halter, 2004; Kenny, 2001; Tognazzini, Davis, 
Kean, Osbourne, & Wong, 2008). Stigma is a social construction which has various nuances and 
is experienced within a socio-cultural milieu. The social stigma associated with mental illness 
represents socially-held and collectively-agreed-upon values, beliefs, and misconceptions which 
serve to characterize, categorize, and label individuals with mental illness (Corrigan & Wassell, 
2008, p.43).  When people agree and apply social misconceptions to individuals with mental 
illness, these stereotypes often lead to prejudice and discrimination, which is referred to as 
enacted stigma (Corrigan & Wassell, 2008; Green, Hayes, Dickinson, Whittaker, & Gilheany, 
2003).  Self  stigma occurs when an individual identifies and internalizes the negative stereotypes 
of mental illness which may result in self-devaluation and a struggle with positive self-esteem 
and a lack of self-efficacy (Corrigan, Larson, & Rusch, 2009). Consequently, people may avoid 
seeking help and accessing mental health care because of the fear of being labeled with a mental 
illness and the fear of being judged, rejected or seen as less than, which is referred to as 
perceived stigma (Corrigan et al., 2009; Green et al., 2003). The experiences and implications of 
social and self stigma are multi-faceted and complex, especially for women struggling with 
maternal mental health concerns. 
The stigma associated with maternal mental illness is inextricably linked to the socio-
cultural context within which a woman finds herself and which serves to define what it means to 
be a woman and a mother (Arendell, 2000; Choi, Henshaw, Baker, & Tree, 2005; Koniak-
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Griffin, Logsdon, Hines-Martin, & Turner, 2006). For feminist researchers and scholars, 
women’s lives and experiences are embedded in society’s notion of motherhood which is 
considered compulsory, natural, and normal for all women and in society’s unrealistic 
expectations of joyful mothering as easy, wonderful, ultimately fulfilling and the peak of a 
woman’s achievement (Koniak-Griffin et al., 2006; Woollett & Boyle, 2000). These socio-
cultural standards then become the measuring stick by which a mother gauges her own 
experience. Pregnant and postpartum women struggling with mental illness may internalize a 
sense of being a bad and/or unfit mother, or being perceived as being a less-than-perfect mother 
which often results in a fear of disclosure (Dennis & Chung-Lee, 2006; McCarthy & McMahon, 
2008; Pinto-Foltz & Logsdon, 2008). Researchers found that pregnant and postpartum women 
under-reported distressing symptoms because they feared having their children apprehended if 
they revealed the level of emotional and mental distress and feared being labelled unfit if they 
admitted being unable to manage their symptoms and cope with the demands of mothering 
(Dennis & Chung-Lee, 2006; McCarthy & McMahon, 2008; Pinto-Foltz & Logsdon, 2008).  
Further, women have reported experiences of stigmatization in their interactions with health care 
providers, and/or their perception of dismissive attitudes, as another major deterrent in seeking 
help and accessing mental health care (Ahmed et al., 2008; Dennis & Chung-Lee, 2006; Pinto-
Foltz & Logsdon, 2008).  
Qualitative health researchers endorse further exploration of women’s subjective 
experience of stigma to increase awareness, understanding and sensitivity surrounding the 
negative impact of stigma and how it may hinder women’s disclosure and treatment engagement 
(Koniak-Griffin et al., 2006; Pinto-Foltz & Logsdon, 2008). A feminist approach to women’s 
experience of stigma and maternal mental illness, both in theory and practice, is appropriate. For 
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example, according to relational-cultural theory (Miller & Stiver, 1997), all disconnections in 
growth-fostering relationships occur within specific socio-cultural contexts and are the source of 
psychological problems.  Some feminist researchers have used a feminist, social constructionist 
approach when seeking to better understand women’s experience of maternal mental illness as 
embedded within and influenced by the socio-cultural discourses of reproduction, motherhood 
and mothering (Arendell, 2000; Choi et al., 2005; Cosgrove, 2000; Mauthner, 1998). “This 
paradigm affords a means for looking at, and taking seriously, interactions, interpretive 
processes, social context, and importantly, relationships” (Arendell, 2000, p. 12) when exploring 
women’s experience of stigma associated with maternal mental illness. 
Several strategies have emerged to decrease the effects of stigma in order to improve 
help-seeking willingness and access to appropriate mental health services such as: a) providing 
education and training opportunities for health care providers to increase the knowledge about 
maternal mental illness and treatment options; b) providing accurate information to women and 
their families to enhance treatment engagement; c) increasing direct client-provider contact, 
interactions, and experience promoting familiarity with people with mental illness; d) and 
promoting a collaborative approach in providing mental health care services (Corrigan & 
Wassell, 2008; Kates et al., 2011; Marcus, 2009; Rockman, Salach, Gotlib, Cord, & Turner, 
2004).  
The study’s purpose was to explore and describe women’s subjective experience of 
maternal mental illness, accessing mental health care services, and the role stigma had in their 
experience.  Analysis focused attention on the bio-psycho-social dimensions of their experience. 
According to Tufano (2000): 
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Within the biopsychosocial model, a client is understood from a variety of influential 
components that include the biological origins of disease as well as the social 
implications for one’s environment and interpersonal experiences. From this approach, a 
vital concern for health care professionals is to recognize and clarify how family and 
societal attitudes contribute to one’s disability, and how these perceptions affect both the 
physical and emotional course of recovery for clients within the rehabilitation process (p. 
113).  
The Present Study 
 A qualitative investigation of women’s experience of maternal mental health and 
accessing care was undertaken in order to hear women’s voices and explore their lived 
experiences. The research design was an interpretive descriptive study (Thorne, 2008) informed 
by a feminist perspective (McCormick & Bunting, 2002). Semi-structured interviews with six 
postpartum women provided an opportunity to explore women’s experiences of having a 
maternal mental illness, the role of stigma, and accessing mental health care. Analysis focused 
on the bio-psycho-social dimensions of their experiences with the intent of increasing 
understanding about the complexities of a clinically relevant human phenomena, and generating 
new insights. By gaining contextual understanding of patients’ health experience, knowledge is 
expanded in ways intended to guide and enhance clinical practice and health outcomes.  
Organization of Thesis 
The thesis is organized as follows. Chapter 2 presents a review of the existing literature 
within three areas of interest: a) maternal mental illness in terms of incidence, prevalence, risks, 
psycho-social factors, and barriers and facilitators to treatment; b) stigmatization of maternal 
mental illness in terms of social and self stigma associated with mental illness, the social 
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construction of motherhood, the impact of stigma on help-seeking and disclosure; and c) 
accessing mental health care. Chapter 3 focuses on the study’s qualitative methodology, 
specifically interpretive description (Thorne, 2008) within health care research. In Chapter 4, 
findings are presented describing and exploring the similarities, differences, and shared 
meanings of women’s lived experience of maternal mental illness, stigma, and accessing mental 
health care services. Further, unique findings and the interconnections between the bio-psycho-
social dimensions of their experiences are described as well as participants’ recommendations for 
mental health care and advice for other mothers with mental illness. Chapter 5 includes a 
discussion of findings integrated into the existing literature, conceptualization of findings using 
Brown’s (2006) Shame Resilience Theory, strengths and limitations of the research, implications 
for clinical/counselling practice, and suggestions for future research. 
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CHAPTER 2: LITERATURE REVIEW 
 
The following chapter provides an overview of the research literature regarding maternal 
mental illness in women of childbearing years, various aspects of the stigma associated with 
maternal mental illness, the social construction of motherhood, and accessing mental health 
services. The literature reviewed has been organized into four sections: a) maternal mental 
illness; b) the stigmatization of maternal mental illness; and c) efforts to reduce stigma.  
Maternal Mental Illness    
 Mental illness in pregnant and postpartum women has become a public health concern 
which has gained attention in recent years. Several risk factors for developing maternal mental 
illness and various psycho-social stressors that influence its incidence and prevalence are 
identified in the literature, as well as the potential harmful impact of maternal mental illness on 
the mother, child and family unit. The use, efficacy, and safety of certain psychotropic 
medication and level of treatment engagement are other topics reported in the literature.  
Incidence, prevalence, and risk factors. Depression is one of the greatest causes of 
worldwide maternal mental illness in women of childbearing age - approximately 15 to 44 years 
of age (World Health Organization, 2008). In Canada, up to seven percent of all women are 
affected by depression, with lifetime prevalence of 12.3%, which is increasingly becoming a 
major public health concern (Marcus, 2009). Recent estimates of the initial onset of depression 
during pregnancy range from 1.6% and 5.7% during the postpartum period; women with a 
history of depression have a two-fold risk of developing a major depression in the perinatal 
period (Banti et al., 2011), that is, occurring either during pregnancy or within the first 12 
months after delivery (Gavin et al., 2005).  
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Maternal mental illness is most commonly associated with postpartum depression (PPD). 
Indeed, there is a substantial body of research literature on PPD, in comparison to other maternal 
mental illnesses, occurring during antepartum and/or postpartum periods. Other variants of 
maternal mental illness include: antepartum depression, antepartum and/or postpartum anxiety, 
and postpartum psychosis; however, these are often represented using the umbrella term of 
postpartum depression (Brockington, 2004; Marrs, Durette, Ferraro, & Cross, 2009). Some 
authors suggest that PPD represents a constellation of symptoms of which depression is the most 
recognized (Marrs et al., 2009). Psychological distress, an emotional disturbance that affects day-
to-day living and social functioning, is associated with symptoms of anxiety and depression 
(Drapeau, Marchand, & Beaulieu-Prevost, 2012; Payton, 2009), which “becomes a medical 
concern when it is accompanied by other symptoms that, when added together, satisfy the 
diagnostic criteria for a psychiatric disorder” (Drapeau et al., 2012, p. 106). For the purpose of 
this study, the term maternal mental illness will be used to represent the variants of diagnosis of 
psycho-pathology in pregnant and postpartum women previously mentioned.  
Postpartum depression refers to a major depressive disorder occurring after giving birth, 
which affects between 10 to 25% of women worldwide, within the first postpartum year 
(Brockington, 2004; Gold, 2002; Marcus, 2009; McCarthy & McMahon, 2008). Women who 
have previously experienced PPD have a 50% higher risk of recurrent episodes following 
subsequent pregnancies (Gold, 2002; Marcus, 2009). When PPD goes untreated, it may lead to 
the rarest and most severe form of maternal psychiatric illness, postpartum psychosis, which can 
affect 0.1 to 0.2% of women with maternal mental illness (Brockington, 2004; Marcus, 2009). 
Puerperal or maternal psychosis refers to a form of mania, severe depression with delusions, 
confusion, stupor, or acute polymorphic psychosis (Brockington, 2004). Women with psychosis 
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often experience distressing symptoms of hallucinations, delusions, confusion, are frequently 
hospitalized, and may pose a safety risk to themselves and their children, if left untreated. 
Approximately 50 to 70% of women, who have a history of psychosis with a previous 
pregnancy, have a higher risk of developing another psychotic episode following subsequent 
pregnancies (Marcus, 2009).  
Antepartum depression, depression during pregnancy, impacts up to 20% of women in a 
primary health care setting, and 29.3% for socially high-risk (i.e., living in poverty) women 
(Bowen, Stewart, Baetz, & Muhajarine, 2009).  Some authors suggest that prevalence rates for 
antepartum depression range from 4 to 57%, in different populations of pregnant women 
(Bennett et al., 2004; Marcus, 2009); however, other researchers indicate that prevalence rates 
vary significantly based on screening tools used, diagnostic criteria, and time of screening 
(Marcus, 2009). Bowen et al. (2012) found prevalence of depression during the first trimester at 
14.1%, also 21% of women who were depressed early in their pregnancy, and 27% who were 
depressed in late pregnancy, continued to be depressed in postpartum (Bowen et al., 2012).  
Researchers have shown that for 50% of patients being seen in primary care settings for 
mental health issues, anxiety and depression occurred simultaneously (Matthey, Barnett, Howie, 
& Kavanagh, 2003). Recent studies indicate co-morbidity between anxiety and depression is 
more common than previously thought (Austin et al., 2010; Bowen, Bowen, Maslany, & 
Muhajarine, 2008; Wardrop & Popadiuk, 2013; Yelland, Sutherland, & Brown, 2010). High 
levels of co-morbidity between anxiety and depression (up to 33%) have been identified in 
mothers with mental illness (Austin et al, 2010; Britton, 2005), which certainly highlights the 
importance of recognition and treatment of both issues when women present with maternal 
mental and emotional distress.  
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Maternal anxiety is usually examined in the context of women already reporting 
depressive symptoms (Wenzel, Haugen, Jackson, & Brendle, 2005). There is less research 
literature focusing on maternal anxiety which occurs during and/or after pregnancy (Britton, 
2005; Ross & McLean, 2006). However, some researchers suggest that maternal anxiety is 
common and problematic for many women. Wenzel et al. (2005) reported prevalence rates of 
Generalized Anxiety Disorder to be as high as 8.2% in postpartum women. Symptoms of 
antenatal or postnatal anxiety may not be recognized or addressed in pregnant and postpartum 
women and may remain untreated/undertreated as a result (Bandelow et al., 2006; Britton, 2005; 
Wardrop & Popadiuk, 2013). Britton and colleagues found that 24.9% of women had a moderate 
amount of pre-discharge anxiety and 1% had severe anxiety (Britton, 2005). Matthey et al. 
(2003) asserted that when conceptualization of poor psychological adjustment includes anxiety, 
prevalence rates of maternal psychiatric illness increase significantly. Treating anxiety during 
pregnancy may prevent the development of PPD in some women (Austin et al., 2007). Some 
researchers found that the postpartum period seemed to increase the risk for the onset and/or the 
exacerbation of panic symptoms in women (Bandelow et al., 2006). Women who reported  stress 
during pregnancy had a higher risk of panic symptoms (Bandelow et al., 2006). 
Anxiety disorders are the most prevalent psychiatric disorders, affecting about 16% of 
Canadian women, with up to 30% lifetime prevalence (Health Canada, 2002). Anxiety disorders 
in women commonly occur in their mid-20s (Pigott, 2003). Pre-existing anxiety/panic disorders 
often persist or worsen with pregnancy (Bandelow et al., 2006; Gold, 2002). Women who 
experience prenatal anxiety are three times more likely to report severe PPD symptoms, 
compared to women without anxiety (Austin et al., 2007; Bowen et al., 2008). Further, a history 
of an anxiety disorder appears to be associated with a greater risk for developing postpartum 
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anxiety and/or depression, than does a history of a depressive disorder (Matthey et al., 2003). In 
addition, a history of depression and mood fluctuations may increase the risk for developing 
anxiety (Bowen  et al., 2008). Anxiety might also increase because psychosocial stressors play a 
significant etiological role in the development of anxiety, for those who have a vulnerability 
(Wenzel, Haugen, Jackson, & Robinson, 2003). For instance, Bowen and colleagues (2008) 
found that anxiety symptoms may be more predominant than depressive symptoms in socially 
high-risk pregnant women; and younger pregnant women may be at a higher risk for developing 
anxiety than older ones.  
It is also important to consider pre-existing mental illness, such as bipolar disorder, when 
dealing with women’s mental health during and after pregnancy. Bipolar disorder affects 1-2% 
of the population, and often occurs in women during childbearing years, making them extremely 
vulnerable during the postpartum period, with a rate of relapse estimated at 33-50% (Gold, 
2002).  
Some authors claim that few screening assessment instruments are sensitive enough to 
indicate or differentiate between maternal mental illnesses (Matthey, 2008; Wardrop & 
Popadiuk, 2013). Despite the evidence of anxiety and depression co-morbidity in maternal 
mental illness, there is less research and inconsistent protocols regarding anxiety screening; as 
well, there are few tools sensitive enough to assess for various forms of anxiety (Wardrop & 
Popadiuk, 2013). However, some researchers found that anxiety symptoms in pregnant and 
postpartum women were detected using the Edinburgh Postnatal Depression Scale (EPDS) as a 
multi-factorial screening tool to measure maternal anxiety (Austin et al., 2007; Bowen et al., 
2008).  
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Several bio-psycho-social risk factors are associated with the development of maternal 
mental illness: personal or family history of affective disorders; prior history of PPD or 
postpartum psychosis; lack of social support; single marital status; lower socio-economic status; 
poor health functioning; unplanned pregnancy; relationships issues; stressful life events during or 
near the time of delivery; substance abuse; and a difficult pregnancy (Gold, 2002; Kalra & 
Einarson, 2006; Marcus, 2009).  
Bio-psycho-social factors of maternal mental illness. Women who suffer from 
prolonged and/or undertreated maternal mental illness are less likely to breastfeed and have an 
increased risk of biological/biomedical complications during pregnancy such as: spontaneous 
abortion and pre-eclampsia, higher rates of surgical deliveries, and epidural use (Bonari et al., 
2004; Marcus, 2009). Furthermore, it is more likely that newborns of women with significant 
maternal mental illness will experience negative outcomes such as: preterm birth, increased 
admission to the neonatal intensive care unit, lower birth weight; decreased Apgar scores, 
smaller head circumference, feeding and sleep problems, and lower gestational age (Marcus, 
2009).   
Several psycho-social factors and untreated or severe maternal mental illness have 
profound bio-psycho-social effects, not only on the new mother and baby, but also on her partner 
and other relationships. Children of mothers who experienced depression and anxiety, during or 
after pregnancy, often exhibit difficulties with psychological adjustment and development such 
as: negative emotional, social and cognitive development, delayed language and intellectual 
abilities, insecure attachment, and have psychopathological difficulties, such as Attention-Deficit 
Hyperactivity Disorder (ADHD), autism, schizophrenia, and affective disorders (Gold, 2002; 
Marcus, 2009; Talge, Neal, & Glover, 2007). The incidence of paternal depression during the 
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first postpartum year ranged from 1.2% to 25.5% in community samples, and from 24% to 50% 
among men whose spouse had PPD (Goodman, 2004). The strongest predictor of depression in 
fathers during postpartum was the presence of PPD in their spouse (Goodman, 2004). Untreated 
PPD also increases a mother’s risk for ongoing maternal mental illness, which often results in 
poor mother-child interactions affecting the child’s attachment, temperament, and 
behavioural/cognitive development (Da Costa, Dritsa, Rippen, Lowensteyn, & Khalifa, 2006; 
Gold, 2002). Furthermore, failure to address maternal mental illness leaves women more 
vulnerable to chronic depression greatly impacting a mother’s opportunity for recovery and 
wellness, which may interfere with her ability to mother, often with the added challenge of 
parenting a child with emotional/behavioral difficulties (Matthey et al., 2003; Seto et al., 2005). 
Chronicity of maternal mental illness has a significant negative impact on a woman’s quality of 
life, physical and emotional well-being, social interactions, self-care and sleep quality (Bowen et 
al., 2012; Da Costa et al., 2006; Seto et al., 2005). Indeed, the lack of detection and treatment of 
maternal mental illness has devastating and long-lasting bio-psycho-social implications for the 
mother, the baby, and the family unit.  
Treatment of maternal mental illness. Many people in our society believe that pregnant 
women should not take any medication (Einarson, 2009b). There is controversy surrounding 
pharmacological treatment for pregnant and postpartum women (Einarson, 2009b, 2010; Wisner 
et al., 2009), but also limited research on alternative options for treating maternal mental illness. 
Although research indicates the frequency and potential negative effects of maternal mental 
illness are an increasing concern, symptoms of anxiety and depression in pregnant and 
postpartum women are often overlooked by primary health care providers as well as the women 
themselves (Cohen & Nonacs, 2005; Gold, 2002; Marcus, 2009). However, for a woman who is 
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anxious and/or depressed taking medication may be necessary to alleviate distressing symptoms 
and circumvent negative effects on herself and her baby. Some researchers estimate 3% to 13% 
of pregnant women take psychotropic medication during pregnancy (Bowen et al., 2012; Cooper, 
Willy, Pont, & Ray, 2007; Wisner et al., 2009). Several antidepressants have demonstrated safety 
for use during pregnancy with rates of major malformations in the fetus at 2.5% in pregnancies, 
and within the rate of spontaneous risk in the general population at 1% to 3% (Einarson, Choi, 
Einarson, & Koren, 2009).   
Cohen et al. (2006) found a 68% risk of relapse among pregnant women who discontinue 
existing antidepressant treatment. Although evidence-based information regarding the efficacy 
and safety of using certain antidepressants during or after pregnancy is readily available, 
researchers found that there was a tendency among health care providers to be overly cautious 
and to under-treat pregnant women (Cohen et al., 2006; Einarson, 2009b). It is important to 
weigh the risks and benefits to both mother and baby when using psychotropic medication to 
treat maternal mental illness. The mother’s previous history of mental illness, present 
functioning, and risk for developing more severe symptoms need to be considered (Einarson et 
al., 2009; Yonkers et al., 2009).  
 Diagnosis and treatment engagement. Diagnosis and treatment engagement are 
important topics because untreated or undertreated maternal mental illness increases the risk of 
unfavourable pregnancy outcomes for the mother and child (Marcus, 2009). Treatment 
engagement is understood as taking psychotropic medication as prescribed and tends to increase 
when women are screened by their health care provider and informed about their depressive state 
(Marcus, 2009). Mothers are reluctant to disclose feelings of emotional and mental distress 
without having the question asked first by their physician (Dennis & Chung-Lee, 2006). 
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According to Pinto-Foltz and Logsdon (2008), few postpartum women receive treatment despite 
screening and referrals. According to several researchers, pregnant and postpartum women with 
mental health problems often do not seek and/or receive adequate mental health care due to the 
following: a lack of personal insight and awareness of symptoms; a lack of knowledge of PPD; 
denying or minimizing their feelings of distress; a lack of and/or limited access to mental health 
care services; and the under-diagnosis by health care providers who tend to minimize and may 
not recognize women’s depressive symptoms (Dennis & Chung-Lee, 2006; Gold, 2002; Marcus, 
2009; Pinto-Foltz & Logsdon, 2008; Sobey, 2002).  Further, the controversy surrounding the use 
of psychotropic medication in pregnant and postpartum women contributes to high anxiety levels 
not only among women, but also their health care providers (Einarson, 2010).  
Some women might decide not to seek care or fully participate in care as a means of 
avoiding the label associated with a diagnosis of mental illness - label avoidance (Corrigan, 
2004). However, for some women, a diagnosis provides a sense of relief and reassurance because 
they perceive it as confirming a medically recognized problem, rather than being a result of  
personal defect or inadequacy, which releases them from self blame and responsibility (Edwards 
& Timmons, 2005; Mauthner, 1998). Feeling stigmatized was part of the women’s experience of 
reaching out for help for maternal mental illness (McCarthy & McMahon, 2008). Qualitative 
research on the lived experience of women suffering with and seeking care for maternal mental 
health problems revealed several help-seeking barriers: lack of knowledge of PPD and/or lack of 
insight and awareness of symptoms; aspects of stigma associated with maternal mental illness; 
feelings of shame and being a bad mother; and a fear of disclosing (Dennis & Chung-Lee, 2006; 
Edwards & Timmons, 2005; McCarthy & McMahon, 2008; Pinto-Foltz & Logsdon, 2008).  
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Stigmatization of Maternal Mental Illness 
Stigma is ubiquitous, multidimensional, and embedded in a socio-cultural context; it is 
experienced in all cultures and encountered in various stages of life (Hinshaw & Stier, 2008; 
Pinto-Foltz & Logsdon, 2008). Each society defines what is normal and socially acceptable, or 
unacceptable, and open to stigmatization (Goffman, 1963; Pinto-Foltz & Logsdon, 2008).  
Stigma is a social construction which refers to a mark, flaw, or spoiled identity resulting from a 
personal characteristic or attribute, viewed as socially undesirable, and perceived as deviant, 
different, defective, and to be discounted  (Goffman, 1963; Stuenkel & Wong, 2009). Stigma 
experienced externally, social/public stigma, is associated with socially-held and collectively 
agreed upon beliefs and preconceptions which become stereotypes that serve to characterize, 
categorize, and label the stigmatized person or group (Corrigan & Wassell, 2008; Corrigan & 
Watson, 2007; Kenny, 2001).  Prejudice occurs when one agrees with existing stereotypes 
(stereotype agreement) and applies it to an individual (stereotype application), which results in a 
negative evaluation and may lead to discrimination (Corrigan & Wassell, 2008). Discrimination 
refers to a behavioural reaction and the unfair evaluation and treatment from others, as a result of 
prejudice (Corrigan & Wassell, 2008); this is also referred to as enacted stigma (Green et al., 
2003; Stuenkel & Wong, 2009).  
Internal stigma, or self stigma, refers to the effects of identifying with and internalizing 
negative social stereotypes and misconceptions which impact individuals both cognitively and 
behaviourally (Corrigan & Wassell, 2008; Kenny, 2001). Identification involves not only the 
awareness of existing negative stereotypes, but also indicates an element of agreement with these 
negative misconceptions and then applying these to one’s self; internalization involves the 
integration of social attitudes, beliefs, and expectations into one’s sense of self (Goffman, 1963). 
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Consequently, individuals may experience self stigma as a self-devaluation, a loss of self-esteem 
and self-efficacy and will often struggle with a positive self-concept (Corrigan et al., 2009) as 
they may internalize feelings of shame and being a bad mother (Dennis & Chung-Lee, 2006; 
Edwards & Timmons, 2005; McCarthy & McMahon, 2008; Pinto-Foltz & Logsdon, 2008). Self-
efficacy is a person’s belief and confidence in their own ability to manage various life situations  
(Bandura, 1977, 1994). Decreased self-esteem and self-efficacy may result in a why try response 
which is an unwillingness to engage in various aspects of life, or to seek help and access 
appropriate care, in order to avoid the negative impact of stigma (Corrigan et al., 2009). Further, 
perceived stigma, which refers to an individual’s internalized perception of being devalued, 
judged, or rejected by others, brings about feelings of shame, embarrassment, and fear of being 
labelled and treated differently (felt stigma), even though the stigmatized characteristic/attribute 
is not known or apparent (Green et al., 2003); that is, “individuals view themselves as 
discreditable” (Stuenkel & Wong, 2009). Self stigma is often associated with negative emotional 
reactions, such as shame, anger, fear, anxiety, low self-esteem and low self-efficacy (Corrigan, 
Watson, & Barr, 2006), self-blame, guilt, remorse, and feelings of being self-indulgent (Kenny, 
2001).  However, just because people are aware of the stigma of mental illness does not 
necessarily mean that they will internalize it and suffer a decrease in self-esteem and self-
efficacy (Corrigan et al., 2006).  
Stigma of mental illness. Stigma has many nuances, exists as a matter of degree, and has 
deeply embedded historical/cultural roots, such as the stigma surrounding mental illness. 
Because of prevailing societal beliefs, people living with mental illness are viewed through a 
discriminatory and prejudicial lens. The stigma of mental illness refers to “a collection of 
negative attitudes, beliefs, thoughts, and behaviors that influence the individual, or the general 
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public, to fear, reject, avoid, be prejudiced, and discriminated against people with mental 
disorders” (Gary, 2005, p. 980). According to Kenny (2001), the term mental illness has been 
linked to descriptors which serve as labels, such as crazy or mad, and linked to negative 
stereotypes and misconceptions of people with mental illness as being dangerous, unpredictable, 
unreliable, unlikeable, incompetent, and bizarre; hence they are to be feared. People with mental 
illness are viewed as more blameworthy than those with physical conditions; are often perceived 
as being in control of their illness, responsible for causing it, or having brought it upon 
themselves; and viewed as a manifestation of unacceptable behaviour or immoral character, or as 
having a poor prognosis (Corrigan & Watson, 2007). 
Corrigan and Wassell (2008) described mental illness as a double-edged sword since 
people not only experience disabling symptoms and emotional distress, but also personal 
demoralization, as a result of stigma. Stigma of mental illness is the result of ignorance and 
misunderstanding surrounding the origin, symptoms, nature and presentation of psychiatric 
illness (Kenny, 2001). Many individuals with mental illness do not seek mental health care to 
avoid being diagnosed with a psychiatric illness, and being marked with the label crazy or mad, 
and thus, escaping the negative effects of social and self stigma (Corrigan & Wassell, 2008). 
This label avoidance is manifested as concern about being stigmatized, judged, misunderstood, 
and rejected, that is, perceived stigma (Corrigan & Wassell, 2008; Kenny, 2001).  
Research indicates that self stigma is the main obstacle that prevents many women living 
with mental illness from seeking help and having a chance for recovery as they often have 
feelings of embarrassment and shame and fear being judged (Corrigan & Wassell, 2008; 
Edwards & Timmons, 2005; Halter, 2004; Kenny, 2001; Tognazzini et al., 2008).  “The harsh 
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reality is that [people with mental illness] suffer in silence and their lives reflect the invisible 
pain and suffering that stigma causes” (Tognazzini et al., 2008. p. 30). 
Social construction of motherhood. Pregnant and postpartum women living with mental 
illness are not only affected by symptoms of psychological and emotional distress, and by the 
effects associated with the stigmatization of mental illness, but they are also embedded in 
society’s notions of motherhood, and what it means to be a woman with a reproductive body. 
The stigma associated with maternal mental illness reflects a deeper, more entrenched social 
zeitgeist, a very gender-specific one which defines what it means to be a woman, and a mother. 
Motherhood is a construct that is culturally defined within social, economic and historical 
contexts (Francis-Connolly, 2000; Nicolson, 1999; Woollett & Boyle, 2000). Woollett and Boyle 
(2000) described the social construction of motherhood: 
Motherhood is constituted as compulsory, normal and natural for women, for their adult 
identities and personal development, and is regulated through binary oppositions in which 
the warm, caring and ‘good’ mother is contrasted with ‘bad’ mothers, selfish, childless, 
and career women, and empty and deficient infertile women (p. 309). 
The idealized view of good mother has roots in the 19th century and remains the social 
measuring stick by which many mothers gauge their real-life experiences (Koniak-Griffin et al., 
2006; Nicolson, 1999).  At an early age, acceptable social gender norms are learned and often 
fostered in the family system, hence, it is almost impossible to remain uninfluenced by the social 
scripts dictating what it means to be a woman, mother, and wife. Women’s gender identity is 
reinforced by the social and traditional preconceptions of motherhood and the onerous 
expectations of joyful mothering (Arendell, 2000; Koniak-Griffin et al., 2006). Indeed, our 
society endorses self-identification with negative conceptions of mental illness through the use of 
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language and the media (Wahl, 2003). Media, in various forms, is the major source of 
information on health and illness for most people, and thus plays an important role in shaping 
attitudes and beliefs, for better or worse; however, it also serves to maintain and perpetuate the 
negative stereotypes and images of maternal mental illness.  
Adrienne Rich’s classic feminist research (1986/1997) described the image of good 
mother as a woman whose sole identity is motherhood. Mothering is considered as the ultimate 
fulfillment and the essence of womanliness and femininity (Arendell, 2000; Koniak-Griffin et 
al., 2006). This is in contrast to the stereotype of the bad mother which entails the notion that 
good women (i.e., normal) do not show aggression, rage, hostility, anger, violence, or short 
tempers (Chrisler & Johnston-Robledo, 2002) which translates into mothers should be happy, 
calm, content, and grateful. 
Historically, scientific and biomedical discourses have informed the traditional, social, 
and biological conception of motherhood as women’s primary function views women as 
essentially a set of reproductive organs with a body, helped perpetuate the myths of motherhood 
and mothering as being an easy, natural, normal and wonderful experience, the peak of women’s 
achievements, the greatest joy in a woman’s life, and the only reason for their existence 
(Cosgrove, 2000; Koniak-Griffin et al., 2006; Nicolson, 1999). Moreover, the notion of maternal 
instinct implies that all women naturally desire and give birth to children, that they will know 
how and want to care for them, which leaves little room for individual differences amongst 
women’s experience of motherhood and mothering within their socio-cultural context (Choi et 
al., 2005; Nicolson, 1999). Intensive mothering was a term coined to describe the dominant 
expectations of Western mothers as the ideal and preferred caregivers for children and devoted to 
the care of others, self-sacrificing, without needs and interests, and the good mother (Arendell, 
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2000). Furthermore, in today’s Western society, cultural representations of womanhood has 
expanded to include the notion that today’s woman can do it all, have it all, and manage it all - a 
superwoman or supermom who is able to cope with the numerous competing demands of family 
and work (Choi et al., 2005; Francis-Connolly, 2000) and doing it all with a smile.  
Unfortunately, the reality of motherhood is very different from the myth. The notions of 
the perfect mother who does not need help to cope and manage mothering have possible 
deleterious effects on women suffering from maternal mental health problems. Asking for help 
or feeling unable to cope is difficult because of an underlying belief that mothers should be 
happy and able to cope without help, which creates dissonance between reality and actuality 
(Choi et al., 2005; Nicolson, 1999). Maternal ambivalence is grounded in this paradoxical nature 
of the experience of mothering as being both positive and negative (Arendell, 2000). 
Ambivalence refers to a pervasive state of existence encompassing cognitive, behavioral and 
emotional being (Leichtentritt, Blumenthal, Elyassi, & Rotmensch, 2005). Several researchers 
identified ambivalence as an over-arching theme in some women’s experience of  maternal 
mental health problems (Leichtentritt et al., 2005; McKillop, 2009). The ambivalence was found 
between their experience and feelings of women with mental health problems and their 
perception of the social expectations and the myth of motherhood. Mother blaming refers to a 
type of enacted and/or felt stigma which blames the mother for undesirable outcomes (e.g., 
children with emotional/behavioural problems or birth/physical defects)  independent of her 
choices which make mothers with mental illness subject to prejudice, discrimination, and 
discredit from others (Koniak-Griffin et al., 2006). Subsequently, the self stigma associated with 
being a woman with a mental illness is inextricably linked to her socio-cultural milieu.  
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Stigma of maternal mental illness. According to Pinto-Foltz and Logsdon (2008), 
several characteristics are related to self stigma associated with maternal mental illness such as: 
an unpleasant personal experience; self-identification; permanency; a perceived unfavourable 
attitude from others; label attachment; feeling of being discredited by others for being viewed as 
deviant and inferior to the norm; and discrimination by others when attempting to assume a 
normative role. The internalized sense of being a bad and/or unfit mother, or being perceived by 
others as being a less-than-perfect mother, exemplifies a deeper and more pernicious 
stigmatization associated with being a woman with a mental illness and her ability to mother.  
The depth of self stigma depends on the degree of identification and internalization of negative 
social stigma associated with maternal mental illness and unrealistic expectations of motherhood 
which undermine a sense of self-esteem, and thus self-efficacy (Corrigan et al., 2009).  
Self-identification with negative stereotypes of mental illness and cultural myths 
surrounding motherhood can result in feelings of inadequacy and negative self-evaluation, which 
in turn, result in the fear of disclosure. Under-reporting of distressing symptoms is common as 
women do not want to be perceived as bad mothers and fear having children apprehended were 
they to reveal the level of their emotional distress and admit being unable to manage their 
symptoms of mental illness and cope with the demands of mothering (Dennis & Chung-Lee, 
2006; Edwards & Timmons, 2005; Einarson, 2009b; Marcus, 2009; McCarthy & McMahon, 
2008).   
Seeking care. Fear of disclosure due to self stigma and perceived stigma is recognized as 
the main barrier for women seeking help for maternal mental illness (Dennis & Chung-Lee, 
2006; Edwards & Timmons, 2005; Einarson, 2009b; Marcus, 2009; McCarthy & McMahon, 
2008). Some authors found disclosure to be related to perceived stigma, perceived social support 
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and self-esteem (Bos, Kanner, Muris, Janssen, & Mayer, 2009). A qualitative systematic review 
conducted by Dennis and Chung-Lee (2006) found women’s rationales for lack of disclosure 
were diverse and included reasons such as: thinking that they could or were expected to cope 
with depression; not wanting to be burdensome; giving their family a bad name and risking being 
seen as responsible for problems in the family; fear of having children taken away; and to avoid 
shame, perceived and enacted stigma and fear of being labelled mentally ill.  
Pinto-Foltz and Logsdon (2008) found the amount of perceived control a person has over 
their condition was highly correlated with stigmatization. People were less likely to experience 
self stigma when they believed they were in control of their lives and their treatment (Corrigan & 
Wassell, 2008). Self disclosure is a means of managing information about personal failings that 
may be subject to stigma: that is, having control by deciding “to display or not to display; to tell 
or not to tell; to let on or not to let on; to lie or not to lie; and in each case, to whom, how, when, 
and where” (Goffman, 1963, p. 42). Disclosure of mental health status, which is coming out to 
others, may benefit some people who selectively disclose (Bos et al., 2009; Corrigan & Wassel, 
2008).  Selective disclosure is when a person with mental illness decides to let only some people 
know about their mental illness (Corrigan & Wassell, 2008). On the other hand, coming out may 
lead to disapproval from others, which may lead to social avoidance (Corrigan et al., 2009).   
As a way to avoid the deleterious effects of stigma, some people choose secrecy - 
withholding information and not letting anyone know about their mental health history (Corrigan 
& Wassell, 2008). Others will attempt to pass as normal; passing refers to a type of covering 
which involves an effort to restrict or conceal any display that may identify the stigma (Goffman, 
1963; Corrigan et al., 2009).  However, secrecy and passing can have a psychological cost in that 
there always remains a fear of discovery (Goffman, 1963). The lack of disclosure of distressing 
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symptoms of mental illness greatly impinges on a woman’s ability to access and receive the 
appropriate level of mental health care.  
Stigma and health care providers. Another deterrent to seeking care for maternal 
mental illness can be negative interactions with health care providers. Studies indicate that health 
care professionals and students, such as doctors, pharmacists, and nurses, may hold stigmatizing 
views towards women with maternal mental illness, despite having training expected to enhance 
acceptance of patients with mental health (Gawley, Einarson, & Bowen, 2011; Thornicroft, 
Rose, & Kassam, 2007; Tognazzini et al., 2008). According to Pinto-Foltz and Logsdon (2008):  
Stigma is poorly understood and often remains unrecognized by nurses [and other health 
care providers] within themselves and others. Unrecognized stigma is a barrier to 
understanding patient behavior and providing individualized emphatic care (p. 22).  
New mothers have reported various experiences of stigmatization when seeking help for mental 
illness problems and hesitancy about mental health services (Ahmed et al., 2008; Dennis & 
Chung-Lee, 2006; Edwards & Timmons, 2005; McCarthy & McMahon, 2008; Pinto-Foltz & 
Logsdon, 2008). Women reported feeling stigmatized by attitudes of some health care providers 
who minimized or were reluctant to respond to their emotional and practical needs and concerns, 
which impacted access to mental health services and the level of care received (Ahmed et al., 
2008; Dennis & Chung-Lee, 2006; Edwards & Timmons, 2005).   
Additional health care barriers to seeking help for maternal mental illness include: 
inappropriate or lack of assessment; insufficient training and lack of knowledge about PPD and 
treatment safety; perceived dismissive attitudes of health care providers; tendency to minimize or 
overlook symptoms of maternal psychological distress; having insufficient time during 
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consultation; tendency to prescribe medication, rather than talk, to alleviate symptoms 
reinforcing feelings of women inadequacy; as well as fearing implied weakness or perceived 
failure (Dennis & Chung-Lee, 2006; McCarthy & McMahon, 2008).  
Educational opportunities to promote more knowledge, familiarity and understanding of 
maternal mental illness are needed to circumvent the stigma of mental illness (Corrigan & 
Wassell, 2008; Rockman et al., 2004; Schulze, 2007; Thornicroft et al., 2007; Tognazzini et al., 
2008). In particular, researchers suggest that more needs to be done to educate health care 
professionals and students about the symptoms, treatment and consequences of maternal mental 
health on mother, baby and family; to increase awareness, understanding, and sensitivity of the 
negative impact of stigmatization; and to understand how self stigma and perceived stigma 
hinders women’s disclosure and treatment engagement (Koniak-Griffin et al., 2006; Thornicroft 
et al., 2007; Tognazzini et al., 2008).  
Efforts to Reduce the Stigma of Maternal Mental Illness 
Education and contact. Researchers suggest three strategies to decrease the effects of 
stigma in order to improve help-seeking willingness and access to appropriate mental health care 
services: protest, education, and contact (Corrigan & Wassell, 2008).  Protest is a reactive 
strategy that aims to diminish the negative attitudes about mental illness by promoting more 
positive attitudes supported by facts (Corrigan & Wassell, 2008). Education challenges social 
misconceptions about mental illness by providing accurate information to those living with 
mental illness, their families, and their health care providers (Corrigan & Wassell, 2008). 
Providing education to women and their families to better inform them about maternal mental 
illness, treatment options, and the risks/signs of PPD is recognized as a major help-seeking 
facilitator (Cohen & Nonacs, 2005; Dennis & Chung-Lee, 2006). People with more years of 
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education are likely to have more knowledge about and/or experience with mental illness, which 
in turn leads to less stigmatization (Arvaniti et al., 2009; Corrigan & Watson, 2007). Continued 
education within the health care system is needed to promote positive messages and accurate 
information about people with mental illness and to increase awareness of and sensitivity to the 
impact of stigma (Corrigan & Watson, 2007; Kenny, 2001). Health care providers need to keep 
abreast of current research to be knowledgeable about maternal mental illness, its treatment, and 
the role stigma plays in women’s experience of seeking help (Dennis & Chung-Lee, 2006; 
Koniak-Griffin et al., 2006). 
Contact or familiarity refers to knowledge of and experience with mental illness, which 
has the best impact of the three strategies to reduce stigma (Corrigan & Watson, 2007). Open 
interactions with people with mental illness during training allow health care providers to learn 
about patients’ lived experience and gain insight into how illness and stigma impacts their life 
(Tognazzini et al., 2008). Familiarity with people with mental illness coupled with small 
amounts of targeted education was more effective in lowering stigma than contact alone 
(Corrigan & Wassell, 2008; Corrigan & Watson, 2007). Health care providers should also strive 
to be aware of their own perceptions of mothers with mental health concerns and how these 
might contribute to stigmatization (Kenny, 2001; Koniak-Griffin et al., 2006).  
Researchers have highlighted the importance of a collaborative approach between 
primary health care providers and mental health professionals to provide mental health care to 
women living with mental illness, has been shown to decrease stigma, increase client and health 
care provider satisfaction, and decrease use of traditional mental health services (Bowen et al., 
2008; Kates et al., 2011; Rockman et al., 2004). Primary health care refers to basic health care 
programs and services and signifies an individual’s first contact with the health care system, 
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usually with family physicians (Bowen et al., 2008; Canadian Collaborative Mental Health 
Initiative, 2006; Rockman et al., 2004). Research indicates that women with maternal mental 
illness are more likely to seek help from primary health care providers than mental health 
professionals (Gold, 2002). Women with mental illness report less stigma when accessing mental 
health care in a primary care setting; and their children with emotional/behavioural problems 
were four times as likely to be identified and treated (Weissman et al., 2004). Further, rates of 
treatment engagement increase modestly when women were screened by their health care 
provider and informed that their depression/psychological status was indicative of maternal 
mental illness (Marcus, 2009). 
Some authors found that family physicians with access to a collaborative mental health  
care report greater knowledge, better skills, more comfort in managing psychiatric disorders, and 
greater satisfaction with mental health services (Kisely, Duerden, Shaddick, & Jayabarathan, 
2006). Researchers identify the need for mental health care programs based on the shared care 
model which incorporate opportunities for educating health care professionals, are meant to 
improve women`s access to psychiatric care and consultation, and promote collaboration, 
consultation, and respect amongst primary care providers and psychiatrists (Bowen et al., 2008; 
Kates et al., 2011; Rockman et al., 2004). The key elements of collaborative partnership between 
health care providers entail: effective communication, consultation, coordination, co-location, 
and integration (Kates et al., 2011).  
Summary 
Mental illness in pregnant and postpartum women has become a growing public health 
concern. Prolonged and/or under treatment has bio-psycho-social effects/implications for mother, 
baby and family yet pregnant and postpartum women with mental health problems often receive 
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inadequate mental health care and/or do not seek help. Listening to women’s voices and 
exploring their lived experiences of accessing maternal mental health care and stigmatization 
adds to the current literature, which is primarily biomedical in nature and uses quantitative 
research methods. Thus a qualitative inquiry was undertaken informed by the following research 
question: What are women’s lived experiences of maternal mental illness, stigma and accessing 
mental health care? 
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CHAPTER 3: METHODOLOGY 
 
This chapter presents a description of and a rationale for using a qualitative health research 
approach within a feminist framework. The research method, interpretive description (Thorne, 
2008), is described and the research design logic is presented by situating the study and the 
researcher. Procedures for recruitment, data generation, and data analysis are presented. Lastly, 
evaluation criteria and ethical considerations are discussed.  
Qualitative Inquiry 
Qualitative inquiry encompasses a wide range of philosophical/epistemological positions, 
methodological approaches, and analytical processes. However, all qualitative inquiries seek to 
understand the meaning that individuals construct from their own lived experiences and social 
interactions, which cannot be quantified, measured, or de-contextualized (Denzin & Lincoln, 
2000; Kearney, 2001). This interpretive and naturalistic approach is based on the following 
characteristics: validating subjectivity; acknowledging multiple realities; expanding knowledge 
through discovery, description, and understanding; collaborating with participants; being 
embedded in a context; and exploring with an emergent flexible design, using inductive analysis 
(Denzin & Lincoln, 2000; Kearney, 2001; Thorne, 2008).  
Qualitative health research. In order to improve patients’ quality of care and enhance 
health care practice, clinical health researchers often quest for knowledge that can be applied to 
real people living with complex and difficult health problems (Kearney, 2001; Thorne, 2008).  
Qualitative health researchers seek to explore and understand complexities and generate new 
insights about the experience of clinically relevant human phenomena (Thorne, 2008). Applied 
qualitative health research is concerned with investigating questions from the field to gain 
sufficient contextual understanding of patients’ health experience in order to apply expanded 
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knowledge in ways that could guide and enhance clinical practice (Thorne, 2008; Thorne, 
Reimer Kirkham, & MacDonald-Emes, 1997).  In this way, new insights could offer clinicians a 
set of possibilities for clinical exploration, increase awareness of problems to watch out for, and 
deepen sensitivity to and understanding of patients’ illness experience, behaviours, and choices 
(Kearney, 2001; Thorne, 2008).  
Interpretive Description 
The research method for this study, interpretive description (Thorne, 2008), was 
particularly suited to applied clinical health research using the subjective experiential knowledge 
of women living with maternal mental illness, stigma and accessing mental health care services. 
Thorne (2008) differentiated interpretive description from other qualitative inquiry, in that it 
provides a reasoned approach to knowledge development in the applied health care field, with 
the purpose of expanding capacity for understanding implications of phenomena in clinical 
practice, and to better informing care of the unique and distinct individual. This approach allows 
applied qualitative health researchers the flexibility to deconstruct the lens of previous 
knowledge, provide an alternate perspective, generate new insights and new questions, and apply 
evidence to clinical practice (Thorne, 2008).  
Several of the defining features of interpretive description were particularly well-suited to 
for the design of this study. Interpretive description: a) provided a coherent methodological 
framework within which a fairly wide range of options could be used for research design and 
implementation, data collection and analysis; b) considered knowledge as socially constructed 
and acknowledged multiple perspectives; c) accounted for the impact of cultural and social 
forces; d) sought to articulate themes, associations, and patterns of experience, action and 
expression; and e) interpretations were illuminated through inductive analysis of descriptive data 
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provided by participants who share their subjective experiences about a clinical phenomenon 
(Thorne, 2008). Further, these features make this approach conducive to a feminist analysis of 
women’s experience of maternal mental illness, stigma, and accessing care.    
Using an interpretive descriptive approach for this research allowed the capture of not only 
the complexity and uniqueness of individual women’s experience of maternal mental illness, 
stigma, and accessing mental health care, but also allowed the intricacies and interconnections 
between bio-psycho-social dimensions of experience to explored.  
Research Design  
     According to Thorne (2008), different kinds of knowledge are derived from different 
approaches and what we seek to understand ought to guide methodological selection. The 
rationale for and the quality of the research endeavour using interpretive description, depends 
upon the match between: first, the knowledge sought, the research question, and the 
methodological approach; and second, how this research design logic matches the researcher’s 
disciplinary orientation, epistemological stance and theoretical lens, background knowledge of 
the phenomena, and personal experience (Thorne, 2008). Hence, the importance of two critical 
elements in an interpretive description research design: a) situating the study based on an  
literature review which determines what is currently known about the phenomenon being 
studied, what methods were used to gain that knowledge, and what kinds of understandings were 
derived; and b) situating the researcher within a theoretical framework which takes into 
consideration the researcher’s disciplinary orientation, epistemological standpoint, and 
background knowledge of the phenomenon being studied (Thorne, 2008). 
Situating the study. The review of the literature revealed the significant and far-reaching 
implications of untreated/undertreated maternal mental illness on mothers, their children, and the 
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family unit. Further, researchers found many women often receive inadequate mental health care 
and/or do not seek help for various reasons (discussed in Chapter 2). One of the greatest barriers 
to seeking care was the stigma associated with it. The present study’s goal was to uncover new 
knowledge about this particular population of women using a feminist lens to better understand 
the “subjective, experiential, tacit, and patterned aspects” (Thorne, 2008, p. 36) of their 
experience of maternal mental illness, stigma, and accessing mental health care services. Using 
interpretive description was well suited to an exploration of women’s experience and illuminated 
aspects of care that the women identified as influencing their treatment engagement/satisfaction 
and health outcomes.  
Feminist research. A feminist framework was used in this study to explore women’s 
experience of maternal mental illness in their private/personal life and within their socio-cultural 
context as women’s subjective experiences are both defined and shaped by their networks of 
relationships and interconnections (Cosgrove, 2000; Mauthner, 1998; Thorne & Varcoe, 1998). 
As such, stigma and maternal mental illness can be understood as a gendered issue that requires a 
feminist approach, both in theory and practice. The goal of feminist research is to capture, 
explore, and understand women’s experiences from the vantage point of a particular group of 
women (Campbell & Bunting, 1991). McCormick and Bunting (2002) summarized the common 
characteristics of feminist research:  
a) valuing of women and attaching validity to their experiences, ideas, and 
needs; 
b) recognition of the conditions that oppress women; 
c) desire to bring about social change through criticisms and political action; 
d) women and issues of gender are the central concern;  
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e) research questions and answers are for the benefit of some groups of women 
rather than simply about women; 
f) women’s current and historical context relevant to the research variables (e.g., 
reproduction, political implications) are recognized; 
g) there is an emphasis on subjectivity and women’s context of experiences; 
h) there is a collegiality and mutual dialogue between different levels of the 
research team and between the researchers and the participant women; 
i) interactions are non-hierarchical in nature and structure; 
j) reflexivity, the self-questioning of the researchers’ assumptions and biases, is 
ongoing; 
k) flexible open boundaries are honored;  
l) there is a recognition that bias is impossible to eliminate completely (p. 822). 
Feminist researchers have illuminated the importance of using a feminist, social 
constructionist approach when exploring and seeking to better understand women’s experience 
of maternal mental illness embedded and influenced by the socio-cultural discourses of 
motherhood and mothering (Arendell, 2000; Choi et al., 2005; Cosgrove, 2000; Mauthner, 1998). 
Further, feminist researchers/theorists such as Miller and Stiver (1997) understand that all 
disconnections in growth-fostering relationships occur within specific socio-cultural contexts and 
are the source of psychological problems, as in relational-cultural theory. Uncovering and 
deconstructing the meaning of living with maternal mental illness requires an interpretive 
understanding that seeks to discover patterns, relationships, and associations within the unique 
experiences being described (Kearney, 2001; Thorne, 2008).  
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Situating the researcher. Thorne (2008) explained the importance of revealing one’s 
disciplinary background, epistemological stance, theoretical understandings of the phenomenon, 
and personal experience as a way to lend integrity and clarity of purpose to the research process. 
The researcher is the instrument by which data are collected, analyzed, categorized, described, 
and interpreted. Hence, it is important for the reader to be informed about the researcher’s 
intellectual positioning and theoretical orientations, as well as for the researcher to minimize any 
unintended impact on the research.  
My diverse undergraduate and graduate academic background has led to a multi-
disciplinary orientation that encompasses the health sciences and clinical healthcare practice, 
philosophy and feminist studies, as well as counselling psychology. Having a health science 
background has provided me with an understanding of the biomedical model of health and 
illness, which helps me appreciate the knowledge gained by medical research and its application 
to clinical practice. I also believe that scientific and biomedical discourses have had a great 
influence on socio-cultural discourses. Consequently, I ascribe to a more holistic view of health 
and wellness that encompasses a bio-psycho-social model within a socio-cultural context. As a 
result, I consider knowledge development not only to benefit from quantitative inquiry, but also 
consider qualitative inquiry to be necessary to expand existing knowledge, adding depth and 
understanding of subjective, experiential, and socially constructed human experiences. 
My epistemological stance and theoretical lens are founded on a relational-cultural 
ontology and a feminist, social constructionist view of knowledge development. Hence, the 
meaning we make of experiences is constructed through historical/cultural influences and social 
practices, processes, and institutions, as well as through interactions and encounters with people, 
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culture, and the media. That is, reality is neither fixed nor measurable, but rather composed of 
multiple realities, constructions, and interpretations that fluctuate with time and place.  
My research interest in women’s issues, specifically mental health and wellness, began 
with my introduction to feminist studies. Being a feminist has influenced my epistemology, 
methodology, worldview, praxis and psycho-therapeutic approach, and my way of being-in-the-
world. My feminist and therapeutic orientation is based on a relational and empowerment 
approach. As a feminist researcher, I take into consideration historical influences and the socio-
political landscape in which women find themselves and how these factors influence their 
experience of mental health, stigma, and seeking help, in addition to the impact of the psycho-
social aspects and implications. I believe that the personal is political and that in order to further 
understanding women’s experiences, women’s stories need to be explored, and women’s voices 
need to be heard. I also realize that my early research interest in women’s mental health and 
wellness stemmed from my desire to better understand my own experience.  
Due to my experience and personal struggles with maternal mental health problems, I feel 
strongly about bringing deeper awareness and understanding of maternal mental illness, and the 
impact stigma has on women’s self-perception and everyday life. Through my studies and 
research, I began to understand motherhood on many different levels and to see that being a 
woman/mother with mental illness was a gendered issue, socially constructed and influenced by 
history, culture, and context, and that the many bio-psycho-social factors are often ignored in a 
biomedical system. I became curious about what it means to be a woman with a reproductive 
body and how women make meaning of the experience of pregnancy and maternal illness within 
their social context. As such, a feminist analysis allowed me to explore the dialectic between the 
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private/personal sphere and the public/social spheres of women’s experiences of maternal mental 
illness.  
I was mindful of my role as a feminist researcher both during the interview and data 
analysis process. However, at times I struggled with my role as a researcher being more familiar 
with the role of counselling graduate student. I attempted to build rapport, trust, and respect from 
the onset of the interview while being sensitive to the needs and comfort level of each 
participant. I focused on and actively listened to the women’s stories to get a sense of their lived 
experience. I engaged in reflexivity by keeping notes on impressions, observations, reflections, 
and conceptualizations, as well as my biases and assumptions throughout the research process. I 
saw my role of researcher as a collaborator in the interactive process between researcher and 
participant, and by accepting and affirming each participant individually. I was mindful of power 
imbalances existing between us. I needed to acknowledge my own position as a white, middle-
class women, wife, and mother of four sons who experienced maternal mental illness with 
increasing severity and intensity with each pregnancy along with feelings of fear, shame, blame 
and guilt. The experiences of stigmatization, often in my encounters with other health care 
professionals had a significant impact on my ability and willingness to seek help. Hence, I could 
empathize with the participants, which helped me build rapport and sensitivity to their 
experiences.  However, I also attempted to bracket this by intentionally setting aside my 
preconceptions, assumptions, and potential biases and by staying close to the data in order to best 
represent the women’s stories, views, and voices. 
An interpretive descriptive approach allowed me to take advantage of my 
interdisciplinarity and aligned with my feminist epistemological orientation, the purpose of the 
research, research question, and the use of interviews to explore the bio-psycho-social 
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implications of stigma and maternal mental illness, in a clinical practice setting and in the 
context of women’s lived experience.  
Participant Selection 
For this study, the sampling was purposeful. Purposive sampling is based on selecting 
participants with the specific knowledge and/or experience of the clinical phenomenon being 
studied (Thorne, 2008). This provides information-rich cases that offer an opportunity for in-
depth exploration of the central issues. The purpose of this study was to explore women’s lived 
experience of maternal mental illness (clinical phenomena), the role of stigma (socio-cultural 
context), and accessing mental health care services (specific clinical population).   
Participants were recruited from a pool of 120 women who accessed mental health care 
between 2006 and 2009. All the participants were initially contacted by phone at which point the 
purpose of the study was explained and they had an opportunity to ask questions regarding the 
research process and the nature of the study. Once the women consented to participate in the 
study, arrangements were made for a time and place to conduct the interview for the convenience 
and comfort of the participant.  
The interviews were conducted within a three-week period and then the audiotapes were 
transcribed by a professional transcriptionist and then coded by myself. In consultation with my 
committee, we judged that there were sufficiently rich data from the six interviews and 
recruitment stopped.  
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Data Collection 
Individual interviews provided the primary source of data, supplemented by journal notes, 
and basic demographic information from intake questionnaires: age, number of pregnancies, 
number of visits, location seen, and follow-up visits for medication adjustment or counselling. 
Conducting interviews in qualitative inquiry entails a partnership between the researcher and the 
participant engaged in the process of making meaning of the experience and information shared. 
Interviews are designed to delve deeper into the information and/or knowledge about a 
phenomenon to yield exploratory, descriptively rich and explanatory data (Thorne, 2008). 
Interviewing participants facilitated a feminist approach as it allowed each woman’s unique 
experience of living with a mental illness to emerge in her voice and through her perspective. 
This allowed the women to share their experience at a psycho-social level, within a socio-
political context, exposing the impact of various aspects of stigma on their experience of 
maternal mental illness and accessing mental health care services.  
With input from committee members, an interview guide was developed, partially based on 
the literature on maternal mental health and stigma, and accessing mental health care. The guide 
consisted of a set of semi-structured questions meant to draw out the experiences of each 
participant. The questions addressed pre-determined areas of exploration within the research 
topic, such as: a) women’s experience of accessing care; b) their understanding and experience 
of stigma of mental illness; c) how they viewed themselves as mothers needing help for maternal 
mental illness; d) recommendations they would suggest for services; e) and advice they would 
suggest for other women dealing with maternal mental illness. No stipend was paid for 
participation; however, participants were told child care and/or parking would be paid, if 
required.  
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At the beginning of the interview each woman signed and was given a copy of the 
informed consent, although one agreed verbally over the phone, agreed to have audio-taping, and 
were asked whether they wanted to review the transcript of their interview. Using an interview 
guide was a way to provide some structure, while maintaining a relatively high degree of 
flexibility. During the interview, I tried to remain flexible and tolerant of distractions and 
interruptions. I was mindful of the participant’s level of comfort and when she was crying or 
when a sensitive issue was being shared, I would ask if she wanted to continue or not. This 
helped build rapport and trust, but also took us off track at times.   
At the end of the interview, participants were verbally debriefed and given a debriefing 
document that outlined the research in general and provided information regarding counselling 
services and community resources, should they feel the need the further discuss any of the topics 
raised during the interview or want further support. The form also included phone and email 
contact information for local services, the researcher and supervisors, and other community 
supports, in case they had further questions or concerns.  
Immediately following each interview, I wrote about my impressions and observations and 
described the mood and context of the interview, which was the information not captured on 
tape. These field notes were helpful in providing context and tone of the interview, and for 
reflection when referred to at times during the analysis process. One interview with each 
participant was conducted. Although a second interview with participants would have been very 
useful, especially to allow each woman to clarify and comment on my interpretations, all 
participants declined to review their transcript and participate in a follow up interview which 
they stated was due to a lack of time and energy associated with mothering.  
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Data Analysis 
The analytical process is not only interpretive, iterative, synergistic, and integrative, but 
also subjective because the instrument for analysis is the researcher who essentially makes all the 
final decisions and judgments concerning coding, categorizing, decontextualizing, and 
recontextualizing the data (Starks & Brown Trinidad, 2007; Thorne, 2008). Further, the process 
of data generation and data analysis in qualitative research is an interactive and dynamic 
endeavor engaged in throughout the entire research process.  
The qualitative data management software, NVivo™ was used in the early phase of the 
analysis process to manage and initially code the verbatim transcripts. This provided 
maneuverability for putting data bits into broad-based groupings; however, this did not replace 
being immersed in the data, nor did it replicate the inductive nature of the analytical process. 
 According to Morse (1994), all qualitative analyses involve a set of cognitive phases that 
help depict the intellectual processes by which the raw data are considered, examined and 
reformulated to become the final research product: decontextualizing, comprehending, 
synthesizing, theorizing, and recontextualizing (as cited in Thorne, 2000). Decontextualizing 
refers to uncovering and deconstructing the meanings of women’s experience of maternal mental 
illness and stigma which is accomplished by separating the data from the “original context of 
individual cases and assigns codes to units of meaning in the texts” (Starks et al., 2007, p. 1375).  
Initially, the focus of the analysis was on fully comprehending each case to develop a 
sense of the whole, before being combined or aggregated thematically and conceptually, using 
various layers analysis and angles of perspective. I began by reading each transcript once, to get 
a general sense of the whole, trying to reflect on my sense of the interview, and each woman’s 
telling of her story. I then reviewed each transcript multiple times, using a detailed, line-by-line 
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approach, where I assigned a label to each idea or conceptual chunk in each line. The labels were 
intended as “mental devices” by which information could be sorted, retrieved, and organized - 
“conveyers of conceptual meaning” (Thorne, 2008, p. 168). 
Using NVivoTM, I openly coded each transcript, identifying data bits (direct quotations) 
in each interview assigning broad conceptual labels, which resulted in 52 coded concepts (e.g., 
advice, barrier, support, concern, media, initiating event, history, stigma, comments from others, 
health care providers, self-esteem, satisfaction, emotional responses, etc.). Open coding, 
according to Thorne (2008), involves “fracturing the data – taking it apart and examining those 
discrete parts for the similarities and differences they reveal” (p. 145). This facilitated the 
process of decontextualization, but also produced an overwhelming amount of discrete data bits 
that were then organized into narrower conceptual categories, without regard to context, in order 
to distinguish similarities, identify redundancies, and begin clustering the data (Kearney, 2001). 
To do this, I used post-it notes as a visual aid, each with one of the labeled concepts, and 
arranged these into narrower categories revolving around common themes or properties, in the 
form of a conceptual map, providing some logical structure from which to launch further 
analysis. I worked with the data “from pieces and parts into patterns and relationships” (Thorne, 
2008, p. 166).  Discrete data bits were aggregated into broad conceptual categories, for example 
the data chunks aggregated under: 
a) outcome/impact - relationships, work/school, and current condition;  
b) stigma issues - comments from others, myths of motherhood, IVF, stereotypes, 
stigma, identification, normalization, labeling, and language;  
c) treatment - symptoms, medication, PPD, diagnosis, bipolar, anxiety/depression, 
compliance, side effects,  risk factors, sleep, stress, screening, and fertility drugs; 
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d) other themes -  (i.e., people, contextual factors, elements of care, feelings and 
attitudes, advice to women, coping strategies, women’s background and history, 
health care providers, contextual factors, emotional responses, and attitudes).   
As a means of organizing the raw data chunks pertaining to each conceptual category, I 
used the software to aggregate these labels and printed a transcript of the raw data (direct 
quotations) for each conceptual data category. I then read the women’s truncated quotes, line-by-
line, from the perspective of these conceptual categories, to identify and explore interactions, 
relationships, and recurring themes, and the conditions and contexts within which they were 
embedded. This allowed me to refine them into narrower and denser descriptive categories, to 
distinguish the basic concepts contained within each transcript, to determine what elements 
characterized those concepts, and then, labeled each descriptive category. For instance, the 
descriptive categories associated with accessing service were: access, wait time, follow-up, 
health care providers, other services, health care system, screening, alternative therapies, 
referring/attending doctors, overall experience/satisfaction. I then used the descriptive categories 
to discover and openly explore patterns and relationships.  
According to Sandelowski and Barroso (2003), descriptions “always depend on the 
perceptions, inclinations, sensitivities and sensibilities of the describer” (p. 913). Hence, I 
attempted to be mindful to repeatedly return to the raw data to help distinguish between the 
women’s descriptions and my own, staying as close to the data as possible. In order to 
accomplish various levels of description and interpretation, several analytical strategies - 
iterative and inductive process, creative synthesis, and constant comparison-were used to 
explore, described and interpret the data for this study, which required varying levels of 
immersion into the details and specifics of the women’s experiences within three dimensions. 
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The inductive and iterative process was sifting and sorting through data chunks to detect, 
describe, and interpret conceptual categories, search for inconsistencies and contradictions, and 
generate conclusions about what was happening and why (Thorne, 2000, p. 69). Constant 
comparative analysis was oriented toward finding commonalities and patterns within the 
phenomena, while taking into account the social processes that influence behaviour and 
experience (Thorne, 2000, p. 69). A creative synthesis through analytic processes helped detect 
the main narrative themes within the accounts the women gave about their lives, and discover 
how they understood and made sense of their lives (Thorne, 2000, p. 69).  
The next level of interpretation was synthesizing a portrait of the phenomenon that 
accounts for relations and linkages within its aspects (Thorne, 2008). For this level of analysis, I 
explored the descriptive categories in terms of the three dimensions of women’s experience: 
personal experience of living with mental illness; stigma; and accessing mental health care. The 
goal was integrating concepts into a linked and logical manner, which provided a synthesis of 
shared meanings and shared experiences as they emerged (Kearney, 2001). To facilitate this, I 
used a visual aid by constructing tables and matrixes for each dimension, which contained 
truncated data bits to represent the descriptive content of each woman’s experience within each 
category. This allowed me to explore common instances, frequencies, similarities, and 
differences in the women’s stories which offered a more holistic picture of what it means to live 
with maternal mental illness and the stigma, and seeking help and accessing care. This allowed 
the interpretation to go beyond shared meanings and experiences by providing a depiction of 
experiential variations (Kearney, 2001).  
Third phase of analysis was theorizing about how and why these relations appear as they 
do searching for the tacit knowledge which is implicit, hidden from self-consciousness (Audi, 
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2001). Throughout the analysis, I used various reflective and analytical practices to keep track of 
my thoughts and ideas as they were evolving, and as I engaged deeply with the data. I challenged 
myself to not only bracket any preconceptions and assumptions, but also I challenged myself to 
consider what I might be missing or what alternate interpretation may pertain to what I was 
seeing (Thorne, 2008). Using visual aids, such as post-it notes, creating tables, matrixes, and 
mind maps to help me conceptualize and externalize my inductive reasoning and visualize 
linkages and relationships. Documenting patterns and themes this way allowed me to reconfigure 
what was found into a form that had potential to shift my angle of vision (Thorne, 2008). Each 
new relationship, and level of interpretation raised further questions; I repeatedly returned to 
reading the raw data and jotting down new ways of thinking about it, comparing and contrasting 
data categories until they no longer continued to give new insights. I would return to the research 
literature to see whether there was anything within my findings that would offer a different angle 
of interpretation on any initial impressions and interpretations (Thorne, 2008). This level of 
interpretation provided dense explanatory descriptions of women’s lived experience of maternal 
mental illness, stigma, and accessing mental health care. 
The final phase of analysis, recontextualization, “examines codes for patterns and then 
reintegrates, organizes, and reduces the data around central themes and relationships drawn 
across all the cases and narratives” (Starks et al., 2007, p. 1375). The core categories provided a 
recontextualization from which to generate an evolving descriptive understanding and 
interpretive analysis of the women’s experience of mental illness, stigma, and accessing mental 
health services by putting new knowledge about the phenomenon and relations back into the 
context of how others have articulated the evolving knowledge (Thorne, 2008). 
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Thorne (2008) cautioned against potential problems in inductive analysis: premature 
closure; misinterpreting frequency; and hyper-reflexivity. Due to having to take a leave from my 
research, for compassionate reasons, having several months distance from the research presented 
possible challenges with premature closure. I had to re-engage my research mindset and 
analytical process, by re-immersing myself into the data, starting from square-one in order to re-
acquaint myself with what I had done previously; however, this also provided the opportunity to 
getting to know my data, the women’s stories, intimately. This slowed down the analysis 
significantly and extended the time it has taken to complete my master’s thesis, which at times 
made it tempting to rush the process. But rather, it became an active process that allowed me to 
look at the data from a slightly different perspective, at various times during the research 
process. I started by re-reading each participant transcript, and then re-creating my train of 
thinking in developing the emerging concepts, and getting a sense of the whole. I attempted to 
inductively make sense of relationships by shifting attention from individual cases to the whole; 
constantly comparing each category to all the other categories to explore similarities, differences 
and general patterns which allowed me to gradually achieve an increasing the level of clarity and 
complexity (Kearney, 2001; Thorne, 2000, 2008). 
This became a dialectic process of description, interpretation, reflection and affirmation, 
where the interpretation of each part is dependent on the interpretation of the whole (Audi, 
2001). Indeed, it gave new insights into what was emerging from the women’s experiences, 
things that I had missed when I was engrossed in the initial stages of the analysis, immersed in 
volumes of information, and bogged down by the mechanics of the data management software.  
Misinterpreting the frequency was minimized by engaging in the numerous steps and 
deeper layers of good inductive analysis, previously discussed. This helped to identify the 
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relevance, significance, and/or redundancy, of certain descriptive codes and helped to ensure 
complexity by identifying the multi-faceted interconnections within women’s lived experiences 
and shared meaning (Kearney, 2001).  
Hyper-reflexivity occurs when the researcher becomes self-absorbed and has difficulty 
sorting out their interaction with the participant and the data being shared (Thorne, 2008). These 
analytical problems were minimized in this study by being fully engaged in the iterative, 
inductive, and evolving data analysis process which allowed me to come to know the data 
intimately by being fully immersed in the data at times, while at other times, stepping away to 
gain some distance to have a fresh look at what was emerging. Interaction with committee 
members about the analysis also helped with this. I was also mindful, as a feminist researcher, to 
be a faithful witness to the women’s experiences, views, and voices. I did this by bracketing my 
preconceptions and assumptions attempting to keep an open mind; I also returned to the original 
interview transcript to check out whether my descriptions or interpretations were a reflection and 
honest representation of the women’s experiences.  
The final stages of analysis consisted of determining how to present the findings, thinking 
about the writing, and striving for an adequate balance between description and interpretation in 
conceptualizing the findings (Thorne, 2008). This also entailed going back to the literature to 
check whether new insights were new or simply missed when conducting the initial literature 
review. Each phase of writing the thesis and implementing suggested revisions, provided another 
level of analysis, as I was able to identify nuances previously missed, and further refine and 
condense the presentation of the findings in a more cohesive and accessible manner. This helped 
to develop an overall organization in which to convincingly present the findings, which allowed 
me to describe, interpret, and articulate the interconnections of three dimensions of women’s 
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lived experience of living with maternal mental distress, the implications of stigma, and 
accessing mental health care services.  
Evaluation Criteria 
All qualitative research methodologies have developed quality criteria to assist with 
guiding the way in which a study is conducted and findings are presented to the intended 
audience (Thorne, 2008). These distinct guidelines are used to ensure rigor and credibility and 
judge the quality of the research process and product (Thorne, 2008). Research quality, for 
interpretive description, depends on the match between the question, the method, the design, and 
the researcher’s stance, while credibility involves maintaining clarity of purpose (Thorne, 2008). 
Thorne (2008) delineated four principles for articulating standards of evaluation within 
interpretive description: a) epistemological integrity; b) representative credibility; c) analytic 
logic; and d) interpretive authority.  
Epistemological integrity is assured when the research process reveals a research 
question that is consistent with the stated epistemological standpoint and interpretation of data 
and interpretive strategies which follow logically from that question (Thorne, 2008, p. 224). By 
using a feminist framework to inform the exploration of women’s lived experience of maternal 
mental illness, the social construction of motherhood and pregnancy, and the impact on 
accessing care, integrity was achieved.  
Representative credibility was addressed through the research process by being immersed 
in, and having a prolonged engagement with, the data by using multiples angles of inductive 
analysis. This was supplemented with notes of observations, impressions of interview and 
participant, and the context and environment. Interpretations were checked by returning to raw 
data and individual interviews to confirm that what was being represented was as close to the 
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women’s experience as possible. The women were not representative of all women’s experiences 
of maternal mental illness. This study is but a glimpse.  
Analytic logic was ensured with the detailed descriptions and interpretive analysis of each 
interview and each descriptive category to comprehend the women’s unique perspective and how 
they made meaning of their experience of being a mother with a mental illness, in the context of 
their lives. 
Interpretive authority was addressed by taking into account and acknowledging my 
epistemological stance, disciplinary background, and personal experience and the role this had 
on the research design, analytic process, and descriptions and interpretations of the findings. 
However, I strived to bracket any biases and assumptions I had throughout the research process 
by taking steps to document reflections and observations along the way, and by staying as close 
to the women’s experiences as possible, often going back to the original interview script to 
confirm my interpretations as being fair witness to the women’s stories, views, and opinions.  
Ethical Considerations and Approval 
The current study received ethical approval from the University of Saskatchewan’s 
Behavioral Research Ethics Board. Participation was strictly voluntary and through the informed 
consent process, participants were assured confidentiality, anonymity, and the right to withdraw 
at any point during the study. Participation in the study did not affect access to mental health care 
services or care providers. The documents, transcripts, and consent forms, are available solely to 
the researcher and supervisor and will be stored in a secure location for five years.  
To ensure confidentiality, pseudonyms were used to protect each woman’s identity: Amy, 
Elyse, Sue, Gabby, Tina, and Skye. Following the interview, participants were provided with a 
debriefing document that included information regarding counselling services and community 
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resources in the event of needing to further discuss any topics raised during the interview, or if  
needing further support. This form also included the researchers’ contact information in case 
they had any questions or concerns.   
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CHAPTER 4: FINDINGS 
 
The purpose of this chapter is to describe the findings which reflected women’s lived 
experiences of maternal mental illness and accessing mental health care. Three dimensions of 
experience are explored: a) life with maternal mental illness; b) aspects of stigma; c) and 
accessing mental health care services. Each of these dimensions are described and interpreted 
separately not only to bring forth each woman’s unique voice and situation, but also to illustrate 
the shared meaning of living with maternal mental illness within these bio-psycho-social 
domains of experience. Further, the findings explore the interconnections between living with 
mental illness, the impact on women’s sense of self and the influence of social and self stigma on 
seeking/accessing mental health care. The chapter concludes by presenting the women’s 
recommendations for enhancing service provision and favorable health outcomes and their 
advice for other mothers living with mental illness.  
To protect confidentiality and anonymity, pseudonyms were used for each participant. 
Direct quotes ensured that participant voices were central to describing the findings and were 
italicized. Deleted words have been represented by ellipses, and added words are represented by 
square parenthesis. Each participant was offered the opportunity to review a written transcript of 
her interview. However, all declined to review their transcript and expressed a lack of time and 
energy related to being new mothers. Interviews were sixty to ninety minutes in length, except 
for the one conducted over the phone, which was 30 minutes.  
Women’s Experience of Maternal Mental Illness 
Although the sample was gathered in a relatively random way from a list of attendees, the 
six participants represented a rather homogeneous group of white, middle-class women living in 
an Anglo-prairie medium-sized Canadian city who accessed mental health care services. At the 
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time of accessing services, five of the six participants were 31 to 39 years of age, except for Skye 
who was 18. Five of the women were married, except Elyse who was divorced from her previous 
spouse and was living common-law at the time of the interview. Three women had post-
secondary education, two of which were health care professionals, two were working in retail, 
and one was an exercise instructor. Three of the women had a child from prior pregnancy, and of 
these, two women (Amy and Elyse) experienced postpartum depression (PPD) after their first 
delivery. They were both treated pharmacologically and discontinued the medication 
prematurely. Three of the six participants (Sue, Tina, and Gabby) had a history of infertility, and 
used fertility drugs and in-vitro fertilization (IVF) to conceive, which impacted their experience 
of mental illness and stigma; Tina and Gabby both had twins as a result. This was quite unusual 
in a small sample size and revealed interesting findings that added to the richness of the data 
analysis as this provided the opportunity to explore the bio-psycho-social implications of 
fertility, the process of IVF and maternal mental health.  
Participants. Each participant shared her experience of having maternal mental illness, 
living with and managing emotional and mental distress, and the impact this had on her life and 
relationships. Although each story was unique, many similarities were noted in their descriptions 
indicating a shared experience and shared meaning of living with maternal mental illness. This 
dimension of women’s experience coalesced into the following common areas: a) personal and 
family history of mental illness; b) debilitating symptoms and mental/emotional distress; c) 
potential contributing factors; d) diagnosis and treatment; e) impact on relationships with spouse, 
family, co-workers and others; f) impact on their sense of self and effort in seeking help (self-
efficacy); and g) their health outcome.  
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Amy. At the time of the interview, Amy (33 years of age), was married and expecting to 
return to work full-time within a few weeks. Her spouse and two children (ages 4 and-a-half-
years and 22 months) were home, but out of earshot, during the interview.  When she accessed 
mental health care, she was 28 weeks gestation and seen once, during her second pregnancy. Of 
the six participants, Amy’s symptoms of mental illness were the most extreme and debilitating, 
and continued to be an ongoing struggle at interview time. Amy acknowledged having PPD after 
the birth of her first daughter, for which her first family physician (out-of-province) prescribed a 
psychotropic medication; however, she discontinued these prematurely due to side effects: 
because it was an emotional blocker, I was taken off the medication [six weeks postpartum]. 
That was it. I wasn’t offered any other alternative at that point. Amy was still experiencing 
mental and emotional distress at 30 months postpartum, when she became pregnant with her 
second child. Amy described her emotional state and the escalation of distressing symptoms:  
I was terrified when I found out that I was pregnant the second time, because it was so 
bad with the first. I was never out of the woods with the first pregnancy, but the second 
time around, it was exasperated (her words) greatly, and it came to a point where I 
couldn’t live with the thoughts and visions coming into my head, particularly stepping 
into the kitchen. I couldn’t look at knives, and couldn’t look at the frying pan. I couldn’t 
go into any room without picturing me hitting her with something. 
Amy acknowledged reaching a felt crisis point before finally going to her family 
physician for help: One day I got to the point where I was really frustrated with [my daughter]; 
it may have been because of lack of sleep. I am not sure. I put on her coat a little too rough and 
she fell on the ground and hit her head. … I realized that I just had an absence of concern. It was 
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like I didn’t care and that really scared me tremendously because I didn’t know at that point if I 
was a danger to her.  
Although Amy had PPD with her first pregnancy, she had prematurely discontinued 
medication and seemed ill-informed of her risk for developing PPD with future pregnancies. As 
a result, she did not seek help until she experienced a crisis point with the second pregnancy. 
Amy’s family physician immediately referred her: I was at a critical point that is why I went to 
my doctor. We were coming in desperation. He was very concerned, and immediately took it very 
seriously. Due to the severity of the symptoms, her history of PPD, and her risk for developing 
extreme psychiatric illness, her physician prescribed a small dose of anti-depressant to initiate 
pharmacological treatment, in the interim to accessing mental health care services. As a result of 
the relief she was experiencing with the medication when accessing care, Amy recalled being 
told to continue the medication and to follow-up with her family doctor. She stated that she felt 
no other treatment options or services were offered. Unfortunately, the relief of her symptoms 
was short-lived. After being on medication for a short while, Amy recalled:  
I was starting to have problems again. I finally got to the point where I was on higher 
doses of medication, and I was sitting at the patio window, trying to talk myself out of 
leaving the house, not leaving my daughter alone in the house. I was just going to leave 
the house and start walking, and just go. I thought to myself, maybe she needs to be taken 
away; maybe I need to be hospitalized. I can’t live like this anymore. My family doctor 
was gradually increasing [the meds] because it was starting to come through my dreams, 
and I was starting to struggle again, so it was gradually being increased to more and 
more.  
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Amy and her spouse had recently moved from another province at that time and had no 
family support nearby. Amy identified the lack of proximity to family as a significant factor in 
her experience of mental illness: we have no support here; there is nowhere to go and no family 
to help. In addition, she shared that her family’s religious beliefs also contributed to the feeling 
of isolation and distress:  
My family doesn’t believe in any mental conditions and/or disorders. Both sides - my 
mother’s side and my father’s. It did stop them from accepting [that I was dealing with 
mental illness]. Initially, they told me not to believe it because we are religious and the 
devil was just attacking me.    
Recently, when she and her husband reached out to them for help when they were having 
marital problems: 
It was great. It was wonderful to get their support. Now, however, they can’t deny there is 
a [mental illness] problem, especially last month when we hit a wall. We didn’t know 
what to do, we were at the end of our rope. … [Going home] oh my goodness, it saved my 
marriage. My husband and my marriage are the last things that I have anymore.  
Amy spoke of the significant challenges her family endured, as a result of her unmanaged 
mental illness. Amy described the impact that her mental illness had on her husband, as she kept 
calling him home from work, which made it difficult for him at his workplace:  
I was calling him home so many times that it was getting to be of concern at his job. ... I 
nearly lost my marriage. ...  Even up to a month ago, I was asking my husband if we 
should separate, because I couldn’t stand for him and the children to be going through 
the pain that I was putting them through. 
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Amy was very emotional when she described the effects of having a mental illness had 
on her two children and how her family was significantly impacted: 
I never really had a life with my children as youngsters. I barely even remember - all 
those years wasted. The children have been suffering. [Now] my daughter screams. My 
oldest daughter has been having bowel movements in her pants. … So, we went from a 
very successful couple with two beautiful children, who are angels, and happy with lots of 
friends, to nobody, no family around, no finances, no savings, no security, almost no 
vehicles, maybe no home. Thankfully, we still have our marriage. 
As a result of her struggle with maternal mental illness and the impact this had on her 
family, Amy stated that she and her husband, with much sadness and disappointment, made a 
life-altering decision: 
Because of this [mental illness], because we felt that there wasn’t medical support, we 
actually decided not to have any more children, which I would have loved to have a lot of 
children. I come from a culturally very big, big family, where there are 10-12 children ... 
so I felt a huge loss that way. I am still trying to deal with that.  
Amy’s mental illness had significant impact on her physical health for which she often 
felt judged: 
I was very athletic - I kayaked, rock climbed, biked, played on the playground, ran - I did 
everything, every sport possible. But yah, I am 80 lbs. overweight, and people think that 
you are, you know, being lazy, taking vacations.   
During the interview, Amy shared that she was still experiencing mental and emotional 
distress, grieving the loss of having more children, feeling the responsibility of being the sole 
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income-earner; she expressed her concern about returning to work and doubted her ability to 
manage the stress and anxiety: 
Now, I am back at work and really shouldn’t be. I am not sure how long I can last. I am 
supposed to start in one week. There are huge concerns about that. I am going back full-
time. I don’t think that I will ever be able to handle stress again. So, I am actually 
legitimately concerned.  
At the time of the interview, Amy stated that she was not coping well and when asked 
about finding help she expressed frustration, hopelessness, and helplessness:  
There is absolutely no [mental health care] support. My only relief, which I have been 
open about, because I just don’t care anymore, is that someday I will die and that it will 
end. And I was told that it will end sooner than that, but I think that they are lying. I can’t 
stop thoughts coming to my head, which are negative. I do two forms of self-mutilation 
now. I have been struggling with insomnia. So, in this state, I am going back to work.  
In sum, several bio-psycho-social factors seemed to impact Amy’s experience of mental 
illness: previous history of PPD; premature discontinuation of psychotropic medication; under 
treatment of PPD; lack of information about maternal mental illness; did not recognize 
symptoms; lack of family support; religious beliefs; lack of community support/resources; and 
stressful life events. Several psycho-social implications were noted: impact on husband 
(interference at work, job-loss, financial bankruptcy, and depression), children (behavioural 
concerns), relationship (decision to not having more children and financial strain), work (fears 
returning and doubts ability to manage stress), and the impact on herself (lack of physical, 
emotional, and mental wellbeing, lack of sleep and self-care); ability to mother; and her current 
mental health problems.    
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Elyse. At the time of the interview, Elyse (36 years of age) had two children (ages 12 and 
18 months), was currently living with her common-law partner, and had returned to work full-
time. Elyse shared that she had mental health issues as a young adult, but had never been treated 
pharmacologically or with counselling. She recognized early signs of anxiety and depression 
stemming from never having dealt with a traumatic rape experienced as a teenager.  
Elyse was previously treated for PPD after her first pregnancy: I went to a psychiatrist, a 
couple of times after my first. But, she admitted to stopping the psychotropic medication 
prematurely, without consulting her physician, because it made her mentally foggy. At that time, 
her mental illness affected her marital relationship, which resulted in divorce, many years prior 
to receiving care:  
I was actually relieved that her dad and I divorced because he didn’t deal with me. It 
wouldn’t have worked anyway, because I was miserable with him. Actually, he kind of 
made it [PPD] like that was the whole reason. 
When Elyse became pregnant with her second child, she began to experience increasing 
amounts of excessive stress and anxiety stemming from extreme job-related stress as a result of 
being transferred, put on the night shift, and having additional responsibilities at work. Elyse 
experienced a cascade of debilitating symptoms and reached a point where she was no longer 
able to manage the tasks of day-to-day living, which greatly impacted her work:  
I was good at what I did, but then I couldn’t do it and it got to the point where I didn’t 
want to. I couldn’t make a decision, you know, what to go where, any little thing.  I 
couldn’t decide anything, nothing came naturally, and it got to the point that I couldn’t 
even go to work - I actually stayed in bed an extra five days, after I walked out. 
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Similar to Amy, Elyse described reaching a crisis point before finally seeking help. She 
described her family physician as being very supportive, aware of her history and risk of PPD, 
and taking her concerns seriously. She expressed how grateful she was that her physician had 
referred her immediately for mental health care. Elyse admitted that she did not recognize, or 
associate her current symptoms and state of extreme mental and emotional distress, to her history 
of PPD with her first child: I didn’t recognize it and I was just lucky that my doctor did. When 
she accessed mental health care, she was prescribed medication which provided relief after being 
adjusted over the course of a few follow-up visits: It helped after a little while. I wasn’t near as 
anxious and not as much set me off. She [the psychiatrist] had to adjust it a few times during the 
pregnancy. Similar to Amy, Elyse stated that she was not offered other treatment options, 
services and support, such as peer support or a PPD support group, when she accessed care. 
Further, both participants did not seem to know the implications of taking or discontinuing 
psychotropic medication and their increased risk for relapse. For instance, Elyse said that she had 
stopped taking the prescribed medication in the early postpartum (after giving birth) period:  
I came off the medication [on my own] about six months after starting. Just because I felt 
I didn’t need it anymore. I felt that I was kind of over it, it’s a phase. It should just kind of 
clear up by now. I felt fine, and like I said, that was kind of my history.  
As with Amy, Elyse seemed unaware of her risk for developing PPD with her second 
pregnancy and unaware of the possible consequences of discontinuing medication prematurely, 
despite being treated twice for PPD. Additionally, both these women described experiencing 
ongoing mental and emotional distress at the time of the interview, and both were well past the 
first year postpartum. Elyse (18 months postpartum) shared she was having a difficult time 
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coping and was very emotional throughout the interview. Elyse acknowledged that she would 
currently benefit from seeking help and being back on medication: 
I would feel more in control. I wouldn’t be as emotional ... you don’t have the outbursts 
and you are not so quick to lose your mind. So, I would rather take the [mental 
fogginess] over this instability.  
She also seemed to realize that her current inability to manage her stress and anxiety was 
due, at least in part, to having stopped the medication prematurely.  Elyse believed she would be 
able to cope more effectively with her current condition if she were to use medication. However, 
she perceived taking medication as also requiring her to engage in the treatment process and 
being willing to work on life/relationship issues, which she admitted to avoiding. Elyse alluded 
to having some marital concerns and her daughter’s possible behavioural issues:  
[My] daughter doesn’t sleep in her crib, so she is with us all night. It was almost like it’s 
my comfort. Part of me doesn’t want her to sleep in her own room because maybe then I 
have to deal with you know - us. Now it is about her.  
Elyse felt supported by her mother and her common-law partner when she was accessing mental 
health care services, but at times felt isolated from friends because of her hesitancy to share her 
experience. Elyse’s work was also being affected, especially in regards to her relationships with 
her co-workers and her own high expectations: Even at work, I’ll try to fix everything and it 
drives me crazy when people make mistakes, but it pisses me right off when I do.  
At the time of the interview, Elyse admitted to not coping well with everything in her life, 
her work, her relationship, her self-care, and her willingness to seek help:  
I struggle all the time actually, and I know that I am not 100% - not even close. I find that 
I am moodier because I feel tired. I feel overwhelmed. I worry a lot. I spend extra hours 
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at work, I watch TV, and in a lot of ways, like I am physically there, but I am not, you 
know, [emotionally present].   
When asked what was holding her back from asking for help now, Elyse had a strong emotional 
response:  
I don’t think I’m ready. It is easier to be unattached - like to go through talking about 
[our relationship]; to go through having to work at it. Not working at it is easy - it is very 
easy. It is just - I don’t want to work at it. 
In sum, several bio-psycho-social factors impacted Elyse’s experience of mental illness: 
previous history of anxiety/depression in young adulthood (untreated); traumatic experience 
(rape at age 18); previous history of PPD and premature discontinuation of psychotropic 
medications; stressful life events (marital problems, previous divorce, and being a single mom); 
job-related stress; and did not recognize symptoms. Several psycho-social implications were 
noted: impact on marital relationships; felt supported by mother; daughter with possible 
behavioural issues; work (over-work, co-workers, and unrealistically high self-expectations; lack 
of social connections; and the impact on her ability to mother and her present condition (lack of 
physical, emotional, and mental wellbeing and lack of sleep and self-care) and her current mental 
health problems.    
Skye. The youngest participant, Skye (she first accessed maternal mental health care at 
age 18 and was 20 years of age at interview) was married, working part-time, and had a 24-
month-old son. She accessed care in her first trimester and was seen once. Skye revealed not 
only a personal history of anxiety and bipolar disorders, but also a strong family history of 
bipolar disorder. She described distressing and debilitating symptoms of anxiety/panic attacks 
stemming from a phobia of vomiting:  I have a phobia of vomiting, a really, really bad one to the 
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point where it would turn into a panic attack and that doesn’t help when you are pregnant and 
you are nauseous all the time.  
She was diagnosed with bipolar and anxiety disorders as an adolescent, which was 
managed with a combination of psychotropic medication. Of note, Skye welcomed the diagnosis 
of bipolar disorder expressing relief and validation:  
I was actually kind of relieved to be honest because I knew that there was something not 
right. Because I think I was17 when I got diagnosed, so there is still hormones, and you 
are still a moody teenager, but I knew that it was beyond what all my friends were going 
through, so it was kind of nice to know that there was a reason.   
When she became pregnant, her physician expressed concern about the safety of the 
psychotropic medications Skye was taking for bipolar/anxiety disorder; aware of her risk of 
developing PPD, she was immediately referred for mental health care by her physician:  
I had to stop all [medication] because they weren’t sure what was safe and what wasn’t. 
He put me into top priority because I have a lot of bad anxiety and phobia issues and he 
wanted to make sure that I got help with the medications, ASAP.  
Skye stated that she was told to continue one psychotropic medication, which was safe to 
use during pregnancy, and to discontinue the others. However, she said that she was never 
informed about her risk of relapse, her risk for developing PPD and the implications of taking 
and discontinuing medication in light of her bipolar disorder. Further, Skye said she was not 
offered other treatment options, services, or support.  
Skye admitted to using the medication for a while during her pregnancy, but explained 
the negative side effects were hindering her ability to function daily, much like Amy and Elyse 
who also experienced medication side effects, which influenced their decision to discontinue 
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taking them. In addition, Skye stated that the medication became too costly; hence, she 
discontinued them during her pregnancy without consulting a physician:   
[It made me] feel zombie-like. ... It would have helped, if I wasn’t so exhausted all the 
time. The medication, if you don’t sleep 16-20 per day, then you feel that you are dying, 
basically, because you are so tired. And I actually couldn’t afford the medication at the 
time. And I did ok after a while.  
However, unaware of her increased risk of developing PPD, Skye did not recognize her 
emotional and mental distress after having her baby. In fact, it was Skye’s mother who 
questioned and recognized symptoms of PPD: 
I had a really bad postpartum period. My mother was worried, she had come down to see 
me because I was emailing her, and she noticed that I wasn’t happy. … My mother 
realized that it was probably postpartum, so she came to see me and see how we were 
doing. So, that was good to have someone that close to you who knows exactly what it 
means. 
Skye spoke of the support and help she received from her husband and mother, which 
allowed her to manage her symptoms. She attributed this support and understanding, at least in 
part, to her family member’s personal experience with mental illness: 
[My husband] had been amazing and helpful with my anxiety. Actually, he learned a lot 
of tricks to help me calm down. … My mother is bipolar and so was my brother, so 
everyone was there to help me, if I didn’t have enough help. My mother went for years, 
until she was just about 40, without medication, and not really knowing that she had it. 
And so, she understood me. I probably wouldn’t have gotten through a lot of stuff if it 
hadn’t been for her support.  
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Skye indicated that although her spouse was very supportive, he did not understand the 
struggles she was experiencing after she had the baby:  
My husband, he gets some things, but he never really understood the postpartum part, so 
he never got why I wasn’t eating, and even when my son was sleeping, I wasn’t sleeping. 
... There have been times where my husband has had to wrestle me out of bed, when I was 
dealing with my lows, as well as having to take care of my son during the day, and I 
didn’t have the energy to cook us a big meal. 
Despite the positive encouragement and support received from close family members, 
Skye’s experience with mental illness had a significant influence on her relationships with 
extended family, co-workers, and her school administration. Skye described her strained 
relationship with her paternal grandparents, as a reality of living with mental illness:  
My grandparents, they blamed everything on bipolar, they have really old-fashioned 
thinking. ... They blame my parents’ divorce and the fact that my mother is bipolar. ... If I 
feel a lull coming on, and I am going to my grandparents, I will put a big smile on my 
face and say, “I am doing fine” because I don’t want to hear their bantering.   
Skye also commented on how she would censor herself in the often awkward and 
uncomfortable social interactions at her workplace: 
 At my job, they knew about my phobia [of vomiting] I would have a little panic attack. So 
they would need to know that, but they didn’t know about me being bipolar or anything.  
Further, Skye’s experienced the negative impact of not only having a mental illness, but 
also for being a pregnant teenager. She explained how she felt about the way her school’s 
administration treated her: 
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And the high school that I was going to at the time knew that I had bipolar disorder, 
because I had to go for a lot of blood tests because of the medication that I was on. When 
the school found out that I was pregnant, they told me that maybe their school wasn’t 
right for me anymore. So, I went to a different one. ... I honestly think that it was because 
they were uncomfortable, because I explained to the principal that I had bipolar disorder 
and … then when they found out that I was pregnant, they used the students as an excuse, 
saying that, “they would never welcome me.” But I could tell that it was the counsellor 
saying that, and the principal came in, as did the vice-principal. It was obvious that they 
didn’t want me there - the way that they were trying to blame it on the students, but there 
is other pregnant people there. They would have been fine with it. So, I left that school. It 
kind of worked best because I had ridiculously understanding teachers [at the new 
school], and some of the teachers there were influential to me, in the end, because they 
had really good advice on life and childrearing.  
Skye’s sense of ambivalence revealed that she had made meaning of this experience by 
choosing to see the positive and not allowing negative social encounters to diminish her sense of 
self. This seemed to be a protective factor in her experience and seemed linked to her sense of 
self-efficacy. Unlike Amy and Elyse, Skye who was also at increased risk of developing PPD, 
stated that she was currently doing well, without psychotropic medication. Skye proudly 
explained how I basically did it myself and that she learned effective strategies to manage her 
mood disorder by learning effective coping strategies and gaining more self-awareness:  
Actually, I was off medication since before I delivered. I have been doing really well. I 
have learned to tell when things are coming, you know? With the irritability, I have 
learned to basically control for the most part, except for the PMS - that kind of adds to 
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everything - that is pretty bad. But with the lows, I have learned to completely control 
them now.  
In sum, several bio-psycho-social factors influenced Skye’s experience of maternal 
mental illness: previous history of anxiety and bipolar disorders; under treatment of mental 
illness; family history of mental illness; stressful life events (teen pregnancy and asked to change 
schools); discontinuation of psychotropic medication; and a lack of awareness of symptoms and 
risk of PPD. Several psycho-social implications were noted: impact on her school life; impact on 
relationships with spouse, mother, students, co-workers, and extended family; impact on her 
sense of self (learned new skills and sense of wellbeing).  
Sue. At the time of the interview, Sue (39 years of age), was six months postpartum, 
married with one child, and on maternity leave. The interview was conducted at her home, and 
her 6-month-old daughter was awake, and she held her for the duration of the interview. Sue was 
the only participant who participated in a support group for postpartum depression.  
Sue, one of three participants who used in-vitro fertilization (IVF) to conceive; she had 
had numerous miscarriages and had experienced mental and emotional distress with each. She 
had a history of anxiety (untreated), beginning in her 20s, with her first miscarriage. When she 
finally conceived in her late thirties, and after a few years of IVF treatment, she began to 
experience extreme anxiety. She recalled going to her obstetrician, who was aware of her risk for 
developing PPD, and referred her in the last few weeks of pregnancy: my doctor mentioned 
[service provider] when I was pregnant. They were concerned because I had a lot of anxiety and 
they were concerned about me being depressed after.  
Sue delivered her daughter three and a half weeks early and recalled the details of a 
traumatic labour and delivery and the heightened emotional distress this caused:  
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Her heart stopped before she was born, and I was convinced that she was dead. They 
used forceps because we couldn’t wait for me to push, and I saw there were a whole 
bunch of nurses and doctors. Two doctors stayed to do the stitches and everybody else 
had gone around her. My husband couldn’t even see her. They didn’t tell us her gender. I 
had to finally ask after a few minutes, and then she cried once, and I thought, yah. And 
then she stopped. I was convinced that she was dead, and then she cried again, but then 
stopped again. By then, I had just kind of resigned myself to the fact that she was going to 
die. ... And then after [labour and delivery], you are totally exhausted and messed up. So, 
it was horrible and for the next three weeks, I was convinced that she was going to die.  I 
think it took 3 weeks to relax a bit, but it was not until she was 5 months that I was able 
to really relax. Now, I would say that the last two months have been really good.  
Sue was the only participant who had never used psychotropic medication. Rather, she 
preferred a more holistic approach, using alternative therapies: I was on non-prescription 
medication. I have an acupuncturist who does traditional Chinese medicine and he had given me 
a bunch of stuff to prevent a miscarriage, and so I was taking the stuff he gave me. However, her 
struggles with infertility and anxiety had an impact on her relationships—with her spouse, her in-
laws, and co-workers:  
It sure ‘highlights’ the weaknesses in your life. Like, if you have a weakness in your 
relationship, it just makes it “scream” and that kind of thing. … It is hard to get any 
information out of my husband, at the best of times, let alone something personal.  
Although she felt supported at times by her family, she was disappointed with her 
mother-in-law for betraying her confidence: when my sister-in-law found out I was pregnant. I 
didn’t tell her; my husband didn’t tell her. So, I am guessing my mother-in-law told her, which 
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disappointed me. In her interactions with co-workers, Sue was reticent to discuss her pregnancy 
using IVF, which caused her to feel isolated. She mentioned how co-workers would ask 
inappropriate questions: I didn’t want my co-workers to know because I work with a lot of people 
who are harsh and judgmental - most of them. Sue, however, felt supported at times, when 
attending the PPD support group with other women, but yet at other times, she felt alienated: it 
was nice to see other women having similar feelings, anxiety, all that kind of stuff, but at the 
same time, it was kind of isolating because some of them were really judgmental. At the time of 
the interview, Sue was six months postpartum, doing very well, and was managing her 
symptoms of anxiety. 
In sum, several bio-psycho-social factors affected Sue’s experience of maternal mental 
illness: previous history of anxiety; history of miscarriages; using fertility drugs and IVF over 
several years to conceive; perceived supports; and stressful event (traumatic labour and 
delivery). Several psycho-social implications were noted: impact on marital and family 
relationships; impact on social interactions; feelings of isolation; and successful management of 
her anxiety symptoms without medication using a holistic approach.   
Tina. At the time of the interview, Tina, 35 years of age, was married and had three 
children (a preschooler and twins under 6 months. She requested to be interviewed over the 
telephone and at the start of the interview she informed me that she was breastfeeding her twins, 
who were born seven weeks premature. Although the interview was shorter in length, in 
comparison to the others, it contained enough information to include in this study. Tina had a 
personal history of anxiety that was treated successfully with medication.  
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Like Sue, Tina spoke of the challenges of using IVF to conceive and attributed her 
symptoms to her problems of infertility and the lengthy process; but, more specifically, to 
discovering she was having twins:  
[IVF] was the hardest thing that I have ever gone through in my life, and [IVF 
treatments] went on for a period of three years or so. … I started having some anxiety 
issues, shortly after I got pregnant, pretty much immediately. And I think it was triggered 
by the fact that I found out immediately that I was expecting twins. I had a four-year-old 
daughter.  
Tina’s physician took her symptoms of anxiety seriously, aware of her risk of developing 
PPD, and referred her for mental health care. She was prescribed medication and that helped 
immediately. Tina delivered her twins prematurely, which provided significant challenges for 
her. However, when asked how she felt being on medication during her pregnancy, Tina had 
some hesitation about the potential side effects, and how she overcame the worry:  
I felt completely crazy and unable to function without it. So, I just decided that I was 
better off taking the meds and taking whatever risks there might be. I was informed [of 
potential side effects], but my own personal opinion is that the true effects aren’t known 
at this time. So, I took whatever I was told with ‘a grain of salt’ because I actually don’t 
believe that the effects will be long-term. … I just decided not to worry about it.  
According to Tina, taking medication allowed her to cope effectively with her anxiety 
and her sense of ambivalence about taking psychotropic medication, the possible risk, and 
managing her symptoms, she made a conscious choice to not let affect her. She was coping well 
with medication at the time of the interview, and also acknowledged having a good system of 
support:  
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We have a family history of anxiety, so they were just extremely supportive and said that 
I should do whatever it took to feel better, and the friends that I have shared it with have 
been equally supportive.  
This echoed Skye’s experience, reflecting a shared meaning and understanding of a 
positive conceptualization of having a family history of mood disorders. This had a significant 
impact on their sense of being supported through the struggle of living with maternal mental 
illness, seeking help, and accessing mental health care services.  
In sum, several bio-psycho-social factors affected Tina’s experience of maternal mental 
health problems: personal history of anxiety; family history of anxiety; using fertility drugs and 
IVF; multiple birth (twins) and premature birth; stressful life events. In addition, several psycho-
social implications were noted: taking medication when pregnant; impact on relationships, 
support system, and sense of self.  
Gabby. At the time of the interview, Gabby (31 years of age) was married, had twin 
toddlers, and was working part-time. The interview was conducted in the research office. Gabby, 
the third participant who conceived using IVF, recognized the impact her struggle with 
infertility, taking fertility drugs, and having numerous miscarriages, had on her experience of 
maternal mental distress:  
IVF is a whole other area of major anxiety. My husband and I had trouble getting 
pregnant, so when I got pregnant, I was very scared that I would miscarry and how I 
would handle that, if that were to happen. I was kind of scared that I would fall into a 
depression. Infertility was a big issue. I went to see her right away after my positive 
pregnancy test because I felt that my period was coming and I was just like, “I think that 
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I am pregnant, but if I am not I am going to be devastated. I know that I am going to be 
devastated.” We had used fertility drugs, too. So, that added even more pressure.  
Gabby’s physician had referred her for mental health care quite early in her pregnancy, 
aware of her history of anxiety and an eating disorder, her mounting antenatal anxiety, and her 
risk of developing PPD. Gabby’s awareness of her risk of developing PPD was due, at least in 
part, to information her husband accessed: My husband had seen a presentation on PPD. And I 
thought, “What if that all happens?” So, it was good to go [for mental health care]. Gabby was 
pregnant, at the time of referral, and was prescribed medication to manage her mental illness. 
However, Gabby decided to avoid taking the medication, during her pregnancy, due to concerns:  
I didn’t want to fill [the prescription] because … I was worried about side-effects - 
weight gain, diabetes, etc., and didn’t want to take it. … Well, I didn’t go on it when I 
was pregnant. I went on it after, but I really didn’t want to be on it when I was pregnant. 
And I don’t have a problem with pregnant women [being on meds] - it is very engrained, 
“Healthy mom; health baby.” I was so afraid that if I was one of those people who did 
end up with a defect that could have been completely normal, I would totally blame 
myself if anything happened and I didn’t want to do that, so I just avoided that.  
Interestingly, Gabby was a health care professional, yet she chose to avoid taking the 
prescribed psychotropic medication during her pregnancy, which seemed to illustrate a common 
concern expressed by many people (i.e., safety of medication use in pregnancy). Like Tina, she 
was ambivalent about taking medication herself and chose to not take medication during her 
pregnancy, but saw the benefit that other mothers could have from medication. 
Gabby acknowledged a history of an eating disorder during her adolescence and of taking 
medication for her long-time struggles with anxiety:  
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I started them when I was 20, and then I got healthy on them. It was horrible coming off 
them, because of the withdrawal. Then in university, I went back on them, and then went 
off them again. I had a big change after leaving university and moved to a new city, and 
started a new job, so I went back on them again. Then, when we wanted to get pregnant, I 
went off of them, and that was three years trying to get pregnant that I was off them, and 
then I was on them again pretty much thereafter.  
Gabby’s symptoms of anxiety were becoming increasingly problematic in postpartum, 
yet she seemed to minimize her symptoms of distress:   
I know that after I had the babies [twins] and I had gone to one appointment at my family 
doctor’s, I couldn’t stop crying through the whole thing. And they were like, “Oh, go 
back to see the psychiatrist,” and they put me on anti-depressants. … I thought they were 
just catching me on a bad day.  
Although she was aware of her risk for developing PPD, Gabby did not associate the 
mental and emotional distress she was experiencing in postpartum as possible risk factors for 
developing PPD. This was also the case for Elyse, Skye, and Amy, who all seemed to lack the 
knowledge of, the foresight, and the awareness of symptoms to associate PPD. Gabby described 
the psycho-social impact of her mental health problems, and the challenges of parenting twins, 
had on her spouse and their relationship:  
After my kids were one year, my husband was having depression problems and I was very 
upset and was trying to contact [care provider]. ... To help me deal with him. … I thought 
that I needed to know how to handle this. ... He had problems with depression before too. 
And then all of a sudden bang - twins - and you aren’t sleeping and with your career 
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choices, you are trapped. You feel that you can’t start over now because you have 
dependents ... and kids don’t let you mope - you have to play and keep going.  
Gabby described the additional support she received from women in her neighborhood:  
The moms in my neighbourhood, we got together and it was really good because we did 
talk [some of the challenges of being a mom].  I am maybe a bit shy because I never want 
to join groups, etc. So, I was very lucky that the women in my neighbourhood contacted 
me and got me involved. ... I think if I didn’t have that, I think that it would be isolating.  
At the time of the interview, Gabby acknowledged that she was working part-time and 
effectively managing her anxiety with medication and seemed to have a positive sense of 
ambivalence:  
I kind of like how I feel now, so I am just not anxious about getting off of them, but it may 
come to that eventually. ... Right at this point, I feel the balance of it. … And I guess the 
long-term effects I am not concerned about because you read about the long-term effect 
of being depressed as well.   
Several bio-psycho-social factors contributed to Gabby’s experience of maternal mental 
illness: personal history of anxiety and eating disorder; using fertility drugs and IVF; multiple 
birth and miscarriages; stressful life events; lack of awareness of symptoms; lack of knowledge 
of medication. Several psycho-social implications were noted: impact on spouse (depression); 
impact on relationships and social interactions; impact on sense of self (to discussed later); and 
supports.  
In summary, several bio-psycho-social factors were identified across participants’ 
experience of maternal mental illness. All the participants had a previous history of mental 
illness, for which some were treated. Amy and Elyse had previous history of PPD and premature 
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discontinuation of medication; they also seemed unaware of the risk for developing PPD with 
subsequent pregnancies and the implications of medication compliance. Both these women had 
delayed seeking care, during their second pregnancy, until they reached a crisis point. Tina and 
Skye had a family history of mental illness, which facilitated the level of support they received. 
All the participants reported experiencing stressful life events and/or interventions for various 
reasons such as trauma, divorce, miscarriages, and infertility issues. All of the women presented 
with antenatal anxiety, yet most of the women seemed unaware, did not recognize, or lacked the 
insight regarding the signs, symptoms, and implications of maternal mental illness. They recalled 
a lack of information, knowledge, and psycho-education about maternal mental illness, and 
treatment options; and subsequently, three women discontinued medication without consulting 
their physician.  
Several psycho-social implications emerged from women’s experiences of maternal 
mental illness. All of the women indicated that the level of support they received was a 
significant factor in their experience. Although some spoke of supportive family and friends, for 
others it was the perceived lack of family support, social connection, and/or lack of community 
resources/support that affected their ability to cope with their mental illness. Although the impact 
manifested in varying ways, all the women perceived having a mental illness as impacting their 
relationships and various social interactions with their spouse, family members, friends, and co-
workers.  
Of note, two spouses were described as becoming depressed one-year postpartum, which 
proved to have a significant effect on the women’s experience of mental illness. According to 
Amy and Elyse, the chronicity of their maternal mental health problems impacted their marital 
relationships, their children’s behaviour, their level of self-care and self-esteem; and for one of 
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these women, this lead to financial hardship and the life-altering decision to undergo medical 
sterilization.  
For three of the six participants, the potential side effects of using psychotropic 
medication during pregnancy were a concern. Five of the women were prescribed safe 
medication, as a result of accessing mental health care; however, three discontinued use a few 
months after taking them, without consulting their physician and without the knowledge of the 
implications and risk for developing PPD. At the time of the interview, Tina and Gabby were 
still on the medication; Amy and Elyse were off medication and described struggling with 
ongoing symptoms of anxiety and depression; and Sue and Skye described coping well without 
medication.  
An interesting and an unexpected revelation was that three of six participants shared the 
experience of in-vitro fertilization. Three women had a history of infertility, using fertility drugs 
and went through approximately three-year process of IVF, which they described as their most 
difficult life challenge. Further, two had birth complications; and two had multiple births. These 
three women acknowledged this process as a key factor in their experience of maternal mental 
illness. Yet, when reviewing an array of scholarly research for this study neither infertility nor 
the use of IVF, were identified as a risk for developing maternal mental illness. The present 
study’s findings suggested that the areas of reproduction and infertility are significant psycho-
social factors for maternal mental illness and linked to self stigma.  
Women’s Experience of Accessing Mental Health Care 
The second dimension explored was the women’s lived experience of accessing mental 
health care services. Each participant spoke about her treatment experience, care satisfaction, and 
health outcome. The importance of information and the value of the bio-psycho-social approach 
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emerged from the participants’ shared experience and shared meaning of having a maternal 
mental illness, seeking help, and accessing mental health care. Participants shared their advice 
for other women who struggle with mental illness. 
      Aspects of accessing care.  At the time of accessing mental health care, most of the 
participants described a sense of being in crisis, having reached a critical point, and for some, a 
perceived dire need of help. The majority of the women described waiting for their first 
appointment as too long and feeling like an eternity, regardless of whether they received mental 
health care within a few weeks or a few months. Amy and Elyse delayed seeking help until their 
symptoms were extreme, despite having a history of PPD, for which they were previously 
treated. Neither woman seemed well informed and lacked the insight about their risk of 
developing PPD, which had a significant impact on their experience of maternal mental illness 
during their second pregnancy. 
For Sue, there was no wait time and access to mental health care was available right 
away. Sue was seen once at 34 weeks gestation, was not prescribed any medication (she was 
emphatic about not taking any medication), but was to have a few follow-up appointments. She 
delivered her baby three-and-a-half weeks premature, so she never returned to the service 
provider. Although she indicated that the early postpartum period was difficult, Sue felt fine with 
her care: They didn’t think that I needed drugs, and it sounded like they (service provider) really 
didn’t need to see me again. Rather, a few weeks after delivery, Sue attended a few sessions of a 
support group for postpartum women; however, she stopped attending the group because she said 
she felt judged. 
Although Tina was seen in a timely fashion, she expressed how difficult it was to wait for 
the first appointment: 
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It took what seemed like a long time; because I sort of felt that I was in a state of crisis - 
it might have been only 2 weeks, but it felt like a long time. ... Well, initially before I was 
on meds, I really did feel that I was in a state of crisis, and coping day-to-day felt 
impossible, so waiting any period of time for an appointment felt like an eternity.  
Tina stated: in my case, I started meds, and that helped immediately. If that had not been the 
case, once per month would not have been enough.   
Similarly, wait time was not an issue for Gabby, and she was grateful for being seen early 
in her pregnancy. Notably, one year postpartum, Gabby attempted to gain information and/or 
advice about mental health services and resources to help her deal with her spouse who had 
become depressed. She was frustrated with the how difficult it was to access care and/or other 
community resources: I needed to know how to handle this.  
Elyse remarked that she had to wait about two months for an appointment to access 
mental health care, which she felt was too long to wait. She was prescribed medication that 
helped after a little while and she was followed a few more times because the medication had to 
be adjusted a few times during the pregnancy. She continued follow-up with her family 
physician. At the time of the interview, Elyse was 18 months postpartum, and she admitted to be 
struggling with a relapse.  She attempted to gain access to her physician, when she felt she 
needed help the most, but it was not an easy feat. Elyse expressed a sense of hopelessness and 
frustration at being unable to access care, in a timely fashion:  
Like a couple of months ago, I was not doing well for three days, and I went to see my 
family doctor, but couldn’t get in (crying). That just makes you mad. ... and I know that I 
am not 100% - not even close, but I guess that I got it into my head that [I could] get 
back in , you just have to say something, and you could get help again. ... So, I did get an 
  
80 
 
appointment. I think it was not until a month later, and I was off by a day. It was actually 
a Tuesday, but it was supposed to be a Monday, so I didn’t bother to rebook and ... it was 
kind of like, well screw them, forget it.  
Elyse’s experience illustrated the effort required to seek help and access care when in a crisis and 
despair.  The end result seemed to be a why-try-attitude, which was a significant barrier to 
pursuing help for her current symptoms of anxiety and depression.  Amy described similar 
challenges re-accessing care, which seemed to contribute to her current mental and emotional 
distress and seemed to impact her sense of self-efficacy:  
At that point, I think that everyone just quit trying. I did call every phone number, as well 
the nurse, the office, the hotline, mental health services, every single psychologist and 
psychiatrist in the phone book, and everyone kept giving me more numbers to call. I 
finally quit.  
Because Amy was a health care professional, she further questioned her own ability: 
I say to myself, as an educated medical professional, how on earth did this happen to me? 
I was calling every number, going to the ER, going to my doctor, telling my husband 
everything, and he called in to say, “We need help! How on earth did this happen?” 
In sum, all the women during their pregnancy received mental health care quickly 
because their primary health care providers recognized their symptoms of antenatal anxiety and 
were aware of their risk of developing PPD and the need to access mental health care in a timely 
manner. Nevertheless, several the women described the waiting as being extremely difficult due 
to their distressing symptoms. Amy and Elyse who had a previous episode of PPD, delayed 
seeking help and accessing care in part due to a lack of knowledge and insight of their risk of 
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developing PPD with a second pregnancy. Although the initial access to mental health care was 
not an issue for the participants, trying to re-access care at a critical time was a significant 
concern for Amy and Elyse. Further, the perceived dismissive attitude of some health care 
providers was a barrier for Amy in accessing timely and appropriate care, which impacted her 
ongoing struggle with mental illness. 
On the other hand, many of the women in this study described their relationship with 
their primary health care providers as a vital and positive factor in their experience with mental 
illness and accessing care. All indicated that their physician took their concerns seriously, took 
immediate action and referred them for mental health care services, and provided ongoing 
support.   
Gabby’s family physician recognized her risk of maternal mental illness: It was good for 
me to have that safety net there so quickly. Similarly, Skye praised her family physician: my 
family doctor is probably one of the most amazing doctors. He basically turned into a counsellor 
half the time. Although Skye was ambivalent about the various experiences of getting help from 
health care professionals for her mental illness, she acknowledged the importance of having a 
positive connection with a mental health provider; that this was a key factor for therapeutic 
success:  
I think that a lot of it was after you found the one person that you are really comfortable 
with, it is really hard to find that same person again. ... I had an amazing counsellor, who 
helped me. ... I went to a couple of other counsellors, but I wasn’t as comfortable as I 
was with her.  
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In sum, the women’s experiences illuminated several bio-psycho-social aspects of 
gaining access to mental health care services. All of the women’s primary care providers 
recognized their symptoms and risk of maternal mental illness and referred them immediately for 
mental health care. The women felt supported and validated by their physician, which indicated 
the importance of the relationship women have with their primary health care providers. 
Although, the primary care providers continued the follow-up care, some were uncomfortable 
adjusting women’s psychotropic medication, especially during pregnancy. The effort and 
difficulty of gaining access/re-access to mental health care seemed to influence their depth of self 
stigma and their sense of self-efficacy, which seemed to contribute to their current condition and 
ongoing symptoms of anxiety and depression.  
Care satisfaction and outcome. Participants were asked about their satisfaction with 
accessing mental health care and about the care they received. Sue described her experience as 
being both positive and negative and seemed ambivalent. She said: it was more of a “tell us your 
history” and that was it. So, there wasn’t - other than talking about it - there wasn’t really 
anything [that was helpful other than the support group].  Although on the one hand, the support 
group helped her realize that other women had similar experiences, on the other hand, she felt 
some of the women were judgmental.   
Tina also seemed ambivalent about accessing mental health care although she found 
relief with the medication: I didn’t find the therapy particularly helpful, at all. I felt that I was 
disclosing a lot of information and wasn’t getting any feedback, or anything to help me. And then 
again, I responded very quickly to the meds, and at that point, I didn’t really feel that I needed 
anything else. I felt quite normal.  
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On the other hand, Gabby’s experience of accessing mental health care was described as 
helpful: it was good, and it was just nice to talk. I find that I learned something anyways. Like it 
was good to talk about the eating disorder again and to talk about the issues I had with 
infertility, because that was a big issue. Gabby recognized that it was good that the doctor had 
caught the PPD and referred her for mental health care: It was good that they caught it so soon, 
because what a waste to have gone through that. That year was hard enough - we had twins and 
it was hard enough and to feel the way that I was feeling. However, she expressed that although 
she was currently managing her anxiety with medication, she felt tied down by the health care 
system: I feel like I start to feel frustrated that I am so tied to the health system, when I have to 
go to get a prescription refilled, and I have to go to my doctor to get prescriptions, so that part I 
feel annoyed by.  
Elyse delayed seeking help until her symptoms of mental and emotional distress were 
extreme and she was grateful that her physician had recognized her symptoms and referred her 
for mental health care. She was seen several times to adjust the medication, during her 
pregnancy, and she was satisfied with the care. However, Amy and Elyse reported struggling 
with symptoms twenty-four months postpartum. Skye was the only participant who reported 
having a previous diagnosis of bipolar/anxiety disorders and was being treated, prior to accessing 
mental health care services. Skye shared feeling dismissed and being disappointed. Of note, 
although Skye’s experience accessing mental health care was uncomfortable, she chose to frame 
it in a positive manner, or in a way that suggested that it did not bother her. In other words, she 
stated that she did not receive any benefit from accessing mental health care, but decided to not 
let it have a negative impact of her ability to manage her mental health. This seemed to reflect a 
sense of self-efficacy:  
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[Although] the care services really didn’t do anything for me, I just kind of moved on 
when things didn’t work out. I didn’t really think much of it (laughter). … It was kind of 
disappointing, but it wasn’t hard because I understood that sometimes [doctors] don’t 
work out the way that you want them to.  
Amy expressed her disappointment and frustration that she was not provided feedback:  
The interview had very general questions. ... I felt that there were questions, and there 
was a lot of talking to me and not asking, and to be honest.  … I never learned about how 
common it [maternal mental illness] is, how to treat it, how long it lasts for, and what are 
the conditions may aggravate it. I learned nothing except to ask questions for surveys. 
Yah, there was nothing that I walked away with. No education whatsoever. We did have 
specific questions. That was more it. [The health professional] talked because we asked 
specific questions, but looking back, those questions were not relevant to the bigger 
picture of wellness. … Interestingly, no one ever did screen me for psychosis. And I can’t 
say that I wasn’t psychotic. 
In sum, the women were able to make sense of their experience of accessing mental 
health care, in a manner that suggested it contributed, either positively or negatively, to their 
experience of maternal mental illness. For a few women, a sense of ambivalence seemed to have 
a protective factor. The lack of helpful information about maternal mental illness and the 
opportunity to talk about their concerns when accessing mental health care was a factor in four of 
the participants’ overall care satisfaction with their treatment experience.  For some women the 
experience of accessing mental health care services involved aspects of stigmatization.  
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Information and research. Some of the women stressed the importance of obtaining or 
having access to information about various aspects of maternal mental health, such as 
signs/symptoms, risk/implications, treatment options, and psycho-educational resources.  This 
was identified as a crucial factor in the management of their condition.  
For Amy, the lack of information seemed to be a factor in her sense of self-efficacy and 
ongoing struggle with mental illness. This was also true for Elyse; the lack of awareness about 
PPD, her risk, and the implications of treatment engagement contributed to current condition. 
Moreover, for Amy and her spouse, the impact of not having enough information and/or access 
to resources and supports resulted in the decision to not have more children which she stated was 
a great loss.  
Gabby mentioned that her husband had seen a presentation on PPD which contributed to 
their increased awareness of the risk of developing PPD; subsequently, Gabby did not hesitate to 
access care early in her pregnancy. Yet, she did not recognize the symptoms she was 
experiencing during her postpartum period as being associated with having PPD. This was also 
true for Amy, Elyse, and Skye, which suggests the need for spouse and close others to have the 
information about maternal mental illness, as they are often the ones who can be more aware and 
vigilant.  
Gabby commented on the importance of doing research on maternal mental illness: It just 
seems obvious to me that when you are having hormone changes, obviously your moods are 
going to be greatly affected. Then, you are having major changes as well, which is going to 
affect your moods. It is an important area of research and you know, you are able to find more 
information about it and what people go through. Skye described how she educated herself and 
searched out information to help her manage her mental illness, without medication; this 
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empowered her to develop effective strategies and more self-awareness of her fluctuating moods: 
I have learned to tell when things are coming. Her spouse and her mother were also instrumental 
in being aware of her mental and emotional lability. Skye appeared to be very proactive in 
gaining a deeper understanding of mental illness by reading and informing herself. This reflected 
a sense of self-efficacy. Further, she acknowledged that reading about mental illness was 
instrumental in not only helping her manage and understand her own mood disorder, but that 
reading was also essential for everyone to engage in, to bring more awareness and understanding 
of those who suffer with mental illness:  
I just read [about schizophrenia] so that I could talk to [my friend] about her mother and 
actually know what I was talking about. And the same with bipolar - there is a book 
called “Manic” - I recommend that bipolar people read it. … Then you understand the 
way you feel and why you act the way you do. … So, anyone who does or doesn’t have a 
mental illness should read it. … It doesn’t scare you anymore. You are willing to ask 
questions. … You are able to ask questions about it. … And it is good to answer the 
questions because you are helping them to better understand and they don’t see you as a 
threat and they don’t see you as weird or crazy. The more questions they ask and you 
answer, the better they understand what you are going through.  
Although Skye’s experience of accessing care did not meet her needs, she acknowledged 
the importance of promoting public awareness and expressed her desire to contribute to research:  
I think that it kind of puts it out there, what mental illness actually is. … I so wanted to 
help with this study, so I filled out the surveys and stuff because it is important studies. … 
I felt happy knowing that I was at least helping out [a study], and figuring out this stuff.  
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In sum, what emerged as an important aspect of women’s experience of maternal mental 
illness and accessing care was the amount and quality of information/education they received 
from health care providers in regards to the risks and implications of maternal mental illness (for 
women, spouse, and family), signs/symptoms, treatment engagement and options, and psycho-
educational resources. Although some women were aware of the risk of developing post-partum 
depression they did not associate it with their symptoms of anxiety; however, their health care 
provider and/or family member had recognized it. The women’s sense of self-efficacy seemed to 
reflect a range of factors influenced by a lack of information and resources versus having an 
understanding, knowledge, and information about maternal mental illness.  
Women’s Experience of Stigma 
The previous sections recount some of the bio-psycho-social dimensions the women 
experienced living with maternal mental illness, accessing mental health care and revealed the 
multi-faceted factors that impacted many aspects of their day-to-day functioning, their level of 
emotional and mental distress, and their relationships with their spouses, families, and others. 
The socio-cultural context in which the women experienced their maternal mental illness 
provided another dimension of lived experience. Throughout the women’s interviews were 
several illustrations of the ubiquitous nature of social stigma associated with mental illness and 
the often invisible threads of self stigma, which were intertwined with the unrealistic 
expectations of joyful motherhood. For some women, stigma was a major factor in their 
experience of maternal mental and feelings of shame, in their ability to cope and in their 
willingness to seek help. Table 1 illustrates the themes of shame, vulnerability, and fear that were 
identified across interviews.   
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Table 1 
Stigma and Associated Emotions of Shame, Vulnerability, and Fear 
Theme Select Illustrative Quotes 
Shame  And you are just like an outcast, like you got this big bulletin board on your 
head that says, “I am messed up.” 
 Largely because my own religious beliefs, this stopped me from answering 
truthfully and also because I know that I should be a certain way, as a 
mother.  
 I hide a lot of what I was feeling. …. [I would think] just get over yourself. 
Having been through it, I still feel it that way. Because to me, it is selfish 
because it is not just about you, it shouldn’t be. 
 You know that [mental illness] is accepted, but at the same time, you are 
like, “I don’t want to be one of them.”   
 You can’t share with your friends how you are feeling because I would be 
like, “She should be so grateful. I mean not everybody can have babies, so it 
is a good thing it happens. They would think, “Women have babies, and it is 
perfectly normal, and they are fine and great, so why aren’t you?” It was 
like you were defective; you are not the perfect mom. 
 I had a pharmacist tell me, when I was filling my prescription, “Why do you 
need this, why can’t you just look at your baby and be happy?”  
 I had a big issue with the fact that I got pregnant on fertility drugs. I felt that 
it made it not as good and that people were judging me. 
 After I gave birth, in the mom’s group, it took me a long time to just say “we 
used drugs” because I would just hesitate for a while because I didn’t want 
to talk about it…. It feels like artificial babies. It is weird.  
 I was telling [the doctor] about [my family history of bipolar disorder], and 
I looked at her, and she rolled her eyes… 
 It took me awhile to share the fact that we weren’t getting pregnant, because 
I thought it was a reflection of my marriage - that we didn’t love each other 
enough, or we weren’t compatible enough to get pregnant.  
 I remember thinking all the other mothers were cooler that me - they don’t 
want to hang out with me because I won’t fit in with the mom’s group, kind 
of just really, really bad self-esteem. 
 Being “one of those people” who end up with a defect 
 The big thing that I think is important to know too is that I had never thought 
that I would be angry at my babies because they are babies and they are 
completely innocent and they have not done anything wrong, and I was 
angry at them, and I felt super bad about that. I felt guilty and sad 
 They were going to put me on an anti-depressant, and then on as-needed (an 
anti-psychotic), which I didn’t want to do, because that goes on my profile, 
and they will think that I am a crazy person (laughter).  
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Vulner
ability 
 “There may or may not be people behind that glass.” And I was just anxious 
because I didn’t know that I had a choice to say, “I don’t want all these 
people,” especially if she was going to ask me really personal questions 
about you know - depression and suicide and that kind of stuff.  
 We ended you not having any more children because of this problem and this 
fear. We made decisions that we just probably shouldn’t have and didn’t 
have to. Why was there not support in that aspect?  
 I went into the ER and I was very visibly pregnant. … I had told them that I 
had struggled with postpartum before, I am pregnant now and I cannot 
handle it anymore and I just wanted to come here to see the doctor. She 
laughed and said, “That is not going to happen today.” So, I just started to 
cry and I said that I was told that this person was here and I was sent here, I 
don’t know what to do anymore.  
 I was at a critical point that is why I went to my doctor. We were coming in 
desperation. 
 We have no support here; there is nowhere to go and no family to help. 
 There is absolutely no [mental health care] support. My only relief, which I 
have been open about, because I just don’t care anymore, is that someday I 
will die and that it will end. And I was told that it will end sooner than that, 
but I think that they are lying. I can’t stop thoughts coming to my head, 
which are negative. I do two forms of self-mutilation now. I have been 
struggling with insomnia. So, in this state, I am going back to work.  
 We have no support here. We weren’t offered any kind of community care 
access, everybody wouldn’t even look at him, when he had a medical 
problem. They would just tell him over the phone that he would get better in 
one more week. … For a year he suffered from depression. We went 
bankrupt because of that, so we lost everything, every asset we had. 
 I didn’t recognize it and I was just lucky that my doctor did. 
 I came off the medication [on my own] about six months after starting. Just 
because I felt I didn’t need it anymore. I felt that I was kind of over it, it’s a 
phase. It should just kind of clear up by now. 
 So, we went from a very successful couple with beautiful children, who are 
angels, and happy with lots of friends, to nobody, no family around, no 
finances, no savings, no security, almost no vehicles, maybe no home. 
Thankfully, we still have our marriage. 
 And then after [labour and delivery], you are totally exhausted and messed 
up. So, it was horrible and for the next three weeks, I was convinced that she 
was going to die.  I think it took 3 weeks to relax a bit, but it was not until 
she was 5 months that I was able to really relax. 
 It might have been only 2 weeks, but it felt like a long time. ... I really did 
feel that I was in a state of crisis, and coping day-to-day felt impossible, so 
waiting any period of time for an appointment felt like an eternity.  
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Fear / 
anxiety 
 I was terrified when I first found out that I was pregnant the second time, 
because I was so bad with the first. 
 It was horrible. I was convinced she was going to die. 
 I didn’t want my co-workers to know because I work with a lot of people  
who are harsh and judgmental-most of them 
 So when I got pregnant, I was very scared that I would miscarry and how I 
would handle that, if that were to happen 
 I am scared of going back to work  
 There was always this fear of your children getting taken away if you admit 
how bad you are. I thought to myself maybe she needs to be taken away. 
Maybe I need to be hospitalized; I can’t live like this anymore.  
 She fell on the ground and hit her head. … I realized that I just had an 
absence of concern. It was like I didn’t care and that really scared me 
tremendously because I didn’t know at that point if I was a danger to her.  
 I started having some anxiety issues, shortly after I got pregnant, pretty 
much immediately. And I think it was triggered by the fact that I found out 
immediately that I was expecting twins. I had a toddler. 
 IVF is a whole other area of major anxiety. My husband and I had trouble 
getting pregnant, so when I got pregnant, I was very scared that I would 
miscarry and how I would handle that, if that were to happen. I was kind of 
scared that I would fall into a depression. Infertility was a big issue. I went 
to see her right away after my positive pregnancy test because I felt that my 
period was coming and I was just like, “I think that I am pregnant, but if I 
am not I am going to be devastated. I know that I am going to be 
devastated.” We had used fertility drugs, too. So, that added even more 
pressure.  
 ” I was so afraid that if I was one of those people who did end up with a 
defect that could have been completely normal, I would totally blame myself 
if anything happened and I didn’t want to do that, so I just avoided that.  
 
 
Social stigma of mental illness. When asked to share their views, feelings and 
experiences of stigma, many similarities were noted in the women’s preconceptions and 
descriptions of stereotypes and of the stigma associated with mental illness and the harmful 
effects of prejudice and discrimination. Some of the women’s views illustrated the pervasive 
effects of social labels, of being judged, and of the negative psycho-social ramifications of 
having a mental illness. One of the implications of negative social stigma was being identified 
with a mental illness, the fear of being labelled “crazy,” and having their children taken away, as 
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a result. Some of the women equated stigma with being marked as “other” and as being less-
than. There seemed to be an implied association with being labeled with not only having a 
mental illness, but specifically with being a “mother” with mental illness, who should somehow 
be ashamed and feel unworthy of being a woman and a mother. This suggested a deeper level of 
stigmatization and the underlying social scripts which affect and dictate the everyday lives of 
women living with maternal mental illness and their sense of self. 
All the participants shared the awareness and understanding of the social stereotypes 
associated with mental illness, the impact this had on all aspects of everyday living and on their 
relationships and social interactions. Sue identified several common social misconceptions and 
stereotypes of mental illness: 
From what I have gathered, that if you have mental health issues, you are unworthy, you 
are scary, you are frightening. It is not worth talking to you because you are going to 
snap, or rip someone’s head off. And if you are pregnant - what were you thinking, 
getting pregnant and having a baby, because you are so unstable, and you really don’t 
deserve to have kids. … [Stigma] is labeling someone without knowing all the 
information, assuming. 
For Amy, stigma was not only a preconceived idea, a preset view, but also something that 
impinged on all aspects of life hindering her relationships and social interactions. She alluded to 
a sense of secrecy, a social taboo of disclosing or discussing mental illness, which fostered 
feelings of shame, guilt, and isolation. Having a mental illness and belonging to a faith 
community that denied its existence seemed very difficult for Amy, which was one of the factors 
that impacted her ability or willingness to share her mental and emotional distress with others: 
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[The stigma] oh, at church, at work. It is in so many aspects of your personal life - work 
life, religious life - it is all the same. You don’t talk about it. They don’t understand it - 
people think that you can control it - but you can’t.  
Elyse described stigma as being in state of despair and being marked as other - unworthy, 
which revealed a much more deleterious and insidious aspect of the social stigma of mental 
illness: It is a kind of hopelessness and you will always be that way. And you are just like an 
outcast, like you got this big bulletin board on your head that says, “I am messed up.” This 
spoke volumes about the psychological implications when social misconceptions become a 
gauge by which one’s character and sense of self is judged.   
Skye spoke of society’s underlying fear and misunderstanding of mental illness: “Oh, be 
careful of her because she might go mad on you,” because a lot of people don’t understand the 
disorder. …Mental illness is not like you are going crazy all over the place and talking to ghosts 
in the corner. 
For some of the women, the effects of negative social stigma seemed intensified, as a 
result of their social interactions and the perceived judgmental and discriminatory attitudes and 
behaviors of others. For instance, Skye perceived the circumstances surrounding being asked to 
leave/change school as a consequence of being a pregnant, single, teenage mom with bipolar 
disorder; thus, revealing multiple levels of stigma. Further, she shared an experience, while 
attending high school, which exemplified the pervasiveness of social stigma and the lack of 
understanding of and sensitivity toward mental illness, resulting in negative evaluations from 
others: 
When I was in high school, some of the teachers knew [I was bipolar], but the students 
didn’t. The students openly made fun of bipolar, and stuff like that, and it would be very 
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awkward.  Well, there was one case in the news about a woman who burnt down her 
house and her children in it. And the students were saying, “Well, she probably had 
bipolar—bipolar people do crazy stuff like that.” And I would be feeling uncomfortable, 
in the corner, because they didn’t know. I actually had a teacher in a psychology [class] 
who one day, said, “Imagine what it would be like to have a bipolar mother and an 
alcoholic father. That would be awful!” And I was thinking, “That was my life growing 
up - thanks, buddy!” You feel that they would look at you differently, like you could snap 
on them at any moment, and I am not like that. 
In addition, Skye’s relationship with her grandparents revealed the entrenched nature of 
negative social images of mental illness: When [my grandparents] found out that that was going 
to a psychiatrist - they automatically assumed, “That is good, you are not going to be crazy 
anymore.”  However, Skye was ambivalent, and rather pragmatic, about the social reality of 
prejudice and discrimination associated with mental illness and the underlying need to be 
cautious in her social interactions. Skye’s sense of ambivalence seemed to have a positive 
relationship with her sense of self-efficacy: 
When I started working, they would never know [I have bipolar] because even though 
they legally can’t, they can sometimes judge you differently, because of it. Legally, they 
are not supposed to, but they do. That is just how it is.  
In summary, the participants had a shared meaning and common understanding of the 
negative stereotypes, and social misconceptions associated with mental illness. Some of the 
women identified the psycho-social implications experienced as a result social stigma. All of the 
women had an awareness of the stigma of mental illness, and for some women an identification 
and internalization of the stigma and shame, which impinges on all aspects of life and social 
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interactions. Some alluded to a sense of social taboo or secrecy when interacting with others. The 
women had a shared experience of social stigma, either internally (impact on relationships and 
sense of self) or externally (the insidious harmful effects of prejudice and discrimination and 
negative evaluation from others). This highlights the importance of a woman’s social-cultural 
context in gaining a better understanding of and greater sensitivity to her experience of maternal 
mental illness and the entrenched and often unconscious adherence to the rigid social norms 
surrounding what it means to be a mother which relates very much to what it means to be a 
woman. 
Mental illness and the social construction of motherhood. Participants acknowledged 
the social norms and expectations of joyful motherhood as a factor in their experience of 
maternal mental illness and stigma. They spoke of the underlying pressure to conform to the 
unrealistic and rigid ideals of motherhood through their relationships and in their social 
interactions. This was often in the form of inappropriate questions and unsolicited advice or 
comments from others - including health care professionals. This was illustrated in Amy’s 
description of the myth of motherhood:  
Oh, absolutely [there are expectations]. To be happy, to have it together, to be on the 
scene and vibrant, be at home, or be working. There was a real sense of having to have 
an achievement greater than motherhood, I suppose. You know just to have it all 
together. This is supposed to be the best time of your life. … About being happy - I had a 
pharmacist tell me, when I was filling my prescription, “Why do you need this, why can’t 
you just look at your baby and be happy?” When I had asked her what these side effects 
were, so that I could just understand what was going on with my own self - that is what 
she told me. … 
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As a result of the experience of stigmatization, Amy felt judged, disempowered, and doubted her 
experience and judgment 
Gabby echoed the negative social misconceptions associated maternal mental illness and 
the use of medication, which illustrated an underlying fear of being labeled, marked, and 
identified with a socially stigmatized group: 
There are definitely people who don’t understand it, and I suppose there may be people 
who would be choked, if you were on anti-depressants, when you were postpartum, or 
that you could be ‘one of those women who smother their babies.’ 
Further, Elyse spoke of the psycho-social implications of the social norms and 
expectations of motherhood and mothering used not only as the gauge by which others judge 
mothers, but more specifically a gauge by which women judged themselves and internalized the 
shame.   
Myth versus reality of motherhood. Some of the women spoke of the disconnection 
between the expectations of joyful motherhood and the realities of the challenges of parenting. 
To varying degrees, all of the participants seemed to identify with and/or internalized the myth of 
motherhood; that is, the socio-cultural norms that views mothering as being easy, natural, normal 
and wonderful, the peak of women’s achievements, the greatest joy in a woman’s life, and the 
only reason for a woman’s existence  
Skye was ambivalent when she acknowledged the reality of being a mother was not 
always positive and had its challenges:  
I would admit that there have been some times when I was upset when I shouldn’t have 
been (laughter). I am human, children can be annoying sometimes, I am not going to 
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sugar coat that one - sometimes they will look at you and they know that they are doing 
something wrong, and they will break that thing that you absolutely love right beside you. 
And of course you are going to lose your cool. ... We are not perfect humans. 
Gabby described an incident at her mom’s group when sharing the challenges of 
mothering, which seemed to exemplify the expectation of being happy mothers and contented 
wives:  
The moms in my neighborhood, we got together, and it was really good because we did 
talk about [that]. I remember saying, “I have never been more angry at my husband in 
my entire life.” And, you know, they would just be like, “Yah, me too.” That was just 
completely irrational anger and then I remember thinking, “If he drinks from the milk 
carton one more time without pouring it in a glass, we are getting divorced.”  
For Gabby, being able to share these negative emotions with other women had been beneficial in 
normalizing her experience and feeling supported.  
Sue spoke of how society makes women feel for wanting to have time away from their 
children, which pointed to a discrepancy between society’s parental expectations for men and 
women:  
When a guy spends an hour per day with his kid, he’s a great dad. But, if she wants to 
have time off, she wants to be away from her kid and then everyone thinks how come you 
want to be away from your kids?”  My life was different before; his life was different 
before; it has to change.  
Tina also acknowledged the challenges of mothering and needing help with accepting a 
sense of ambivalence: a lot of it is difficult, but the difficult times don’t last very long, so I try not 
to dwell on them.  
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The women identified and internalized negative socio-cultural messages and scripts of 
motherhood to varying degrees. Of note, for some participants accepting a sense of ambivalence 
seemed to be a positive effect on their sense of self, which was also linked to participants’ sense 
of self-efficacy. 
Motherhood and infertility. Sue, Tina and Gabby, who conceived using IVF, spoke of 
their experience with infertility and the process of IVF as a major factor in their experience of 
the stigma. Each woman had a keen awareness of the negative social stigma surrounding 
infertility, using fertility drugs and IVF, and multiple births. All had a strong desire to avoid the 
harmful effects of stigmatization. Further, they had a shared experience of feeling judged and 
receiving unsolicited comments and intrusive questions from others, which was internalized to a 
greater or lesser degree. 
Sue’s thoughts on the stigma surrounding infertility revealed a number of negative social 
misconceptions of women who have difficulty conceiving, especially the underlying negative 
evaluation of being an older mother - she was 39 years of age when she delivered:  
A lot of people say, “It’s because you are older.” It’s not like I told people, people don’t 
know, and they comment, “Oh, when you are older, it hurts your chances [of getting 
pregnant].” “Oh, you are an older mom; therefore you have no eggs. You are going to 
have a kid with Down’s syndrome or another significant disability.”   
Tina and Gabby, who had twins, spoke directly of the effects of negative social stigma 
associated with the use of fertility drugs, and especially with having multiple births, which 
indicated a shared experience of being judged. Tina expressed her frustration with such inquiries 
when people noticed her twins: The number one question they ask is whether they run in the 
family or fertility drugs. ... But it isn’t really something that I wanted to share with people 
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because I don’t feel that it is any of their business. Gabby echoed similar sentiments; however, 
she went further to point out that feeling judged had a significant impact on her sense of self and 
her ability to share her experience with others: 
Speaking of stigma issues, I had a big issue with the fact that I got pregnant on fertility 
drugs. I felt that it made it not as good and that people were judging me. I even had 
issues when I was working. People would ask me, “Oh, you have twins, was it natural or 
did you use drugs?” or “Do they run in your family?” and then I just felt instantly judged 
like there was something wrong with my body, or that I couldn’t. ... And then after I gave 
birth, in the mom’s group, it took me a long time to just say “we used drugs” because I 
would just hesitate for a while because I didn’t want to talk about it. So, there is that 
stigma too.  It feels like artificial babies. It is weird.  
This not only made Gabby doubt her experience, but also made her question her own body as she 
internalized notion that motherhood and reproduction was normal and natural versus artificial 
and unnatural. 
In summary, for the participants having a maternal mental illness was not only about 
experiencing the stigma associated with mental illness; it was also about how they perceived 
themselves and how they felt they measured up as women, mothers, and wives.  
Self stigma and maternal mental illness. The women’s experiences revealed certain 
aspects of self stigma involving the identification with, and the internalization of, the negative 
social misconceptions associated with being a mother with a mental illness, being unable to cope 
and needing help, taking psychotropic medication, and using IVF and fertility drugs to conceive. 
All of the women were keenly aware of existing negative stereotypes of maternal mental illness 
and the unrealistic expectations of motherhood, some agreeing with and/or applying them to 
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themselves, to a greater or lesser degree. Participants spoke of the psychological impact of 
identifying and internalizing various negative aspects of social stigma, that is, self stigma.  
For some of the women, self stigma was associated with the fear of being labeled (bad, 
unfit, crazy), being judged and rejected by others for being a less-than-perfect mother, and for 
needing help with managing and coping, not only with their maternal mental illness, but also 
with the challenges of mothering. As a result, this affected their social interactions, willingness 
to seek help, the degree to which they disclosed their mental illness, their level of treatment 
engagement and their sense of self-esteem and self-efficacy.  
For some of these women, self stigma seemed to be characterized by a sense of self-
devaluation: shame, blame, guilt, remorse, feelings of being self-indulgent, feeling like a failure 
for being unable to handle motherhood, and being defective/weak for needing to take 
medication. Thus, this demonstrated that at some level, these women identified with and/or 
internalized the negative social misconceptions and expectations of motherhood, while some 
anticipated and feared the prejudice and discrimination associated with it, as a result of their 
personal experience. For some women, self stigma and their diminished sense of self were linked 
to feelings of shame, which reduced the motivation to seek care and/or continue with the 
suggested pharmaceutical treatment, and which greatly impacted their self-efficacy, potentially 
hindering their chances of recovery.  
Factors influencing self stigma. Self-efficacy emerged as a key psycho-social factor in 
the women’s experience of maternal mental illness and stigma and the treatment outcome— their 
belief in, confidence about, and sense of personal adequacy in their own ability to manage the 
various challenges of having a maternal mental illness. Further, self-efficacy seemed linked to a 
sense of resiliency and feelings of shame, blame, guilt, and ambivalence. Several psycho-social 
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factors emerged from women’s experience of self stigma and sense of self-efficacy, including: 
the fear of being judged and rejected, the dismissive attitudes of others, the level of disclosure, 
the meaning of being on medication, and the factors influencing the level of self-efficacy.  
Fear of being labeled, judged, and rejected. Some of the participants expressed the fear 
of being labeled ‘crazy’, being judged as an unfit mother, and being rejected, as a result of 
having a maternal mental illness, which impacted how they interacted with their family, friends, 
co-workers, and most importantly, their health care providers. For some participants, this fear 
was a barrier in seeking mental health care and influenced their treatment experience. For Elyse, 
the stigma of having a maternal mental illness meant being marked as less-than-perfect, and 
therefore, a defective mother, and a label to be avoided: You know that [mental illness] is 
accepted, but at the same time, you are like, “I don’t want to be one of them.”  This led to her 
fear of being seen as incompetent: In my job, it would show that I am weak - you know? Elyse 
identified with the social expectations of mothers and had internalized feelings of shame, blame, 
and guilt for being unable to manage her maternal mental illness:  
I can’t handle life and my life isn’t bad. There is nothing bad about my life. I mean when 
I was younger, stuff happened, who doesn’t have that right? There is always something. 
… The self judgment is still there. … You know logically, you should be happy, you 
should be grateful. I mean she is perfectly healthy, there is basically nothing wrong.  
Elyse described her reluctance to share her emotional and mental distress for fear of being seen 
as ungrateful and self-indulgent, causing her to feel isolated: 
You can’t share with your friends how you are feeling because I would be like, “She 
should be so grateful. I mean not everybody can have babies, so it is a good thing it 
happens. They would think, “Women have babies, and it is perfectly normal, and they are 
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fine and great, so why aren’t you?” It was like you were defective; you are not the perfect 
mom.  
Elyse’s fear of being seen as a less-than-perfect mother revealed the impact of internalizing 
feelings of shame:  Just get over yourself. Having been through it, I still feel it that way. Because 
to me, it is selfish, because it is not just about you, it shouldn’t be. This emerged as a factor in 
her ongoing maternal mental health problems, precluding her need for self-care:  
[I am working] full-time and somehow, I find myself trying to do everything, and I know I 
can’t, which is why I am sick right now, because I have worked, I don’t know how many 
days. I will go in on my days off, and I think that I have to do everything now and try to 
make it all better. (crying) …I am more understanding of other people’s faults and I have 
almost zero tolerance for my own faults.  
It is also important to note the role that inadequate self-care, lack of sleep, and 
internalized self stigma and feelings of shame, blame, and guilt, and decreased self-efficacy 
played in her capacity to cope in the midst of her mental and emotional distress, which seemed 
ongoing at the time of the interview. This was also the case with Amy. 
Amy acknowledged her fear of being labeled and judged had hindered her social 
interactions with others, for a number of reasons. Amy recognized how her beliefs, both personal 
and religious, got in the way of getting appropriate mental health care as she was afraid of being 
labeled crazy by admitting the severity of her mental and emotional distress and extreme 
psychotic symptoms during her pregnancy:  
And largely because my own religious beliefs, this stopped me from answering [the 
questionnaire] truthfully, and also because I know that I should be a certain way as a 
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mother. There was always this fear of your children getting taken away, if you admit how 
bad you are.  
Amy’s fear of being labeled and judged was further reinforced by some of her encounters 
with health care professionals which intensified her experience of self stigma and feelings of 
shame when accessing mental health care:  
I went into the ER and I was very visibly pregnant. … I had told them that I had struggled 
with postpartum before, I am pregnant now and I cannot handle it anymore and I just 
wanted to come here to see the doctor. She laughed and said, “That is not going to 
happen today.” At triage at [the ER]. So, I just started to cry and I said that I was told 
that this person was here and I was sent here, I don’t know what to do anymore.  
Amy also described an uncomfortable and stigmatizing experience when accessing mental health 
care 
There was a resident and there was a bunch of people laughing behind the glass. [The 
health professional] said that there were people observing and I was sitting closest to the 
glass, and I could hear them laughing, talking, and chatting, and I just thought, “Oh 
well, this is a joke.”  … [That experience] completely reinforced [the stigma]. 
Apparently, no one took me seriously and no one asked enough questions. 
Amy stated that she felt that some health care providers were dismissive, disrespectful, 
and unprofessional which was a factor in her reticence in disclosing the full extent and severity 
of her symptoms. These experiences fostered feelings of shame, vulnerability, fear, and feeling 
judged, which influenced her treatment experience and her ongoing struggle to manage her 
mental and emotional distress. During the interview, Amy spoke directly of her mounting 
  
103 
 
anxiety of returning to work and her fear of being judged or rejected by her co-workers after 
being on long-term disability, as a result of her severe symptoms:  
I am scared of going back to work - you were talking about perceptions in the public eye. 
I am nervous to go back to work because of my co-workers. It hasn’t been a vacation for 
me for the past 6 months that I have been off work.   
This seemed to reflect a social misperception of women/mothers living with mental 
illness who need to take time off work - a stress leave, for example - and the fear of being 
viewed as self-indulgent or as an indication of being an unfit mother.  
Skye also felt judged and dismissed as a result of her interactions with health care 
providers: 
I was telling [the doctor] about [my family history of bipolar disorder], and I looked at 
her, and she rolled her eyes, and she went like (facial movement). I felt kind of 
uncomfortable. Afterwards, I talked about my highs and stuff, and what they are like. 
And, she basically told me to come back if I wanted to kill myself.  Yah, so I was thinking, 
“Ok, I am not going to come back to you ever” (laughter).  
However, despite the encounter, Skye decided to frame her experience in a positive manner, or in 
a way that suggested that it did not bother her. This seemed to reflect a sense of self-esteem and 
self-efficacy. She was ambivalent about her encounter. As previously seen, a sense of 
ambivalence seemed to be a protective factor in some women’s experience of stigmatization.    
The fear of being judged for using IVF emerged as a factor influencing three of the six 
women’s experience of self stigma, as well as their self-esteem and self-efficacy in various ways, 
which revealed the underlying social scripts of motherhood and female reproduction. Gabby 
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spoke of her struggle with social misconceptions of infertility and the impact it had on her 
experience of self stigma and her sense of self: 
It took me awhile to share the fact that we weren’t getting pregnant, because I thought it 
was a reflection of my marriage - that we didn’t love each other enough, or we weren’t 
compatible enough to get pregnant. The other thing that I felt angry at was my body.  
 And then I just didn’t want to share and people would always ask, “Oh, are you guys 
going to have kids soon?” and I didn’t want to share that we weren’t. I don’t think that I 
shared it all actually, until I was pregnant, that we had that much trouble. And it was just 
so painful when people said that they were pregnant and we still weren’t.  
Gabby shared how this diminished her sense of self and impeded her social interactions: I 
remember thinking all the other mothers were cooler that me - they don’t want to hang out with 
me because I won’t fit in with the mom’s group, kind of just really, really bad self-esteem.  She 
shared the dissonance she felt between social expectations of being happy and the reality of her 
own experience, which fostered feelings of shame, blame, and guilt:  
The big thing that I think is important to know too is that I had never thought that I would 
be angry at my babies because they are babies and they are completely innocent and they 
have not done anything wrong, and I was angry at them, and I felt super bad about that. I 
felt guilty and sad, but think that after talking to the other moms, I felt that it was like a 
normal thing to feel.  
However, Gabby acknowledged the importance of identifying a shared experience with other 
mothers as a means of normalizing her negative emotions and self stigma.  
The fear of being judged and rejected was also a factor in Sue’s experience of stigma in 
her social interaction when sharing her emotional and mental distress with other mothers in a 
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support group: It was kind of isolating because some of them were really judgmental.  So 
anyways, I stopped going at that point.  
The social misconceptions associated with infertility and the use of fertility drugs and 
IVF was a psycho-social factor in Sue’s experience of self stigma and fear of being judged, as a 
result of inappropriate comments from co-workers: 
 [People would ask] just inappropriate questions. You know, I got a lot of stupid 
comments, even when I was pregnant. ... I told one guy at work because his sister had 
gone through similar things. ... He was like, “Yah, at least you didn’t do like Octomom 
because she had just had her babies through IVF, and at least you didn’t use fertility 
drugs,” and I was like “go away.” I wanted to say, “Why would you say that, that is a 
ridiculous comparison, not every woman is going to say put 6 embryos in and fertility 
clinics don’t even do that in Canada!” But, I had to leave it as a stupid comment and 
walk away.   
The role of media was also identified by Gabby as a means of promoting women’s mental health:  
I think that in the world of Oprah and TV, people are more aware and women tend to go 
to the doctor more. I think that mental health is something that people are paying more 
attention to, and I should be more happy in my relationships, and this and that.  
Further, for Elyse, media coverage and celebrity status was identified as important in 
normalizing her experience of maternal mental illness: there is a lot of talk about it. There is 
Brooke Shields - it can happen to whoever. I know that she felt like she was the worst person in 
the world. 
In sum, the fear of being negatively labeled, judged, and rejected by others was evident in 
most of the women’s experience of self stigma. Some of the participants seemed to have 
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internalized negative self stigma, fear, shame, blame, and guilt, to a greater degree, greatly 
impacting their self-efficacy, which was a major stumbling block in their ability to manage 
and/or seek help for their mental illness. However, other women had a sense of ambivalence 
about self stigma, some choosing to frame their experience in a positive manner; while others 
indicated that sharing with other women helped normalize their experience of maternal mental 
illness and the realities of motherhood, decreasing the negative effects of self stigma. 
Level of disclosure. Another psycho-social factor that emerged as a significant factor in 
women’s experience of maternal mental illness and the effects of social and self stigma was their 
level of disclosure. Each participant described the experience of disclosing or sharing with others 
their mental health concerns, having problems conceiving and taking fertility drugs, and /or 
having challenges of being a mother. For some of the participants, being in control of certain 
aspects of their maternal mental illness allowed them to mitigate the harmful effects of social and 
self stigma - being control of deciding who to tell, or not to tell, or how much to tell.  
Some participants spoke of an element of secrecy and feelings of shame and guilt when 
admitting to withholding information or minimizing their mental distress. Some acknowledged 
their efforts to hide their mental illness - passing as normal to avoid being stigmatized, judged 
and/or discriminated against. Elyse felt isolated due to her reluctance to disclose her situation 
with others for fear of being judged. She also revealed that she would censor herself when seeing 
her physician.  
Similarly, Amy did not disclose her situation with friends and revealed how she was 
practiced at hiding, and how she took the time and energy to portray to the public that she was 
normal and competent at handling life and mothering. She also pondered, in retrospect, about 
whether her efforts at passing hindered her access to appropriate care at a critical time:  
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The odd thing is, when things are bad, I actually look good. I do my hair carefully, wear 
my makeup carefully, because I am trying to put on another persona in order to get 
myself from A to B. Perhaps, that was why they turned me away in the ER.  
Amy acknowledged how difficult it was for her to share her concerns with others, especially 
other health care professionals, and that she censored herself:  
Those of us who are in the worst condition don’t want it to leave our hearts. Those of us 
who are in the worst situations are so focused on lying to the public. … I did have 
depression before, and I told them outright that it wasn’t bad - I did lie. I did go off 
medication, it didn’t go way, and this is a known condition…. I hid the self-mutilation, 
and I am not proud of that.  
Not fully disclosing the severity of her mental illness seemed to indicate a fear of being judged, 
which along with feelings of fear, shame, blame and guilt, was a factor in Amy’s treatment 
experience and satisfaction, and health outcome as well as her sense of self-efficacy.  
When asked about sharing her situation with others, Sue indicated being selective in 
disclosing; however she seemed ambivalent about it at times:  
I think that because I have gone to the place where I know that the people who accept it, 
accept it; the people who don’t, won’t. I am fine with that. So the people who accept it - I 
have a pretty good idea of who does and I have a pretty good idea who doesn’t. So, if the 
opportunity came up, and I felt that there was a good reason for it, I might share it with 
the person who would understand. But, the person who wouldn’t understand, I would just 
leave it. There is no point in going there.  
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Sue had selectively disclosed to her family, but became angry and felt disappointed when her 
mother-in-law betrayed her confidence. Sue expressed the need to be in control of her own 
experience and information:  
So I told [my mother in-law] and then my sister in-law mentioned it to me one day. She 
didn’t say it in a judgmental way at all, which surprised me also, but I didn’t want her to 
know. I want to pick because it is my ordeal - I want to know who knows. 
 Tina also seemed ambivalent about selectively disclosing her situation with family 
members and some close friends: I have shared my [mental health] concerns with my close 
friends and family. I don’t feel any sort of stigma from them. It is not something that I would tell 
a stranger. It is sort of a personal issue. Interestingly, Tina chose to avoid a situation in which 
she might have had to disclose the status of her pregnancy when accessing mental health care; 
she commented on how she did not want to be seen by a family friend, so requested to be seen in 
the department of psychiatry: I actually requested not to go to West Winds location because we 
have family friends that work at the clinic and at that point, I didn’t want anybody to know that I 
was pregnant. It was very early on in the pregnancy. 
 Selective disclosure, for Gabby, meant choosing with whom and when to share her 
feelings and experiences with other mom’s in her neighborhood mom’s group, although she 
admitted that it took her a while to feel comfortable to share. She described how sharing her 
feelings of anger and frustration, via email, was helpful in her feeling less isolated: I think that 
email has been very good too because sometimes you can express things in an email that you 
wouldn’t. Gabby recalled a moment of shared experience, where she felt supported as a result of 
being able to reveal her feelings and struggles with other moms in her group, which helped 
normalize and validate her feelings of anger and frustration:  
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I emailed one day and I said that “I am going to stuff this way deep down and I wasn’t 
going to tell anybody that I did this - I got so angry today that I threw a glass down and 
smashed it on the floor.” And they all emailed back and they were like “I am so glad you 
shared."  
Talking to other mothers was definitely beneficial in helping Gabby normalize her experience, 
increase her sense of connection, thus enabling her to manage her symptoms. This was echoed in 
Sue’s experience of attending a support group for moms with postpartum depression which 
helped normalize her feelings, on one hand, but on the other hand, she felt judged and rejected 
for disclosing her feelings, leading her to discontinue attending the group. Similarly, Skye would 
selectively disclose her mental illness as a way to moderate the negative effects of stigma in 
social interactions, hence preserving her self-esteem which also indicated self-efficacy: 
There are people who I have learned to reach/not reach out for help - like my 
grandparents on my dad’s side. ... I just don’t tell them about how things are. If I am 
having a rough time, they don’t hear about it. I don’t need to hear their judgment, 
especially since they have no idea about anything. If they don’t know, they have no right 
to say a single thing, so I am not going to say a single thing to them. 
 In sum, the underlying awareness of the risk of being judged and rejected influenced the 
level of disclosure, which was a significant factor in women’s experience of self stigma and self-
efficacy.  All the women selectively disclosed as a means of moderating and mitigating the 
negative effects of self stigma. Some women attempted to pass as ‘normal’ to be seen as 
competent, avoided situations to maintain secrecy and/or in which they perceived stigmatization 
from family, friends, and others.  
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Being on medication. Another factor influencing women’s experience of self stigma and 
self-efficacy was being on medication and what meaning they made of it. Five of the six 
participants shared their experience of having a maternal mental illness, being on medication, 
and the impact this had on their self-esteem. Sue was the only participant who opted to not take 
psychotropic medication. Three women identified and internalized the negative self stigma of 
being a mother with mental illness who needed psychotropic medication to cope which was 
perceived as a failure, or weakness on their part. For a few women, the feelings of shame, blame, 
and guilt were common emotional experiences associated with maternal mental illness and 
needing pharmacological treatment. 
For Amy, being on medication was associated with the social misconceptions of 
motherhood: It is a perception of failure. It is something that‘s supposed to be natural. … You 
feel like a failure in your mind. Elyse shared this sentiment which illustrated the products of self 
stigma - a sense of shame and guilt:  
I was not [feeling] very good [about myself]. I was kind of like, “there is something 
wrong with you, and something doesn’t work. It is not normal. You shouldn’t have to take 
medication. Your thinking is a bit twisted. You know logically, you should be happy, you 
should be grateful.  
However, she had also described the medication as providing relief of her symptoms and helping 
her cope with mental illness, which seemed to point to some ambivalence. Of note, at the time of 
the interview, Elyse admitted her reluctance and resistance to seeking further help, or resuming 
medication, despite feeling extremely stressed and overwhelmed. She avoided seeking help in 
what seemed to be an effort to convince herself that she could manage without taking medication 
- being a perfect mother also meant being able to cope.  She had previously indicated that her 
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reluctance to resume medication was also due, at least in part, to her unwillingness to address 
relationship issues with her spouse. She appeared to struggle with what her perception of taking 
medication may mean about her, as well as what it may require of her.  
Interestingly, both Amy and Elyse had discontinued the prescribed medication without 
consulting their physician, during their second postpartum period. The rush to be off medication 
illustrated a shared meaning of the underlying negative self stigma associated with taking 
psychotropic medication and the strong, if unspoken, desire to avoid the perception of being an 
incompetent and unfit mother. Further, Amy and Elyse experienced side effects with the 
medication. This had a significant impact on their self-esteem, self-efficacy, and their current 
level of functioning.  
Gabby acknowledged the negative social stigma associated with maternal mental illness 
and the use of medication. She opted to avoid taking medication during her pregnancy, despite 
symptoms, not only to avoid the possibility of adverse effects, but also to avoid self stigma and 
the shame, blame, and guilt associated with - being “one of those people” who end up with a 
defect. What was interesting was her use of language which unconsciously identified an element 
of otherness - not wanting to be “one of them.” The need to take medication in postpartum 
became an issue of self stigma which directly impacted how she felt as a mom who needed help:  
I felt a bit like a failure, just going on medications always does, like you couldn’t keep it 
together. [A perception] I would have on myself [because] you have control of your 
brain, (laughter), and just that you should just stop thinking of what you are thinking and 
start to think something else - it is hard to do. I heard stories of other moms with PPD 
and so I was glad that I didn’t get that far. But, I don’t know, I felt bad about myself.  
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This indicated an internalization of negative aspects of self stigma associated with maternal 
mental illness which increased the feelings of shame, blame and guilt, which had a significant 
impact her self-esteem. What was interesting about these comments was the fact that Gabby had 
stated, a couple of times in the interview, that she had no shame about mental health issues and 
denied fearing outside opinion, because of having gone through it. However, when sharing her 
experiences Gabby seemed to have identified and internalized self stigma, one that clearly 
revolved around taking psychotropic medication:  
I almost felt like I had almost a good reason to be on an anti-depressant, like finally 
somebody knows. You know, if a pharmacist fills my prescription and I have babies, they 
would think, “Yah, she needs that.” I don’t know, that it wasn’t a weakness on my part, 
that I really needed it, but I can’t see that I felt ashamed or that I was going to be 
labeled.  
Her words seemed to reflect a strong desire to justify the need to use medication (having twins), 
rather than being perceived as having a weakness or being crazy. For Gabby, there was a direct 
contrast between her comments about not being ashamed or worried about being labeled and her 
seemingly unconscious resistance to taking crazy drugs:  
They were going to put me on an anti-depressant, and then on as-needed (an anti-
psychotic), which I didn’t want to do, because that goes on my profile, and they will think 
that I am a crazy person (laughter). … I had the prescription written, and I didn’t want to 
fill it … and I didn’t want to take it. And then I brought it to my pharmacy. I knew what 
they would be thinking, “That is why she was so grumpy - because she is crazy.” 
(laughter). Because I was so grumpy that they took so long to fill my prescription and 
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then I thought that they would see that I didn’t fill it and they would think, “She is not 
taking her crazy drugs.” (laughter).  
What was striking was that Gabby associated certain psychotropic medication with “crazy drugs” 
which seemed to indicate, for her, that taking certain medications implied a simultaneously 
membership within the ranks of a stigmatized group - a mother with a mental illness. When 
asked about the contradiction between her reluctance to take medication, despite her health care 
training, and it being alright for other mothers to take meds, Gabby recognized the discrepancy: 
 Well, obviously I am thinking that way. And I would like to think that I don’t, like you 
know, when I see people coming through on those drugs, but I hope not - among 
professionals anyways. And then non-professionals wouldn’t even know what the 
medication is for. 
Gabby began taking medication during postpartum and continued to do so at the time of the 
interview. She seemed to be ambivalent about taking medications; on one hand, she did not want 
to be identified as “crazy” for taking them, and on the other, she was not anxious to get off of 
them. 
For two women (Tina and Skye), taking medication did not have a negative impact on 
their sense of self and self-efficacy. Although, Tina had used IVF and was taking medication, 
since her pregnancy, to help with her symptoms of anxiety, she had not internalized the negative 
self stigma of being a mom needing to be on medication. But rather, she had a sense of 
ambivalence about having to take medication, had been treated successfully for anxiety in the 
past, and had made a conscious choice to not worry about it, which indicated a certain level of 
self-efficacy, and a lack of internalized shame or guilt: I am fine with it. I have no issues with it 
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at all. Only because I felt completely crazy and unable to function without it. … I feel that I am 
able to cope and being on meds has allowed me to be able to cope, so that is as much as I think 
about it. Skye, on the other hand, expressed concern about not being on medication for her 
bipolar disorder, and her ability to be a good mother, since she had stopped taking it during her 
pregnancy: 
I was kind of nervous, you know, not being on medication and becoming a mother. I was 
taking every tip that I possible could to make sure that I was ok. I was kind of worried 
that I wouldn’t be able to do it, [motherhood]. … “What am I doing, should I really be a 
mother? I can’t take care of him, if I can’t take care of myself.” 
 In sum, for some women the self stigma of being on psychotropic medication for 
maternal mental illness was associated with the fear of being labeled - a crazy and less-than-
perfect mother who is unable to cope - which lead to feelings of fear, shame, blame, and guilt. 
This appeared to be linked to the women’s sense of self-efficacy. As a result, some women 
stopped, avoided, or were ambivalent about taking medication, although they all spoke of the 
relief of symptoms. Other women indicated that they chose to continue taking medication, as it 
helped them cope and stay in control of their emotional lability. 
Level of self-efficacy. The women’s level of self-efficacy was influenced by the negative 
effects of self and social stigma. Self-efficacy was demonstrated in their ability to cope and 
manage their maternal mental health problems and in the strategies they used to resist, moderate, 
and/or mitigate the negative effects of self stigma on their self-esteem (feelings of shame, blame, 
and guilt) and/or in their social interactions (fear of being judged, rejected, and isolation), which 
was related to their willingness to seek help, their treatment engagement, and their level of 
disclosure. Self-efficacy seemed to indicate a sense of resiliency which was influenced by 
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several factors associated with the women’s feelings, actions, reactions, and outcomes related to 
the experience of having a maternal mental illness and the self stigma surrounding it: perceived 
sense of control, ability to cope, level of disclosure, depth of self stigmatization, level of support, 
and information access.  
Being in control for participants meant deciding who to tell, and who not to tell, when to 
tell, and how much to tell, taking medication or not taking medication, and being proactive or 
not. This impacted the women’s level of self-efficacy, to a greater or lesser degree. As previously 
discussed, all of the women used selective disclosure as a means of being in control of the 
negative impact of stigmatization; however, for some women the lack of disclosure impeded 
their treatment satisfaction and outcome, their level of treatment engagement, and their social 
interactions, which further impeded their sense of self-efficacy.  
Being in control for Elyse seemed to mean discontinuing the medication on her own, six 
months after delivery because she felt that she did not need it. However, at the time of the 
interview, Elyse’s level of self-efficacy seemed limited; she seemed to have diminished self-
esteem, feelings of being overwhelmed, and was not coping effectively. Elyse also avoided 
sharing her situation with friends as she feared being judged and rejected, which contributed to 
feelings of isolation and shame.  
Similarly, after prematurely discontinuing the medication, Amy’s sense of self-efficacy 
was limited, due in part, to a fear of being judged and a resistance to seeking help, influenced by 
her beliefs, her personal experiences of enacted stigma, and the dismissive attitudes from others 
impacting her self-esteem. For Amy, being in control also meant trying to manage, contain, and 
avoid her mental and emotional distress without support: 
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The curtain dropped on what I feel inside, and even last week, I just really felt that I 
made a stride forward, and even [my husband] couldn’t see it. I am so practicing at 
hiding. To break that wall down - that is all I have left holding me together. Why on earth 
would I jeopardize that? Why would I ask for a cathartic experience when there is 
absolutely no support?  
Of the six participants, Amy and Elyse appeared to have the lowest level of self-efficacy, 
at the time of the interview. They had stopped medication prematurely, for various reasons, and 
were attempting to manage their symptoms on their own. Their level of self-efficacy was 
reflected in their coping strategies: avoidance; denial; resistance; overworking; and withdrawal. 
Further, they acknowledged a sense of hopelessness and helplessness, which seemed to hinder 
their willingness to seek help and engage in various aspects of life, to avoid the impact of self 
and social stigma.  
Skye had been diagnosed with bipolar disorder which had been pharmacologically treated 
since her teens. She stopped all but one of the psychotropic medications, early in her pregnancy. 
However, Skye discontinued the one medication, during her pregnancy and had been coping and 
managing well with her mental illness at the time of the interview. However, unlike Amy and 
Elyse, this did not result in a relapse, but rather Skye demonstrated a high level of self-efficacy, 
healthy self-esteem, and effective self-care. Further, Skye seemed to have a low level of self 
stigma and did not indicate feelings of shame, blame, and guilt; but rather demonstrated 
resilience to the negative effects of stigma and had a sense of ambivalence about her experience 
of maternal mental illness. Having support from her spouse and family and their vigilance and 
awareness of signs were also factors in her level of self-efficacy. This was interesting, especially 
being the youngest participant (18 years of age when pregnant and age 20 at time of interview) 
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with a history of bipolar and anxiety disorders. She was proactively engaged in finding useful 
resources, in reading to increase her knowledge and understanding of mental illness, and in 
learning new skills to manage her mental and emotional lability and the challenges of parenting.  
Skye described how she learned to monitor and manage her moods and how she taught herself 
effective coping strategies:  
Actually, I was off medications since I was pregnant. I have been doing really well. There 
was a book called the “Anxiety & Phobia Workbook.” I got that and that helped out big 
time actually. ...  So I basically did it myself. … I have learned to tell when things are 
coming, you know? My husband looks out for the signs, like for instance, when a manic 
sign is coming, he takes my bank card away. With the irritability, I learned to basically 
control for the most part, except for when PMS – that kind of adds to everything - that is 
pretty bad, but with the lows I have learned to completely control them now. It is amazing 
- like if I feel like I want to crawl into bed and turn off the lights and not do anything with 
life, I force myself to get up and do something productive that I haven’t done in a long 
time and I will go and run all these errands. It kind of pushes me to get out of that state, 
and it actually works really well because you feel like you have done something, and you 
feel proud, and it builds you up and gets you out of that low. 
Sue seemed to have a sense of self-efficacy despite not taking psychotropic medication 
for her maternal mental illness. Being in control was an important element in her ability to cope - 
who to share with and who not to, and having support. In addition, Sue made it clear when 
accessing mental health care that she did not want to use psychotropic medication: One of the 
first things that I said was, “I did not want to take drugs.” Sue was very proactive in managing 
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her maternal mental illness, had a sense of ambivalence, and chose to frame her experience in a 
positive manner:  
I just thought to myself that I don’t have any control of it. It doesn’t matter what I do. I 
eat really well; I go for walks; I exercise; I was in prenatal yoga; I just tried to enjoy it 
because I thought it might be the only time.  
However, being in control, for Tina, was choosing to continue taking the medication, 
taking a very positive approach to dealing with negative social stigma, having a support system 
which was facilitated by a family history of mental illness (also true for Skye), and having a 
sense of ambivalence about her experience with maternal mental illness, the expectations of 
motherhood, and the influence of stigma, demonstrating her level of self-efficacy:  
I guess my approach to [self stigma] had been to not be concerned with that sort of thing 
and to live my life and to live it in a way that I can be the happiest and this is the way that 
I am the happiest, and so I don’t think of it past that. 
Being in control was a factor when Gabby decided not to take the recommended 
medication, during pregnancy, despite her symptoms and risk, and was greatly influenced by self 
stigma and feelings of fear, shame, blame, and guilt. Consequently, this decision seemed to 
reflect a sense of self-efficacy as she lacked the insight and awareness of her increasing 
postpartum symptoms, until her physician recognized it. At the time of the interview, Gabby (2 
½ years postpartum), was coping well on medication, although she had a sense of ambivalence 
about it. Further, she admitted that having twins helped justify the need to be on medication, 
indicating the insidious nature of self and social stigma. Having a system of support and being 
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able to share with other moms helped normalize her experience which was also a factor in her 
level of self-efficacy. 
Women’s advice for maternal mental health care. The women had several suggestions 
and recommendations about how to improve the care they received. Amy for example said:  
Every time someone is coming in with depression through pregnancy, I mean, keep them 
under observation for pity sake. If you bring up an alternate diagnosis, follow it 
through!! That was ridiculous. You know, if you had asked us two weeks later how things 
were going, we would have told you it was going “down the toilet” and that would be all 
that we would have said.  If there is actually an openness to, “Well, you can call me and 
see me again.” You have to schedule that. There has to be a set protocol for follow-up 
and assume that this is going to be a patient that you are likely going to be seeing and 
checking up on, for probably 2 years. And, educate the patient to stay on medication one 
year after you are well, to avoid recurrence. Educate them about family decisions.” We 
ended you not having any more children because of this problem and this fear. We made 
decisions that we just probably shouldn’t have and didn’t have to. Why was there not 
support in that aspect?   
Gabby saw value in having a support group:  
I was very lucky that the women in my neighborhood contacted me and got me involved. 
But maybe, that could be something that they could improve - just making a moms’ group 
time more obvious and have easy access to that. Because if I didn’t have that, I think that 
it would be isolating. 
Tina thought that a mom’s group could, on the one hand, be helpful to some, but on the other 
hand, it could be a hindrance:  
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it[A support group] could be helpful, but on the other side of that is the more 
appointments you go to, if you have other children, it can sort of add a bit of stress as 
well, just trying to find childcare for them and trying to get to the appointment. So, it is a 
bit of a tricky situation. I believe that providing childcare would be a huge help for 
people.  
Tina also suggested better follow-up and having access to a counsellor: 
It would be very helpful. …Only meeting once per month would not have been much help 
at all, had I not immediately started medication and started to feel better. I think that just 
the frequency of access would need to be improved. 
When asked what additional mental health care services could be offered, Skye stated:  
Well, counselling I find actually to be more effective than psychiatry, in my opinion 
because compared to psychiatry, they are looking for more than just a medication way to 
help you. Whereas, counselling, sometimes you just want to talk. When you are pregnant, 
you can barely go on any medications anyways, so psychiatrists aren’t quite as helpful as 
they would be outside of maternity.  
Skye spoke of the possible misconception some people may have about seeking care for a 
maternal mental illness and validated the importance of being able to talk:  
Sometimes the word ‘psychiatrist’ or ‘psychologist’ can be scary and overwhelming to go 
to. However, hearing ‘counsellor’, you are just thinking that they are someone to talk to. 
I have always felt more comfortable with counsellors. Also, to have someone checking up 
on you - like how you have been doing - like calling every few months to check on you. ... 
just kind of quick follows over time, but it is good to check if they should be back in the 
program or if they need more help because then that feels like you aren’t asking for help, 
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you are being having it offered. You are more likely to take the help, if it is offered, rather 
than if they asked.  
Skye also suggested providing information and education:  
For other people, that would be great to learn [about coping with anxiety]. It would be 
cool also if they could have someone influential in your life, like I said, my husband or 
mother, to help with the coping because for instance, like I said, my husband can tell 
when things are coming and he can help out with the process and it is good to have 
someone like that. And it is good if you had kind of a group and they were able to bring 
someone like [family or husband] with them so that person can also see what they should 
be looking for and better understand what that person is going through. 
Elyse suggested getting a call for follow-up: because a lot of people won’t phone, won’t reach 
out because I know that I wouldn’t have picked up the phone.  
In sum, the women’s suggestions for providing mental health care services emerged 
around four areas: a) follow-up frequency and access; b) information and education; c) support; 
and d) therapeutic approach.  
Advice to other women. Each participant was asked what advice they would suggest for 
other pregnant and post-partum women having mental health concerns and having to access 
mental health care services. Five participants encouraged women to normalize challenges they 
may face by knowing that they are not the only ones going through this experience, by 
recommending that they learn effective coping strategies and gain better insight of their mental 
health struggles by reading about it, and by encouraging other women to take the medication if 
they need it and to continue until they are beyond the risk of relapse.  
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Gabby stated that if I thought that somebody was in trouble - I would just tell them to go 
see their family doctor and get care. Sue’s advice to other women was:  
Just to know that mental health care is there for a reason; and they aren’t the first and 
they certainly won’t be the last; and to not be embarrassed about getting care because it 
is here for a reason - there is obviously a need. That’s all.   
According to Elyse: 
I would say to be honest with yourself because if you are not, you are never going to deal 
with it and I don’t know, just realize that you are worth it even though you don’t think 
you are.  [You need to ask for help] if you need it, then to actually continue with it until 
you are kind of over it. It is really tough [taking medication], but logically you know that 
you should [take meds]. I don’t know how to tell you about getting over not wanting to, 
but you need to. Because a lot of people won’t phone because I know that I wouldn’t have 
picked up the phone.    
Tina’s advice to other women was: just not to hesitate to initiate whatever help you need, 
as early as you can. If you feel that you need it, because it only gets worse, if you are trying to 
cope on your own. Skye advised women to be proactive, learn new skills, and get information:   
To make sure that people know that you don’t have to solely rely on medications all the 
time because I mean that it is good to have - don’t get me wrong - but if you think that 
medications are going to save everything, you aren’t that well off in the end. You have to 
have a backup - like knowing how to get up and out of bed and knowing when to give 
away your credit card and saying that I shouldn’t have this right now. They should also 
know when to ask for help. That kind of stuff is important - medication you can’ rely on 
all the time... And, reading about it does help, like that “Manic” book.  
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Like Elyse, Skye also indicated that it was more difficult to ask for help, but will more likely 
take it if offered.  
In sum, the participants’ advice for other women dealing with maternal mental illness 
emerged into the following factors: a) being proactive in seeking help; b) normalization and 
shared experience; c) support and connection; d) taking prescribed medication; e) learning 
coping strategies; and f) decreasing shame.   
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CHAPTER 5: DISCUSSION 
This chapter provides a summary and discussion of the findings in terms of the bio-
psycho-social dimensions of women’s lived experience of having maternal mental illness and the 
impact of stigma when accessing mental health care. These findings are considered in terms of 
the literature reviewed as well as new literature brought to light with this study. In particular, 
Brown’s Shame Resilience Theory (2006) provides a framework for findings. Implications for 
practice, strengths and limitations of the present study, and areas for future research are 
discussed.  
Restatement of Study’s Context 
The research on maternal mental illness has been conducted predominately on 
postpartum depression (PPD) using quantitative inquiry, which has primarily focused on 
diagnostic issues, prevalence, associated biological factors and the use and safety of 
pharmacological treatments and mainly representing a biomedical orientation. There is limited 
research literature regarding other variants of maternal mental illness, such as: a) antepartum 
anxiety and/or antepartum depression; b) antepartum and /or postpartum psychosis; c) 
postpartum anxiety; and d) bipolar/affective co-morbidity. These are often represented using the 
umbrella term of postpartum depression (Brockington, 2004). For the purpose of this study, the 
term maternal mental illness was used to refer to any admixture of these conditions.  
The choice to use interpretive description (Thorne, 2008) as the research method allowed 
the uniqueness of each participant’s experience of having maternal mental health problems and 
her meaning-making process to shine through illuminating the complex interplay of various bio-
psycho-social factors. This approach revealed a shared meaning of participants’ lived experience 
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of mental illness, in the midst of the entrenched social stigma associated with maternal mental 
illness and the pernicious cultural myths and social expectations of motherhood and 
reproduction. What emerged from the study was the importance of going beyond a biomedical 
approach (in research, assessment, treatment, and health care practice) when caring for mothers 
with mental health problems and their families. In addition, the importance of health care 
providers to being sensitive to and acknowledging, considering, and addressing the socio-cultural 
context and the psycho-social implications of stigmatization which plays a role in women’s 
experiences of mental illness, accessing mental health care, and their health outcome. 
Integration of Findings with Existing Literature 
Despite the differences between the women’s experiences, there were commonalities 
intersecting their stories and evidence of a shared meaning of living with maternal mental health 
problems and its bio-psycho-social impacts on various aspects of daily life, including their ability 
to manage life and mothering, their relationships with spouses, family, and friends at the 
workplace and/or school, as well as their sense of self and wellbeing. The study findings 
identified a variety of biological and psycho-social risk factors, which seemed to contribute to 
the women’s experience of maternal mental illness and their treatment experience and health 
outcome based on a biomedical approach. 
Biological and biomedical factors. Several biological risk factors emerged from the 
women’s experience of maternal mental illness that were also identified in the research literature 
(Gold, 2002; Kalra & Einarson, 2006; Marcus, 2009).  These contributing factors included 
anxiety and depression co-morbidity, a personal and a family history of mental illness, a previous 
history of PPD, treatment engagement, and the risk of relapse.  
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A higher co-morbidity between anxiety and depression than previously thought has been 
recognized, which is associated with an increased risk of developing PPD (Austin et al., 2007; 
Bowen et al., 2008; Matthey et al., 2003). Further, research has indicated that women who 
experience prenatal anxiety are three times more likely to report PPD symptoms compared to 
women without anxiety (Austin et al., 2007; Bowen et al., 2008); and women with bipolar 
disorder are extremely vulnerable to maternal mental illness, during and after pregnancy (Gold, 
2002). The current findings supported previous research identifying the importance of assessing 
and addressing both anxiety and/or depression for women during pregnancy, rather than only 
focusing on depression during postpartum (Austin et al., 2007; Bandelow et al., 2006).  
At the time of seeking care, all of the participants reported experiencing symptoms of 
anxiety during pregnancy, although some also described symptoms of depression, and for one 
woman, psychosis. All of the women had a previous personal history of mental illness, for which 
five had been treated pharmacologically. Most had a history of anxiety, and two had a previous 
episode of PPD. In addition, during adolescence, Skye was diagnosed with bipolar disorder and 
Gabby had an eating disorder. Both, Skye and Tina had a family history of mental illness 
(bipolar and anxiety, respectively). Their physicians recognized and had immediately referred 
them for mental health care, aware of their multiple risks for developing PPD. 
Amy and Elyse’s previous history of PPD was another contributing factor in developing 
maternal mental illness. They both took medication for a while during the first postpartum 
period, but then discontinued without consulting their physician. Although they had PPD after 
their first pregnancy, they were never informed of their increased risk of developing a mental 
illness with subsequent pregnancies, nor did they seem to realize symptoms could develop during 
pregnancy. Both of these women did not seek help in a timely manner. In fact, they delayed 
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seeking help until they reached a felt crisis point and felt incapacitated and unable to manage 
daily functioning. Amy delayed seeking help until she was experiencing disturbing visions and 
thoughts of harming herself and her child, consistent with Gold’s (2002) research, which found 
that women had a 50% higher risk of recurrence of PPD following subsequent pregnancies. 
When PPD goes untreated or undertreated, women are at risk of developing psychosis (Gold, 
2002). According to Einarson (2009b), although information regarding the safety and efficacy of 
psychotropic medication is readily available, women with maternal mental illness are often 
undertreated because of a lack of knowledge or information by health care providers, as well as 
women and their families. This study revealed the need for optimal control of maternal mental 
illness during pregnancy and postpartum and the importance of careful monitoring for high risk 
women (Einarson, 2009b). Further the findings of the present study highlighted the importance 
for health care professionals to inform and educate women and their families about mental health 
status and diagnosis, implications of pharmacological treatment engagement, and risk of relapse, 
also identified in other research (Cohen et al., 2006; Gold, 2002; Marcus, 2009).  
Treatment engagement was a factor in the participants’ experience of mental illness. In 
the context of this study, treatment engagement referred to participants’ compliance with taking 
psychotropic medication as prescribed by a health care professional. Five of the six participants 
were prescribed psychotropic medication as a result of accessing mental health care services, and 
four of them discontinued and/or postponed taking the prescribed medication for a variety of 
reasons (e.g., side effects, cost, stigma), without consulting their physician. The four women 
seemed to lack insight and awareness of being at risk of relapse. Furthermore, of the four women 
who discontinued the pharmacological treatment, two participants had a relapse and at the time 
of the interview described an ongoing struggle with debilitating symptoms of anxiety and 
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depression beyond their second postpartum year.  This was also noted by Cohen et al. (2006) 
who found the risk of relapse with premature discontinuation of pharmacological treatment was 
68%.  underscoring the importance of women understanding and being clearly informed and 
educated about the implications of treatment engagement when medication is prescribed and 
when dispensed.           
Researchers have noted that an under treatment of, or a failure to address maternal mental 
illness leaves women more vulnerable to ongoing mental health problems, greatly impacting a 
mother’s opportunity for optimal health and wellness (Einarson, 2009b; Matthey et al., 2003; 
Seto et al., 2005). It is vital that women and their families receive information and support when 
physicians prescribe psychotropic medications, especially when no other treatment options are 
explored (Gold, 2002; Marcus, 2009). According to Tufano (2000), with a biomedical approach 
“treatment is given in a medically prescriptive manner” (p. 133), which privileges 
pharmacological interventions over psycho-social approaches. Similar to Wardrop and Popadiuk 
(2013), the findings revealed the need to expand a biological focus by considering a woman’s 
socio-cultural context and the psycho-social aspects of her experience of maternal mental illness, 
when providing mental health care. 
Psycho-social factors. In addition to the biological risk factors identified in the present 
study, several psycho-social risk factors were also implicated in the participants’ experience of 
maternal mental health and health outcome. Similar to the research literature that identifies 
support as playing a key role in developing and/or exacerbating maternal mental illness (Gold, 
2002; Kalra & Einarson, 2006; Marcus, 2009), all participants commented that level of support 
was a factor in their experience of living with a mental illness 
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However, Amy’s lack of family and social support contributed significantly to her ever-
increasing mental and emotional distress. As a result of job relocation, Amy lacked a family 
support system due to their distant proximity. Furthermore, Amy lacked the family’s emotional 
support because their religious beliefs did not recognize mental conditions as an illness. This 
prevented Amy’s family from accepting her legitimate concerns, which deepened her feelings of 
isolation. These psycho-social risk factors had a significant impact on Amy’s experience of 
mental illness and health outcome, yet were not identified or considered by the physicians when 
assessing symptoms and recommending pharmacological treatment.  
Another psycho-social factor in participants’ experience of mental illness was the lack of 
specific information, knowledge, and insight about their mental health status, which perhaps 
increased some women’s risk of developing and/or exacerbating their mental health problems, 
also noted in the research literature (Dennis & Chung-Lee, 2006; Edwards & Timmons, 2005; 
Pinto-Foltz & Logsdon, 2008). For example, maybe if Amy and Elyse had received the 
necessary information and education about PPD with their first episode, they would have been 
more aware of their risk during their second pregnancy. They may have been more aware and 
had the insight to recognize the symptoms and not delay seeking care until reaching a crisis 
(McCarthy & McMahon, 2008). Further, if they had the relevant information from their primary 
care provider and mental health care professionals, they would have been aware of the 
implications and risk of prematurely discontinuing the prescribed medication and their risk 
factors for relapse (Cohen et al., 2006; Marcus, 2009. This lack of knowledge and insight seemed 
to interfere with their ability to manage their mental health problems and challenges of 
mothering (DaCosta et al., 2006; McCarthy & McMahon, 2008). 
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These findings suggested the importance of providing information (e.g., increasing 
awareness of the signs and symptoms, the bio-psycho-social risk factors, medication options and 
compliance, and psycho-social implications) and helping women and their families to recognize 
symptoms, seek help, and manage maternal mental illness in a pro-active manner. The 
importance of primary care and mental health providers taking the time to inform and educate 
each woman and her family is also noted in the research literature (Cohen & Nonacs, 2005; 
Dennis & Chung-Lee, 2006). Both the research literature and the findings of the present study 
identified that ongoing mental health problems have significant bio-psycho-social impacts on a 
woman’s quality of life, physical and emotional well-being, social interactions, self-care and 
sleep quality (Bowen et al., 2012; Da Costa et al., 2006; Seto et al., 2005).  
In this study, these impacts were also reflected in the participants’ marital relationships, 
their children’s behaviour, their level of self-care and their sense of self and self-efficacy, 
psycho-social factors also noted by other researchers (Cohen & Nonacs, 2005; Dennis & Chung-
Lee, 2006). Untreated or severe maternal mental illness had profound effects not only on the new 
mother and baby, but also on her partner and other relationships (Matthey et al., 2003). All the 
women in this study indicated that having a mental illness impacted their relationships and 
various social interactions with their spouse, family members, friends, and co-workers, although 
occurring in varying ways.     
Of note, both Amy and Gabby’s spouses became depressed one-year postpartum, which 
proved to have a psycho-social impact on the whole family. According to one study (Goodman, 
2004), the incidence of paternal depression, during the first postpartum year, ranged from 24% to 
50% among men whose spouse had PPD; and the strongest predictor of depression in fathers 
during postpartum was the presence of PPD in their spouse.  
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In summary, findings revealed the importance of providing timely and appropriate access 
to mental health care services not only for women with mental health problems, but also the need 
to include spouses and families in the assessment, management, and education of maternal 
mental illness (Gold, 2002) and the need to provide access to services, resources, and support for 
a longer period of time, beyond the first postpartum year. In addition, findings highlighted the 
importance of using a bio-psycho-social approach rather than only a biomedical approach when 
assessing, treating, and supporting mothers with mental health problems and their families 
(McCarthy & McMahon, 2008; Wardrop & Popadiuk, 2013).  
Infertility. Infertility and the process of IVF were contributing factors in three 
participants’ experience of maternal mental illness. This was an interesting and unexpected 
finding. My review of the literature did not reveal the increased risk of maternal mental illness 
for infertile women and use of IVF. It was only through the course of the interview I learnt that 
three of the six participants conceived using IVF and how this process was part of their 
experience with maternal mental illness.  
Infertility, a prevalent problem that affects about 15% of childbearing age women, refers 
to the inability to conceive after at least one year of regular unprotected sexual intercourse, or 
after 6 months, if a woman is over 35 years old (Leon, 2010; Olshansky, 2004). The ages of the 
women in this study who struggled with infertility ranged from 31 to 39 years of age. One study 
(Punamaki et al., 2006) showed that mothers who used IVF continue to be at increased risk of 
depression and anxiety during pregnancy and were vulnerable to complications at pregnancy and 
labour/delivery, such as premature and low birth weight babies. Both Sue and Tina had 
premature labour and deliveries, and similar to other research (Ellison & Hall, 2003; Fisher, 
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Hammarberg, & Baker, 2005), Tina and Gabby felt their mental illness was intensified by their 
multiple births, which further increased their risk of developing PPD. 
The experiences of the participants who used IVF was reflected in the research literature 
that associated a history of infertility and compounded pregnancy losses with increased levels of 
emotional distress and anxiety. Similar to findings reported in a study that associated a history of 
infertility and compounded pregnancy losses with increased levels of emotional distress and 
anxiety (Ellison & Hall, 2003), the three participants, Sue, Abby and Tina, identified the cause of 
their antenatal anxiety as being specific to the fear of miscarriage and/or being overwhelmed 
with the prospects of having twins. They acknowledged various aspects of the IVF process as 
significant contributing factors to their maternal mental distress, such as using fertility drugs for 
years, enduring multiple miscarriages, experiencing a difficult and/or premature labour and 
delivery (Tina, Sue), and having a multiple birth (Abby, Tina).  
Each referred to the process of IVF, which lasted three years on average, as being the 
most difficult and stressful challenge they had ever experienced in life. This was similarly noted 
in a 10-year follow-up study of women using IVF to conceive, conducted by Sundby and 
colleagues (2007 as cited by Olshansky & Sereika, 2005) who reported that women remembered 
the period of infertility as a difficult time in their lives. What emerged from the findings of this 
study was a shared experience of feelings of loss, fear and pressure that impacted their mental 
health. These factors suggest that the psycho-social elements of women’s experience are 
important considerations when providing care, and confirm research suggesting that women with 
a history of infertility, using IVF, and/or having multiple birth, who experienced severe anxiety 
and stress, are at risk of developing a maternal mental illness; and therefore, should be monitored 
closely before, during, and after pregnancy (Fisher et al., 2005; Olshansky & Sereika, 2005; 
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Punamaki et al., 2006; Slade, O'Neill, Simpson, & Lashen, 2007). Although the homogeneity of 
the study sample reflected a narrow range of women’s experiences, the occurrence of half the 
sample experience infertility and IVF provided a unique element of analysis, revealing psycho-
social factors otherwise masked with the biomedical approach.  
Accessing mental health care services. All participants initially sought help for their 
distressing symptoms from primary care providers, either their family physician or obstetrician. 
This confirmed research that indicates women with maternal mental illness are more likely to 
seek help from primary health care providers than mental health professionals (Gold, 2002). 
Many of the women in this study described their relationship with their primary physician as a 
vital factor in their experience with mental illness and accessing care, also noted in the research 
literature (Dennis & Chung-Lee, 2006; McCarthy & McMahon, 2008; Wardrop & Popadiuk, 
2013); however, most of these studies found that women did not often feel supported by their 
health care providers, which impacted their experience of maternal mental illness and accessing 
care. Women reported feeling stigmatized by attitudes of some health care providers who 
minimized or were reluctant to respond to their emotional and practical needs and concerns, 
which impacted access to mental health services and the level of care received (Ahmed et al., 
2008; Dennis & Chung-Lee, 2006; Edwards & Timmons, 2005). Interestingly, all of the 
participants in this study felt supported and validated by their primary family physician, which 
points to the importance of having validating and mutually empathic relationships (Dennis & 
Chung-Lee, 2006; McCarthy & McMahon, 2008; Wardrop & Popadiuk, 2013).  
The research literature indicated that pregnant and postpartum women often receive 
inadequate mental health care, and/or do not seek help, due to a lack of and/or limited access to 
mental health care services; and they are often under-diagnosed by health care providers who 
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may minimize or discount women’s symptoms of emotional distress (Dennis & Chung-Lee, 
2006; Marcus, 2009; Pinto-Foltz & Logsdon, 2008). However, this was in sharp contrast to this 
study as all of the women’s primary care providers recognized their symptoms of anxiety and 
their risk of developing PPD, were aware of the need to access mental health care in a timely 
manner. This indicated the importance of the early identification of risk factors, and timely 
access to mental health care. Most of the participants described a felt sense of being in crisis, 
having reached a critical point, and for some, a sense of desperation and dire need of help, at the 
time of accessing care, which would indicate a need for crisis support while these women waited 
to access mental health care services, which was also noted by McCarthy and McMahon (2008). 
The issue of follow-up care emerged as a factor in participants’ experience of maternal 
mental illness, treatment engagement and satisfaction, and their health outcome. Other research 
has identified the need for regular follow-up for maternal mental illness, especially women who 
are at a higher risk (Einarson, 2009b; Gold, 2002; Le, Munoz, Ippen, & Stoddard, 2003; 
Wardrop & Popadiuk, 2013). But what constitutes high risk? The findings of this study suggest 
the value of clearly determining criteria for follow-up visits and that focusing on 
pharmacological treatment and symptomology overlooks psycho-social factors at play 
(McCarthy & McMahon, 2008). It is important to expand the assessment of women’s mental 
health risk beyond biological symptoms, standardized scales and questionnaires, by including 
and being sensitive to women’s socio-cultural context and the psycho-social factors in their lives 
influencing their risk (Wardrop & Popadiuk, 2013).  
Although primary physicians in this study were well informed about symptoms and risks 
of maternal mental health, treatment follow-up was a concern for some. Researchers found that 
when physicians pharmacologically treat pregnant or postpartum women for mental illness, they 
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were more cautious and tended to undertreat (Cohen & Nonacs, 2005; Einarson, 2009a; Nonacs 
& Cohen, 2002; Pinto-Foltz & Logsdon, 2008). Some of the participants stated their family 
physicians were uncomfortable and reluctant to adjust the usage and dosage of psychotropic 
medication initially prescribed by mental health care professionals. For example, when Amy was 
seen on an emergency visit, her obstetrician had sought consultation with the care provider by 
phone, in order to discuss adjusting the prescribed psychotropic medication because Amy was 
having increasing symptoms of psychosis; however, this attempt was unsuccessful. This 
indicated that mental health care providers  should  be available for consultation with, and to 
support, family physicians and other health care practitioners in the community, as well as being 
available to answer questions about the program, screening for PPD, and treatment options, in 
addition to providing direct client services (Bowen et al., 2008).  
The effort and difficulty of gaining access/re-access to mental health care services 
seemed to be a factor in some women’s (Amy and Elyse) treatment engagement/satisfaction and 
health outcome and also seemed related to stigma/shame and their sense of self-efficacy, their 
sense of self and their ongoing symptoms, also noted in the research literature (Corrigan et al., 
2009; Corrigan & Wassell, 2008) 
Treatment engagement, satisfaction, and health outcome. Consistent with the literature 
(Marcus, 2009), participants’ treatment engagement increased when women were screened by 
their health care provider and informed about their depressive state. Most of the participants 
seemed to lack the insight or awareness of their symptoms, but their physician had identified 
their risk and promptly referred them to the program. As Dennis and Chung-Lee (2006) report, 
some mothers were reluctant to disclose feelings of emotional and mental distress without having 
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the question asked first by their physician. This was also indicative of the importance of their 
relationship with and the support of their family physician.  
Researchers have identified inappropriate or lack of assessment as a health care barrier 
for women with maternal mental illness (Dennis & Chung-Lee, 2006; McCarthy & McMahon, 
2008). Amy was the only participant who spoke directly about the screening process when 
accessing mental health care services and the tools and questionnaires used to determine the level 
and severity of maternal mental and emotional distress. She believed the screening was 
inadequate in identifying and addressing her symptoms of psychosis and was a barrier in terms 
of accessing appropriate and ongoing care. She reported that she had never been asked directly 
by the attending physician about these possible symptoms (visions and thoughts of harming 
herself and her daughter) during the interview. Further, the screening process did not identify her 
lack of family and social supports, feelings of isolation and other possible psycho-social factors 
which would have been captured had a bio-psycho-social approach been added.  
The level of participants’ treatment engagement, satisfaction, and health outcome varied 
when accessing mental health care, however, did not depend solely on the efficacy of the 
medication. Similar to other research, other factors emerged which seemed to contribute such as 
a) lack of information, feedback, and education from health care providers regarding their mental 
health status and risks at the time of diagnosing and prescribing treatment (Dennis & Chung-Lee, 
2006; Marcus, 2009); b) the biomedical focus on using psycho-pharmaceutical interventions and 
lack of other treatment options (McCarthy & McMahon, 2008); and c) personal experiences of 
stigmatization (Dennis & Chung-Lee, 2006; Pinto-Foltz & Logsdon, 2008). 
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What emerged as an essential aspect of women’s experience of maternal mental illness, 
treatment engagement, satisfaction and health outcome was the amount and the quality of the 
information/education they received from health care providers in regards to risks and 
implications of maternal mental illness (for women, spouse, and family), signs/symptoms, 
treatment engagement and options, and psycho-educational resources.  
Researchers have identified physicians having insufficient time during consultation and 
the tendency to prescribe medication, rather than talk, to alleviate symptoms reinforcing feelings 
of inadequacy and stigmatization which were health care barriers for women with maternal 
mental illness (Dennis & Chung-Lee, 2006; McCarthy & McMahon, 2008).  Although 
participants felt supported by their family physician, some participants spoke of the amount and 
quality of time and “talk” they received from mental health care professionals, and how it 
influenced their treatment satisfaction. Several participants spoke of and indicated a lack of 
talking, feedback, and information when accessing mental health care services, while Skye for 
example commented on the importance and benefit of “talk therapy” for women dealing with 
mental health problems. This reflected previous research which noted that women preferred to 
have talk therapy with someone who was nonjudgmental rather than receive pharmacological 
treatment (Dennis & Chung-Lee, 2006; McCarthy & McMahon, 2008).  
Research has found a significantly greater improvement for maternal mental illness in 
women who received counselling and psychotropic medication during pregnancy (Bowen et al., 
2012); yet only one of the five of participants who were on medication also had the opportunity 
for counselling. As in other studies (McCarthy & McMahon, 2008; Wardrop & Popadiuk, 2013), 
the participants expressed a desire for the therapeutic relationship to be about more than 
medication. They wanted health care providers to be more engaged, aware of and sensitive to the 
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unique concerns and needs of women with maternal mental illness, in addition to creating a safe 
and non-judgmental environment to facilitate their ability to talk freely and get necessary 
feedback and information.  
Stigma and accessing care. The shared experience and shared meaning of accessing 
mental health care services revealed aspects of self stigmatization in women’s experience of 
maternal mental illness. Participants had personal experiences of perceived and enacted 
stigmatization, through their relationships, in their social interactions, often in the form of 
inappropriate questions and unsolicited advice and/or comments from others, including health 
care professionals. Several researchers have similarly found that women’s experience of stigma 
of maternal mental illness was impacted by interactions with health care providers and by 
perceived dismissive attitudes which deter women from seeking help and accessing mental 
health care, and impact treatment engagement/satisfaction and health outcomes (Ahmed et al., 
2008; Dennis & Chung-Lee, 2006; Pinto-Foltz & Logsdon, 2008).  
Some researchers have argued that women treated in primary health care settings for their 
mental health problems report less stigma in getting help than women who were treated 
elsewhere (Weissman et al., 2004). Some participants, Amy and Skye, reported experiencing 
dismissive attitudes and comments from health care providers that impacted their treatment 
engagement, satisfaction, and health outcome, which seemed associated with a fear of disclosure, 
denying and/or minimizing the severity of their symptoms, and increased self stigmatization, 
similar to other studies (Dennis & Chung-Lee, 2006; Marcus, 2009; Pinto-Foltz & Logsdon, 
2008).  
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On the other hand, despite the experience of stigmatization, low treatment engagement 
and treatment dissatisfaction when accessing mental health care services, Skye’s sense of self 
and health outcome were not negatively impacted. At the time of the study, when both of these 
women were two-and-a-half years postpartum, Amy was experiencing ongoing mental health 
problems that continued to negatively impact her spouse, her children and herself, whereas Skye 
was coping well with her mental health and was engaged in a proactive manner. This seemed to 
be related to having some resiliency to self stigma and a level of self-efficacy. Corrigan and 
Wassell (2008) also noted a link between low self stigma and self-efficacy. The study findings 
pointed to the need for more transparency, sensitivity, and self-reflexivity on the part of the 
mental health care providers to minimize their role in and the impact of stigma on women’s 
experience with maternal mental illness, treatment engagement, and health outcomes (McCarthy 
& McMahon, 2008). 
Similar to findings in Dennis and Chung-Lee (2006), participants’ experiences of 
stigmatization while accessing mental health care services revealed the psycho-social 
implications for women being immersed in a biomedical model, which focused on diagnosis and 
pharmacological interventions, and has traditionally placed the site of the problem with the 
individual woman and her body (Koniak-Griffin et al., 2006).  The findings indicated the 
importance and need for health care providers to be much more aware and sensitive to how they 
and/or the elements of mental health care services may be contributing to the woman’s 
experience of stigmatization (McCarthy & McMahon, 2008). 
Stigma and motherhood. Similar to the research literature (Dennis & Chung-Lee, 2006; 
Edwards & Timmons, 2005; McCarthy & McMahon, 2008; Pinto-Foltz & Logsdon, 2008; 
Vogel, Wade, & Haake, 2006, 2007), stigma played a central role in participants’ experience of 
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maternal mental illness, in seeking help, accessing appropriate mental health care, and in their 
treatment engagement and health outcome. However, the manner in which participants 
experienced stigma and its impact varied.  
Consistent with the research literature, the shared experience and shared meaning of the 
participants’ experience of maternal mental illness were indicative of the insidiously and deeply 
entrenched nature of the social expectations of joyful motherhood, perfect and intensive 
mothering, and normal and natural reproduction (Arendell, 2000; Choi et al., 2005; Cosgrove, 
2000; Koniak-Griffin et al., 2006; Woollett & Boyle, 2000). The women’s shared experience and 
shared meaning of mental illness stigma emerged either internally (impact on relationships and 
sense of self) or externally (the harmful effects of prejudice and discrimination and negative 
evaluation from others), as has been noted in the research literature (Corrigan & Wassell, 2008; 
Corrigan & Watson, 2007). All the women were aware and had a common understanding of the 
social misconceptions and the negative stereotypes associated with mental illness, often used as 
pejorative social labels. Being labeled “crazy,” “unfit,” “weak,” and “defective,” was a shared 
concern for most of the women, which impacted some women’s willingness to seek help and/or 
engage in treatment, something that is confirmed in the research literature (Corrigan & Wassell, 
2008; Kenny, 2001).  
Similar to other studies, some of the participants in this study had internalized a sense of 
being a “bad and/or unfit mother,” or feared being perceived as “less-than-perfect,” which lead to 
feelings of anger, shame, blame, and guilt fostering the fear of being labeled (Dennis & Chung-
Lee, 2006; McCarthy & McMahon, 2008; Pinto-Foltz & Logsdon, 2008). For the participants, 
having a maternal mental illness was not only about experiencing symptoms and the stigma 
associated with mental illness, but also about how they perceived themselves and how they felt 
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they measured up as a woman, mother, and wife. This spoke of a deeper level of stigmatization 
and the underlying social scripts affecting and dictating the everyday lives of women living with 
maternal mental illness inextricably linked to their sense of self, a feeling of shame.   
Stigma and infertility. Notably, another layer of the social scripts dictating the norms of 
motherhood and womanhood were revealed in the lived experience of three of the women who 
experienced infertility and had used IVF (Ellison & Hall, 2003; Leon, 2010). These findings 
presented an example of the intersection between the biomedical/biological ideology, the 
medicalization and mechanization of reproduction and the socio-cultural context of women’s 
lives and the impact this can have on how they perceive themselves as a woman with a 
reproductive body and as a mother with a mental illness. The negative stigma surrounding 
infertility, the use of fertility drugs and IVF to conceive, and multiple births illustrated the 
interconnections between social notions of motherhood and the medicalization of female 
reproduction, as being natural, normal, and compulsory for all women (Ellison & Hall, 2003; 
Leon, 2010; Slade et al., 2007).  
The shared experience and shared meaning of infertility was evidenced by the three 
participants who identified the negative social stigma associated with the use of fertility drugs, 
and especially multiple births, as a major factor in their experience of stigma. Further, they had a 
shared experience of being judged, often as a result of intrusive and inappropriate questions and 
comments from others. They described their experience of self stigma in varying degrees which 
included: being perceived as having “artificial babies” and “not normal and natural,” being a 
reflection of the marital relationship, being angry about her age or body, having feelings of 
shame, blame, and guilt and a sense of not belonging or not fitting in with other mothers, also 
identified in other studies (Ellison & Hall, 2003; Leon, 2010; Slade et al., 2007). This study 
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highlighted the importance of identifying and addressing the psycho-social implications of 
infertility and the process of IVF in women’s experience of mental illness and feelings of shame. 
Impact of stigmatization. In this study, the participants’ shared experience and shared 
meaning of self stigma were interconnected with their sense of self. The research literature 
suggests that the impact of self stigmatization depends on the degree of identification and 
internalization of the negative social stigma associated with maternal mental illness, the 
unrealistic expectations of motherhood and the medicalization of reproduction, which undermine 
women’s sense of self-esteem, and thus influence their sense of self-efficacy (Corrigan et al., 
2009; Corrigan et al., 2006). The sense of self-efficacy is related to their belief, confidence, and 
sense of personal adequacy, in their own ability to manage the various challenges of having a 
maternal mental illness (Corrigan et al., 2009; Corrigan et al., 2006).  
Similar to this study, other studies indicated that women often under-report distressing 
symptoms to avoid being perceived as a bad mothers, and fear of having children apprehended if 
they revealed the level of their emotional distress and admitted to being unable to cope or 
manage their symptoms of mental illness and the demands of mothering (Dennis & Chung-Lee, 
2006; Edwards & Timmons, 2005; Einarson, 2009b; Marcus, 2009; McCarthy & McMahon, 
2008). As in this study, others identified self stigma and self-devaluation as the main obstacle 
preventing women from seeking help and/or accessing care (Corrigan et al., 2006; Edwards & 
Timmons, 2005; Kenny, 2001; Tognazzini et al., 2008). 
Another factor influencing the depth of self stigma revolved around being on medication 
and what meaning the participants made of it. Five of the six participants shared their experience 
of having a maternal mental illness, being treated with psychotropic medications based on a 
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biomedical approach, and the impact this had on their self-esteem. Findings of this study concur 
with the literature, which found that not only did self stigma reduce the motivation to seek care, 
but it also impacted compliance with recommended pharmaceutical treatment plans (Corrigan, 
2004; Kenny, 2001), decreased treatment adherence, and resulted in early termination of 
treatment (Sirey et al., 2001; Vogel et al., 2006). Three women identified and internalized the 
negative self stigma of being a mother with mental illness who was taking psychotropic 
medication to cope, which they perceived as a failure, defect, or weakness on their part. As in 
this study, other researchers have identified the stigma attached to the use of certain psychotropic 
medication, especially, antipsychotics, and associated with feelings of fear and embarrassment 
over the illness or the treatment, or because they were afraid to experience any kind of 
stigmatization because of the pharmacological treatment (Sajatovic & Jenkins, 2007; Sirey et al., 
2001).  
One participant with a medical background clearly associated certain anti-psychotic 
medications with being “crazy drugs” and deciding to not fill the prescription for fear of being 
labeled and judged as being “crazy,” which was interesting given her training in dispensing 
medication. Further, when Gabby started anti-depressants during postpartum, she shared her 
need to justify her use of medication as having twins, rather than being perceived as having a 
weakness or character flaw. This illustrated her strong, if unspoken, desire to avoid the mere 
association with taking certain psychotropic drugs which implied a simultaneous membership 
within the ranks of a stigmatized group, crazy mothers who may “smother their babies.”  This 
was a clear example of label avoidance (Corrigan, 2004). This also highlighted the need for more 
training and education of all health care providers to increase the awareness, familiarity and 
sensitivity to the bio-psycho-social implications of stigma and women’s experience of maternal 
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mental illness. Studies indicated that health care professionals and students, such as doctors, 
pharmacists, and nurses, may hold stigmatizing views towards women with maternal mental 
illness, despite having training expected to enhance acceptance, sensitivity to and knowledge of 
patients with mental health (Gawley, Einarson, & Bowen, 2011; Thornicroft et al., 2007; 
Tognazzini et al., 2008). 
In sum, the impact of self stigmatization and the fear of being labelled affected the 
participants’ social interactions, willingness to seek help, the degree to which they disclosed their 
mental illness, their treatment engagement and health outcome, and their sense of self-esteem 
and self-efficacy. “When a person is stigmatized, she is branded in disgrace or shame” (Tufano, 
2000, p. 113). 
Conceptualization of Findings Using Shame Resilience Theory 
The participants’ shared experience and shared meaning of the self stigma surrounding 
maternal mental illness in a biomedical context, and the underlying socio-cultural norms and 
expectations of motherhood can be conceptualized using the shame resilience theory (SRT) 
presented by Brown (2006). Shame resilience theory offers a working definition of shame as “an 
intensely painful feeling or experience of believing we are flawed and therefore unworthy of 
acceptance and belonging” (Brown, 2006, p. 45). Shame, like self stigma, consists of “unwanted 
identities when women self-attribute, or when they perceive others as ascribing to them, a 
characteristic that undermines their self-ideals” (Brown, 2006, p. 46).   
According to Brown (2006), shame is a psycho-social-cultural construct which plays a 
significant role in the lives of women:  
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The psychological component relates to the participant’s emphasis on the feelings, 
thoughts, and behaviors of self.  The social component relates to the way women 
experience shame in an interpersonal context that is inextricably tied to relationships and 
connection. The cultural component points to the prevalent role of cultural expectations 
and the relationship between shame and the real or perceived failure of meeting those 
expectations (p. 45).   
SRT understanding of shame (i.e., self stigma) is a contextualized and multidisciplinary 
approach which brings together several complimentary theories, such as relational-cultural 
theory (RCT) and empowerment theory. Relational-cultural theory assumes “that all growth-
fostering relationships and all disconnections are constructed within specific cultural contexts” 
(Brown, 2006, p. 49). Both relational-cultural theory and SRT identify connection, empathy and 
isolation as central to women’s experiences and have a feminist perspective which focuses on the 
socio-cultural construction of shame; however, these also differ. SRT encompasses 
empowerment theory with central themes that consist of “the concepts of critical awareness, 
deconstructing, normalizing, and contextualizing as processes to facilitate connection, power and 
empathy” (Brown, 2006, p. 50). Therefore, using SRT as a means to conceptualize and analyze 
the bio-psycho-social dimensions of the participants’ experiences and shared meanings of self 
stigma/shame and maternal mental illness was well suited to the methodological approach of 
interpretive description and the goals of the study.  
Similar to SRT, some participants in this study reported feelings of being isolated, 
trapped, and powerless that were enmeshed in the rigid and unrealistic social/cultural 
expectations surrounding motherhood and mothering, which are often imposed, enforced, or 
expressed within relationships and experiences, analogous to Brown’s shame web (2006);  
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The concept of a shame web illustrates how options are limited and expectations are far-
reaching, reinforced at every turn and woven through numerous experiences and 
relationships. . . .  It is the intricate weaving of these concepts that makes shame so 
powerful, complex, and often difficult to overcome (p. 46).  
Aspects of the shame web identified in the findings of women’s experience of stigmatization 
included psycho-social factors and context, socio-cultural norms and expectations of 
motherhood, the biomedical model of care based on the diagnosis of psychopathology with the 
privileging of pharmaceutical treatments, the medicalization of reproduction through the process 
of IVF, the depth of stigma/shame, and the sense of self-efficacy and sense of empowerment.  
Self-efficacy and shame resilience. Consistent with other research (Corrigan et al., 
2009; Corrigan et al., 2006; Gourounti, Anagnostopoulos, & Lykeridou, 2013), the participants’ 
sense of self-efficacy was reflected in their ability to cope and manage their maternal mental 
health problems and in the strategies they used to resist, moderate, and/or mitigate the negative 
effects of self stigma on their self-esteem (feelings of shame, blame, and guilt) and/or in their 
social interactions (fear of being judged, rejected, and isolated). The findings revealed a 
relationship between the depth of self stigmatization (shame) and the women’s sense of self-
efficacy (shame resilience). Please note that the terms self-efficacy and shame resilience are used 
interchangeably. The deeper the shame, the more the women’s sense of self-efficacy seemed 
diminished. In this study, women’s sense of self-efficacy reflected a range of shame resilience 
which was influenced by several bio-psycho-social factors associated with the women’s feelings, 
actions, reactions, and outcomes related to the experience of having a maternal mental illness and 
the self stigma/shame surrounding it.  
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Shame resilience theory provided a conceptual understanding of shame “through the 
development of a continuum schema and identified the strategies and processes women find 
effective in developing shame resilience” (Brown, 2006, p. 45). Shame resilience is determined 
by the cumulative impact of four continuums: a) the vulnerability continuum (level of 
acknowledgement of personal vulnerabilities); b) the critical awareness continuum (level of 
awareness a woman has about the social/cultural forces that shape her experiences and her ability 
to critically assess her personal experiences in this context); c) the reaching out continuum 
(measure of one’s ability to reach out to others to find connection and empathy and de-mystify 
the isolating properties of shame); d) the speaking shame continuum (the fluency with which a 
woman engages in thought and dialogue about shame and resilience) (Brown, 2006, p. 49). 
Shame resilience appeared to be congruent with the range of self-efficacy found in this 
study, which was best conceptualized as a continuum: on one end, the main concerns of the 
participants were the fear of being labeled, judged, and rejected with feelings of being trapped, 
powerless, and isolated. And located on the other end, feeling empowered, connected/supported, 
and free from shame (i.e., self stigma), which reflected Brown’s findings (2006). Researchers 
(Vauth, Kleim, Wirtz, & Corrigan, 2007) have found that diminished self-efficacy undermined 
personal empowerment, as in this study. Corrigan (2006) defined empowerment as a complex 
phenomenon which defined a person’s sense of control over the decisions about all areas of life. 
Study findings paralleled Brown’s (2006) SRT, which emphasized the need to increase women’s 
sense of personal power by understanding the connection between their personal experiences of 
shame and their socio-cultural context. 
Being in control and empowerment. Findings revealed that a sense of self-
efficacy/shame resilience was connected to the women’s sense of being in control of certain 
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aspects of their mental health that allowed them to mitigate the harmful effects of social and self 
stigma and shame by deciding who to tell, and who not to tell, taking medication or not taking 
medication, and being proactive or not, which reflected a sense of empowerment. According to 
SRT, identifying and addressing women’s shame web and enhancing their sense of control, 
choice, connection, and ability to affect change are essential in facilitating women’s 
empowerment and shame resilience (Brown, 2006).  
This study reflected other studies (Corrigan & Wassell, 2008; Keeton, Perry-Jenkins, & 
Sayer, 2008) that found women were less likely to experience self stigma when they believed 
they had control of their lives and their treatment, which for some participants served as a 
protective factor for their mental health outcomes. This sense of empowerment was associated 
with higher self-esteem, quality of life, social support, treatment satisfaction, and facilitated self-
efficacy, also reported by other researchers (Brown, 2006; Corrigan, 2006; Corrigan et al., 2009). 
The present study’s findings identified several psycho-social factors that seemed to influence 
women’s sense of being in control, empowerment and shame resilience, such as treatment 
experience, the level of self-disclosure, coping strategies, ambivalence, and level of perceived 
support, connection and empathic relationship with health care provider. 
Treatment experience. Study findings concurred with several researchers who have 
identified a sense of being in control as a significant factor in women’s experience of maternal 
mental illness and accessing care (Keeton et al., 2008; Pinto-Foltz & Logsdon, 2008). For some 
of the participants, being in control might have meant deciding whether to refuse, start, continue, 
and/or discontinue the prescribed psychotropic medication (discussed previously), although for 
some participants this proved to be a significant factor in the outcome of their maternal mental 
illness, especially in light of not having other treatment options such as counselling, support 
  
149 
 
group and peer support, and information available when accessing care. This was also found in 
other research which indicated that individuals with mental illness were less likely to experience 
stigma and shame when they perceived having control of their own lives and treatment (Corrigan 
& Wassell, 2008). The perceived focus on pharmaceutical treatments, lack of treatment options, 
and lack of resources/services and necessary information/education about their diagnosis and 
mental health status impacted their sense of self-efficacy and health outcome, which was also  
noted in other studies (Keeton et al., 2008; McCarthy & McMahon, 2008. For example, Amy’s 
unsuccessful attempts at accessing care and community resources, at various times in her 
experience, and the lack of information about her diagnosis of bipolar disorder and the 
implications of psychotropic treatment and the risk of relapse impacted her self-efficacy and 
ongoing mental health problems (Corrigan & Wassell, 2008). She felt powerless, trapped and 
isolated, sentiments also expressed by Elyse.  
According to Brown (2006), power consists of awareness, access to choice and the ability 
to affect change. Some participants demonstrated a sense of being in control of and being 
proactively engaged in managing their own mental health problems by choosing to forgo and/or 
discontinue psychotropic medication in favour of alternative and more holistic approaches (yoga, 
diet, stress management, becoming self informed, and choosing to developed adaptive 
cognitive/behaviours strategies to manage mood lability), which facilitated positive health 
outcomes. This was despite the lack of treatment engagement and options. This demonstrated a 
sense of self-efficacy and shame resilience that related to feelings of empowerment, the freedom 
to choose and explore options, and the importance information, education and knowledge to 
enhance women’s sense of being in control and empowered (Brown, 2006).  
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Level of self disclosure. All of the women in this study used selective disclosure as a 
means of being in control of and/or avoid self stigma/shame. For some participants, as seen in 
other research, selective disclosure was helpful in certain situations and with certain people as it 
provided a sense of control, perceived support, and buffered their sense of self; further, selective 
disclosure decreased their self stigma as it helped to normalize their experience facilitating their 
sense of self-efficacy (Bos et al., 2009; Corrigan & Wassell, 2008; Edwards & Timmons, 2005; 
Vauth et al., 2007).  However, for some women selectively disclosing greatly impeded their 
access to appropriate mental health care, their level of treatment engagement, and their social 
interactions, which further impeded their sense of self-efficacy and health outcome.   
The fear of disclosure due to self stigma/shame and the underlying fear of being labeled 
and judged was a significant factor in women’s experience of maternal mental illness and 
seeking help, as in other studies (Corrigan & Wassell, 2008; Dennis & Chung-Lee, 2006; 
Edwards & Timmons, 2005; Einarson, 2009a; Goffman, 1963; Marcus, 2009; McCarthy & 
McMahon, 2008). This was evident in the present study as each participant would gauge, or 
selectively disclose how or to whom, when and how much, they would share personal 
information (about their mental illness and/or infertility issues), in order to moderate or escape 
the effects of self stigma/shame. Some of the participants spoke of an element of secrecy and 
social taboo associated with maternal mental illness, and revealed feelings of shame, blame and 
guilt when admitting to withholding information and/or minimizing the severity of their mental 
and emotional distress (Corrigan & Wassell, 2008). Some acknowledged their efforts to hide 
their mental illness - “passing” as normal or putting on another “persona” - to avoid being 
stigmatized, judged, and/or discriminated against and to be seen as incompetent (Corrigan et al., 
2009). Some avoided situations/people to maintain secrecy, and others would selectively disclose 
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when they perceived stigmatization from family, friends, and others. Similar to the research, 
some of the women’s fear of disclosure was intensified by uunsolicited comments and jokes, 
which fostered feelings of isolation and withdrawal from social interactions, which further 
impacted their emotional status, treatment engagement and health outcome (Slade et al., 2007). 
Findings revealed the participants who seemed to experience more shame/self stigma were more 
likely to fear disclosure and discovery which diminished their sense of empowerment and sense 
of self-efficacy. 
Coping strategies. According to Gourounti et al. (2013), coping refers to “a person’s 
cognitive and behavioral efforts to master, reduce, or tolerate the internal and/or external 
demands that are created by the stressful transaction, which serves the function of regulating 
stressful emotions and managing the problem that is causing the distress” (p. 354). The 
effectiveness of women’s coping strategies emerged as another aspect that influenced women’s 
level of self-efficacy and sense of being in control, which could be conceptualized on a shame 
resilience continuum.  
Several coping strategies that the participants used to moderate and/or regulate their 
experience of mental illness and self stigma/shame could be interpreted as representing a range 
of shame resilience. These behaviours were intricately linked to their sense of self-efficacy and 
included maladaptive behaviors such as self harm, denial, withdrawal, avoidance, resistance, 
disengagement, overwork, limited self-care, and why-try responses. Some of these behaviours 
are noted in the stigma research (Corrigan et al., 2009) and reflect a low sense of self-
efficacy/shame resilience and a high level of self stigma/shame. These maladaptive behaviours 
related to Amy and Elyse’s health outcome, ongoing mental health problems and their feelings of 
being powerless, trapped and isolated. As in this study, researchers have found that maladaptive 
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coping strategies are linked to the risk/exacerbation of maternal mental illness (Gourounti et al., 
2013) and maintenance of high levels of perceived stigma and a decreased sense of 
empowerment (Vauth et al., 2007).  
The participants’ more adaptive coping strategies that reflected a low or lack of self 
stigma and higher sense of self-efficacy included ambivalence, positive attitude, shared 
experience, conscious choice and proactive engagement (healthy lifestyle, learning new 
cognitive/behavioural skills, and seeking and gaining knowledge and understanding), also 
identified in Brown (2006). These behaviours related to feelings of empowerment, of being in 
control, of being free from self stigma/shame, and of being supported/connected (Pinto-Foltz & 
Logsdon, 2008; Restall & Strutt, 2008; Wardrop & Popadiuk, 2013) which played a significant 
role in women’s (Skye, Tina, Sue and Gabby) treatment engagement, satisfaction and positive 
health outcomes.  
Ambivalence as a protective factor. An interesting finding revealed that ambivalence 
seemed to play a role in the participants’ experience of self stigma and was a protective factor in 
their experience of maternal mental illness: “Ambivalence is the existing of two or more opposite 
or conflicting feelings, values or meanings” (Leichtentritt et al., 2005, p. 21). Several authors 
have also noted a shared experience of maternal ambivalence in women’s experience of maternal 
mental illness (Arendell, 2000; Leichtentritt et al., 2005; McKillop, 2009). According to Weigert 
(1991), ambivalence is often experienced or perceived as an undesirable state, seen as a sign of 
weakness or indecision. However, similar to this study’s findings, some researchers have 
suggested that a sense of ambivalence can be perceived as having the confidence to recognize 
both sides of an issue, having the awareness of alternatives and the possibility of positive 
outcomes which functions as a calming influence (Leichtentritt et al., 2005; Weigert, 1991). This 
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study, like others, found that for women with high-risk pregnancies (e.g., Skye, Tina, Gabby, 
Sue), ambivalence had a positive effect “as it is a dialectical concept that can have a calming 
influence on the women, because the possibility of positive outcomes exists” (Leichtentritt et al., 
2005, p. 21).  
The shared experience and shared meaning of ambivalence in participants’ experience of 
maternal mental illness revolved around issues, such as the myth of motherhood versus the 
reality, treatment engagement and treatment satisfaction, biomedical versus bio-psycho-social 
approaches, and the level of support. As in recent studies (McKillop, 2009; Wardrop & 
Popadiuk, 2013), participants spoke of the disconnection between the myth of joyful motherhood 
(always being happy vs. feelings of anger and frustration), intensive/perfect mothering and the 
realities of the challenges of parenting. Some of the women identified and internalized these 
social norms and scripts, to a greater or lesser degree, which became a gauge by which they 
judged themselves, greatly impacting their experience of mental illness, shame, and health 
outcome (Brown, 2006). While other women were more ambivalent about the realities of being a 
mother, needing help, and having a maternal mental illness which seemed to be linked to a sense 
of self-efficacy/shame resilience and low self stigma/shame.  
Some participants were ambivalent about their treatment experience of using 
psychotropic medication versus the lack of treatment options and/or information and education. 
Further, the only participant who attended a support group for postpartum depression described 
her experience as being both positive and negative. Wardrop and Popadiuk (2013) noted women 
with maternal mental illness also benefitted from have support from other mothers, which helped 
normalize their experience. On the one hand, she felt supported when the group helped her 
realize that other women had similar experiences, but on the other hand, she felt some of the 
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women were judgmental. For some participants (Skye, Tina, Gabby) needing medication or 
being on medication did not have a significant impact on their sense of self nor their treatment 
engagement, but rather they had a sense of ambivalence about medication. On one hand, the 
medication provided relief from distressing symptoms and allowed them to cope with their 
mental illness; while on the other hand, they worried about the cost, the safety of the medication 
and/or being tied to the health care system. 
The participants were able to make sense of their experience of stigmatization when 
accessing mental health care in a manner that suggested it contributed, either positively or 
negatively, to their experience. For a few women (Skye, Tina, Gabby), a sense of ambivalence 
seemed to be connected to a lack of shame/self stigma and an enhanced sense of self-efficacy. 
Interestingly, these participants also had a history of anxiety which was successfully treated with 
medication and/or a family history of mental illness. This familiarity may have also played a role 
in facilitating a sense of ambivalence that seemed to reflect lower self stigma and shame, the 
level of treatment engagement and self-efficacy. Other researchers (Corrigan & Watson, 2007; 
Tognazzini et al., 2008) have also identified knowledge and experience through contact and 
familiarity with people with mental illness reduced stigma; however, the research is largely on 
the training and education of health care providers. The findings of this study revealed that for 
some participants their familiarity and contact with mental illness seemed to facilitate a sense of 
ambivalence which was connected to less self stigma/shame and a more positive sense of self-
efficacy/shame resilience.  
Perceived level of support and connection. In this study, the level of perceived support 
and sense of connection influenced women’s experience and outcome of maternal mental illness 
as other researchers have identified (Gold, 2002; Kalra & Einarson, 2006). For the majority of 
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the women, the perceived level of support and a sense of connection (Bos et al., 2009; Restall & 
Strutt, 2008; Wardrop & Popadiuk, 2013) with their spouse, family, close friends, other mothers, 
and especially in terms of their relationship with their family physician, were identified as factors 
in seeking help, accessing care, level of self-efficacy and feelings of being in control and 
empowered, and treatment experience and health outcome. Evident in the findings, some women 
found connection, shared experiences and mutual support through selectively disclosing their 
feelings and concerns with others which helped normalize their own experience, also noted by 
other studies (Bos et al., 2009; Restall & Strutt, 2008; Wardrop & Popadiuk, 2013). However, 
for Amy, the lack of perceived support and sense of connection was clearly a barrier in her 
experience of maternal mental illness; not having family support due to proximity and their 
religious beliefs, a lack of community and social support, and a lack of connection with friends 
and co-workers were significant contributors to her ongoing mental health problems. 
The perceived level of support and sense of connection in participants’ interactions with 
health care professionals and accessing mental health care were related to the importance of their 
relationship with their family physician and the level of empathy, personal experiences of 
stigmatization, amount and/or quality of information, education, feedback, resources and services 
about the bio-psycho-social implications of maternal mental illness, the process of 
assessment/diagnosis and the lack of treatment options and support within a biomedical model. 
These had an impact on women’s experiences of shame, their sense of self-efficacy and their 
feeling of empowerment and was a factor in women’s experience of mental illness and their 
treatment engagement and satisfaction, and health outcome. 
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Implications for Practice  
Several implications for clinical and counselling practice emerged from this study, which 
are important to consider when providing care to women with maternal mental illness. In order to 
fully support women with mental health problems and their families, health care providers must 
go beyond a biomedical lens to identify, address, and consider not only biological risk 
factors/implications, but also psycho-socio-cultural factors/implications, such as lack of support, 
the method of conception, and self stigma. Health care providers need to be aware and develop a 
deeper understanding of the role stigma plays in women’s experience of mental illness and 
treatment experience (Bos et al., 2009; Corrigan & Wassell, 2008; Restall & Strutt, 2008), but 
more specifically how stigma becomes a shame experience (Brown, 2006). It is important to 
include women, spouses and families in the assessment, management and education of maternal 
mental illness and to provide them with information, education, resources, access and support, in 
addition to treatment options (Marcus , 2009; McCarthy & McMahon, 2008). Health care 
providers need more training and educational opportunities to enhance their knowledge, comfort 
level, understanding, awareness, and sensitivity to the bio-psycho-social needs of childbearing 
women’ and their families (Corrigan & Wassell, 2008; Scultze, 2007, Thornicroft et al., 2007; 
Tognazzini et al., 2008). There is a need for the therapeutic approach to go beyond the 
biomedical tradition to promote more transparency, sensitivity and self-reflexivity on the part of 
health care providers and mental health care programs to minimize the impact of stigmatization 
on women’s experience of accessing care, treatment satisfaction and health outcome (Brown, 
2006; Schulze, 2007; Thornicroft et al., 2007). Further, an empowerment approach to providing 
care, which identifies the client as the expert, can guide mental health care and support 
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provisions which emphasizes health, abilities, personal control, and effective change and 
resources (Restall & Strutt, 2008).  
 According to Brown’s SRT (2006),  
The goals for practitioners working with women on shame issues should be to help 
clients identify personal vulnerabilities, increase critical awareness of their shame web, 
develop mutually empathic relationships that allow then to reach out to others, and learn 
to speak shame. Given the focus on raising critical awareness and education, psycho-
educational group work or a combination of individual work and psycho-educational 
group work should be considered (p. 51).  
Moreover, implications for practice should focus on decreasing women’s experience of 
stigmatization and shame and increase their sense of being in control and empowered by 
facilitating their resilience and sense of self-efficacy. In order to do this, shame needs to be 
addressed directly in therapeutic practice and by incorporating a psycho-educational stance to 
inform women and their families of the bio-psycho-social factors and implications of maternal 
mental illness and to empower them with information, education, increased awareness and 
choice (Brown, 2006; Restall & Strutt, 2008). Health care providers can foster shame resilience 
through their support and empathic connection and by addressing women’s feelings of shame, 
powerless, trapped and isolated. Women should be empowered and encouraged to develop 
adaptive coping strategies (sense of ambivalence, for example) and to increase their level of 
support and connection through shared experiences and accessing community resources (Brown, 
2006; Restall & Strutt, 2008; Wardrop & Popadiuk, 2013). By facilitating women’s awareness, 
access to choice, freedom to explore options and the ability of affect change in regards to their 
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own mental health, health care providers can enhance women’s sense of empowerment and 
positive health outcomes (Brown, 2006; Restall & Strutt, 2008; Wardrop & Popadiuk, 2013).   
Study’s Limitations and Strengths 
Key limitations of the study include a lack of diversity among participants; the one-time 
collection of data; and the long period of time that lapsed between data collection and its 
analysis. The women in this study were all Canadian-born, white, middle-class women; and five 
of the six women were in their 30s. The applicability of these findings to other groups of women 
is unknown.  This was also a group of women who chose to volunteer and there may be 
characteristics and motivations that distinguished them from those who chose not to volunteer. 
The use of only one interview limited opportunities for further reflections, which might have 
increased the richness of understanding and allowed an opportunity to delve more deeply into 
particular findings. Last, the analysis and write-up of findings took place over approximately 
four years.  
The value of this study was that, although limited in sample size, it provided a unique 
exploration of the bio-psycho-social dimensions of women’s experience of maternal mental 
illness, the role of stigma, seeking helping, and accessing mental health care and exploring the 
interconnections and relationships between them, from the perspective of women who 
experienced maternal mental health illness and sought care. Researchers have argued that 
qualitative interpretive inquiry is validated, not by numbers of participants, but by the 
completeness of the examination of the topic and the depth to which the interpretation extends 
our understanding (Kearney, 2001; Sandelowski, 1994; Thorne, 2008; Wardrop & Popadiuk, 
2013). The available research on maternal mental illness, the impact of stigma, and accessing 
mental health care is predominately quantitative emphasizing a biomedical approach focusing on 
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psycho-pharmaceutical interventions. This study goes beyond this by providing a detailed 
description and analysis of six women’s lived experience, bringing to light the interconnections 
between psycho-social factors/implications, socio-cultural context and personal experiences of 
stigmatization. Further, the interviews provided the six women with an opportunity to share their 
perceptions of accessing mental health care services, and to offer recommendations and advice 
for improving women’s care satisfaction and health outcomes.   
The findings add to the current literature in the following ways: a new conceptualization 
of self stigma of maternal mental illness and shame resilience using Brown’s SRT; identifying 
ambivalence and familiarity as potential protective psycho-social factors that enhance shame 
resilience; and highlighting a shared experience of infertility and the process of IVF as a 
significant psycho-social-cultural factor in women’s experience of maternal mental illness and 
shame. 
The relevance of the study findings from a clinical perspective is that it underscores the 
importance of identifying, addressing, and being sensitive to women’s experience of 
stigmatization and feelings of shame when providing care and effective treatment options and 
support to enhance positive health outcomes, especially based on an empowerment and relational 
approach (Brown, 2006; Restall & Strutt, 2008). Hopefully the findings provide health care 
providers and other women with a deeper understanding of the importance of considering the 
psycho-socio-cultural context, within which pregnancy and motherhood takes place.  
As suggested by McCormick and Bunting (2002), a feminist lens brought several 
elements to the study that I consider a strength. The study sought to validate and value women’s 
subjective experiences, perceptions, ideas, and needs in regards to their experience of maternal 
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mental illness, stigma and their experience accessing care. The benefit of using a feminist lens in 
this qualitative health inquiry was to validate and facilitate the exploration of women’s 
experience of maternal mental illness and stigma, as gendered issue embedded within and 
influenced by the socio-cultural discourses of reproduction, motherhood and mothering, 
traditionally informed by scientific and biomedical discourses (Koniak-Griffin et al., 2006). 
Feminist researchers have illuminated the importance of using a feminist social constructionist 
approach when exploring and seeking to better understand women’s experiences of maternal 
mental illness embedded and influenced by the socio-cultural discourses of motherhood and 
mothering (Arendell, 2000; Choi et al., 2005; Cosgrove, 2000; Mauthner, 1998). “This paradigm 
affords a means for looking at, and taking seriously, interactions, interpretive processes, social 
context, and importantly, relationships” (Arendell, 2000, p. 1202).  
According to Sandelowski and Barroso (2003), descriptions “always depend on the 
perceptions, inclinations, sensitivities and sensibilities of the describer” (p. 913). A feminist 
approach allowed the emphasis to be on women’s subjectivity, the context of their experiences 
and the meaning made from those experiences constructed through historical and cultural 
influences and social practices, processes, and institutions, as well as through interactions and 
encounters with their family members, others and most importantly, health care professionals.  It 
was through a feminist lens that the bio-psycho-social dimensions and interconnections between 
stigma and shame and self-efficacy and shame resilience emerged and re-conceptualized using 
Brown’s SRT (2006). A feminist stance confirmed the need for reflexivity on all levels, that is to 
say, the importance for researchers/clinicians and health care providers to engage in ongoing 
self-questioning of assumptions and biases and the impact these have on women’s experience of 
mental illness and shame (McCormick & Bunting, 2002). The emphasis should be on 
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understanding, identifying, addressing, and being sensitive to the impact of self stigma and 
shame that may play a role in women’s experience of mental illness, willingness to seek help, 
accessing mental health care services, treatment engagement, and health outcome (Brown, 2006). 
The feminist framework revealed and validated the importance of relationships in 
women’s experiences and interactions with family members, others and their health care 
providers (Arendell, 2000; Cosgrove, 2000). But most importantly, the findings revealed the 
importance of enhancing and facilitating women’s strengths, self-efficacy and feelings of 
connection, empathy, and empowerment which reflects other research (Brown, 2006; Corrigan et 
al., 2009; Restall & Strutt, 2008; Wardrop & Popadiuk, 2013). 
Future Research 
 Findings of the study highlighted several areas of interest and the need for more 
qualitative research investigating the women’s experience of maternal mental illness and stigma. 
There is need for further research on women’s experience of infertility and the process of IVF as 
risk factors for developing maternal mental illness and an aspect of women’s experience of self 
stigma and shame, and the implications of biomedical and medicalized processes of reproduction 
on women’s sense of self and mental health. Study findings were based on a homogenous group 
of women, hence the importance of exploring the experiences of mental illness and self stigma 
among women of other ethnic groups, socio-economic classes, and other age groups which could 
bring greater understanding of these experiences and intersections with culture. 
The study findings suggested the importance of ambivalence as a potential protective 
factor in women’s experience of maternal mental illness and shame/self stigma. Further, 
ambivalence seemed to be linked to shame resilience which warrants further exploration. Using 
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Brown’s SRT (2006) to conceptualize self stigma as shame, and self-efficacy as shame resilience 
and empowerment, support the use of a bio-psycho-social model as a therapeutic approach to 
provide mental health care for childbearing women and their families. This would be an 
interesting area of research which could go beyond the underlying biomedical approach of 
mental health care services typically provided to women with maternal mental health problems.  
Participants shared experiences of maternal mental illness, stigma and accessing mental 
health care services revealed the biomedical context within which assessment, treatment, 
support, crisis intervention, and follow-up are experienced. Current findings suggest that the 
adoption of a bio-psycho-social approach could be more focused and fully integrated into all 
aspects of service provision, including the therapeutic relationship. This is especially relevant in 
terms of addressing and decreasing experiences of stigmatization and shame when dealing with 
maternal mental illness. The bio-psycho-social perspective (such as Brown’s SRT) can provide a 
framework for providing mental health care services and enhancing the process of clinical 
assessment, screening, diagnosis, treatment options and education, including psycho-social risk 
factors, and identifying the impact of socio-cultural context and stigmatization to address 
women’s experience of maternal mental illness. 
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